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A growing body of literature suggests that the intake of specific nutrients impact mental health, and 
recent findings support a causative relationship between dietary patterns and affective disorders, whilst 
also providing evidence of a robust relationship between affective disorders and chronic stress. There is 
however a paucity of evidence regarding the relationship between chronic stress and nutrition. 
This thesis reports on research aimed to provide insight into the relationship between chronic 
stress and the intake of specific dietary nutrients among women. A systematic review examined the 
current evidence regarding nutrient intake and stress levels. A cross-sectional survey followed, in which 
a sample of women provided information regarding their perceived stress levels and nutrient intake via 
diet and dietary supplements. A participatory action research project concluded the study, wherein the 
lived experience of stress and the role of diet and/or dietary supplementation to manage stress was 
investigated. 
The systematic review revealed that there was insufficient evidence to support the intake of 
specific dietary nutrients either via diet or supplementation to manage stress level. After adjustment, 
data from the cross-sectional survey revealed a further lack of evidence to support a robust relationship 
between stress and specific nutrients consumed via the diet or supplementation. The lived experience of 
stress and the use of specific nutrients to manage stress among a group of women in the PAR project 
was influenced by relationships and confusion and scepticism regarding the usefulness of nutrients to 
impact mental wellbeing, while early life stress and thinking patterns were further factors influencing the 
experience of stress. 
Evidence regarding the neurobiological efficacy of nutrient intervention is required to support 
decision-making by clinicians and policy makers in light of the well-established role that chronic stress 
plays in the development of affective disorders among women globally. This study provides a first step 
towards the development of a knowledge base regarding the role that specific nutrients play in the 
stress response among women, although further research is warranted due to the far reaching 
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In modern society chronic psychological stress is a frequently experienced mental state that may 
contribute to the development of affective disorders such as anxiety and depression and associated 
depletion of a variety of nutrients critical for central nervous system (CNS) function. This in turn imposes 
increased metabolic demands on the brain.1-3 Women may be particularly susceptible to chronic stress 
due to a variety of factors, and the use of dietary supplements (DSs) is commonly used to mitigate 
symptoms.4-6 However, there is a paucity of evidence to support the intake of specific nutrients via diet 
or the use of DSs to manage chronic stress, although the global expenditure on stress-targeted DSs 
suggests the use of such products is prolific.7-9  
The objective of this study was therefore to investigate the relationship between perceived 
stress and specific nutrients consumed in the daily diet and/or as DSs in a group of women. The first 
step in answering this research question was to establish the scope, quality and direction of evidence 
related to this relationship through a critical synthesis of research literature based on the Joanna Briggs 
Institute systematic review methodology. This systematic review (Chapter 2) investigated the impact of 
essential fatty acid (EFA), B vitamins, vitamin C, magnesium and zinc supplementation on stress levels 
in women.10 As this review revealed a lack of evidence for the use of specific nutrients to manage 
perceived stress among women, a cross sectional study was performed which examined stress levels in 
relation to specific nutrient intake, consumed in the daily diet and/or via DSs (Chapter 3). The lived 
experience of stress among women, and the use of diet and/or DSs to manage stress, are similarly 
unexamined areas of research, so participatory action research (PAR) was used to investigate these 
concepts (Chapter 4).  
This chapter contextualises the thesis by introducing the stress response, describing possible 
psychosocial, physiological and neurobiological mechanisms related to its proliferation including early 
life stress (ELS) and mechanisms whereby chronic stress may lead to nutrient deficiencies and stress 
management strategies including the use of DSs. Evidence-based medicine (EBM), including why this 
thesis is positioned within the JBI model of evidence-based healthcare (EBHC), is addressed. 
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1.2 Frequency and severity of stress and gender 
The definition of stress, as originally coined by Hans Selye in 1936, has evolved past the understanding 
of being a natural physiological response to a life-threatening event.11, 12 This theory was extensively 
revised in the 1970’s and the definition used today has incorporated the recognition of, and challenges 
related to adapting to new stimuli.13 Stress is understood informally as a specific psychological state of 
mind wherein individuals find their lives unpredictable and uncontrollable, leading to a sense of overload 
or overwhelm in relation to responsibilities, accompanied by a perception that they do not have the 
resources to cope with the situations they encounter.14-16  
The extent to which this phenomena is experienced in the general population has been 
investigated and a number of studies have found that chronic psychological stress negatively impacts 
the lives of a significant number of women globally, with women consistently reporting higher levels of 
stress versus men.17-25 For example, a 2014 national survey (n=1,602) found that Australian women 
reported significantly higher levels of stress (16.73) compared to men (14.97) as measured by the 
Perceived Stress Scale (PSS).14, 17 Similarly, a survey conducted over 2014-2015 on Australian 
dwellings (n=14,700) revealed a higher percentage of women (13.5%) experienced high levels of 
psychological distress compared to men (9.9%).26 Similar gender disparities and trends have been 
observed in surveys conducted in North America,20, 21, 27 Canada,22 the United Kingdom,23-25 and 
Spain.28 This evidence has suggested that globally women experience higher levels of stress and react 
more negatively to life events when compared to men. The stress response provides a physiological 
and neurobiological context for understanding the significant impact that chronic levels of stress can 
have on the health and mental wellbeing of women. 
1.3 The stress response 
The stress response includes the activation of the sympathetic nervous system (SNS), initiation of 
activity within the hypothalamus, pituitary and adrenal (HPA) axis and sympathetic-adrenal-medullary 
(SAM) systems, and de-activation of the parasympathetic nervous system (PNS), which is followed by a 
return to homeostasis when the threat passes.12, 13, 29 The HPA axis is the primary stress control and 
regulatory system, connecting the CNS and the hormonal system.30 This stress-responsive 
neuroendocrine system functions so as to allow adjustment to both physical and psychosocial changes 
perceived as being stressful in their environment.30 This system works well unless stress becomes 
chronic, which impacts brain regions responsible for regulating emotion, such as the limbic system.31-33  
The limbic system is a group of neurally interconnected structures allocated to linking ‘visceral 
states and emotion to cognition and behaviour’ (p. 172).33 The amygdala forms part of this system and 
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is responsible for detecting danger and fear and preparing for the emergency response.34, 35 In addition, 
the hippocampus is accessed to ascertain whether there is a memory for this perceived threat, which 
influences response options.36 Fear and stress perception via these brain regions activate the release of 
corticotrophin releasing hormone (CRH) from the hypothalamus, adrenal corticotrophic hormone 
(ACTH) from the anterior pituitary, stimulating the release of adrenocorticotrophin (ACT) into the 
bloodstream and cortisol, a glucocorticoid (GC), from the adrenal cortex.37 These rising cortisol levels 
inhibit the release of CRH and ACTH to stop further HPA activation in a negative feedback loop.37, 38 
The sympathetic-adrenal-medullary (SAM) system also plays a role in the stress response, by releasing 
catecholamines from the adrenal medulla, such as adrenalin (epinephrine), noradrenaline 
(norepinephrine (NE)) and dopamine.31 When the SAM system is activated, these stress hormones 
interact with the autonomic nervous system (ANS) to regulate effects on the cardiovascular, pulmonary, 
hepatic, skeletal muscle and immune systems in the presence of stress.31 A review of findings that 
examined the stress response, concluded that ongoing HPA activation and cortisol synthesis leads to 
the body becoming less responsive to its effects over time, whilst continued exposure to chronic stress 
results in HPA axis sensitisation to novel stressors.30,39 The continued activation of the HPA and 
developed sensitisation may combine to prevent a return to homeostasis, which may in turn impact the 
limbic systems ability to regulate emotion. Figure 1.1 summarises the stress response. 
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Figure 1.1: The stress response and the hypothalamus, pituitary and adrenal (HPA) axis feedback loops. Positive and 
negative feedback loops initiate and stop the stress response, respectively. The dysregulation of this system, 
during chronic stress when the negative feedback loop is unable to activate the parasympathetic nervous system 
(PNS), leads to a number of negative consequences. 
The physiological and behavioural consequences of being psychologically stressed are similar 
to those following a fight for physical survival, with the aim of quickly returning to homeostasis.1, 29, 40 
However, psychologically stressful situations or psychosocial stressors are more prevalent in western 
society, last for longer, and involve higher brain processing.1, 30, 40 Such stressors also require 
interpretation, in terms of meaning and context for the individual, and elicit processing activity in the 
hippocampus and the pre-frontal cortex (PFC), which engage memory, pattern-seeking and anticipatory 
thinking and behaviour.30, 36, 41, 42 These stress-induced cognitive processes may lead to anticipatory, 
environment-specific habitual stress responses via maladaptive neuroplasticity, although, as it is 
ethically questionable to induce chronic stress in humans, there is insufficient human data to support 
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these findings. For example, Aschbacher et al. reported on a case-control study (n=48) that examined 
the effects of chronic stress exposure by matching post-menopausal women caring for spouses with 
dementia (a chronic stress model) and women with healthy spouses.43 The Trier Social Stress test 
(TSST) was used to evoke stress responses, salivary cortisol and oxidative stress assays were 
administered and validated measurement instruments assessed perceived stress. The caregivers 
reported significantly greater levels of perceived stress and anticipatory cortisol reactivity (p<0.01) 
suggesting that the anticipation of a stressor may lead to anticipatory cortisol reactivity in a CNS that is 
poised for a heightened stress response.43 Thus, chronic stress may predispose women to an 
‘anticipatory’ state of stress making a return to homeostasis via PNS activation problematic. 
Return to HPA homeostasis may also be inhibited through other cognitive strategies. Strauss 
et al. reported that women ruminate more than men.44 Rumination being defined as the engagement of 
‘negative and unwanted past-centred thoughts,’ by Gianferante et al. who reported that women exposed 
to the TSST engaged in more rumination than men, which was predictive of heightened cortisol 
responses to repeated stressors and was associated with a ‘reduced ability to adapt to repeated stress 
that may interfere with healthy post-stress emotional and cognitive processing of the situation’ (p. 
245).44, 45 These results have suggested that high levels of stress hormones may impact the brains 
ability to respond to stress adaptively via accurate emotion perception, processing and regulation, and 
may have a bi-directional relationship with rumination, possibly leading to an inability to return to 
homeostasis. Although the stress response provides insight into how chronic stress may lead to HPA 
dysregulation, it is necessary to examine the impact of chronic stress on women, as they have higher 
reported rates of affective disorders compared to men, and chronic stress plays a role in the 
development of these disorders. 
1.4 Impact of Chronic Stress 
Although the experience of stress is not a mental health disorder, when experienced chronically it may 
lead to the development of stress-associated affective disorders, such as depression and anxiety.46-51 A 
secondary analysis of the American’s Changing Lives (ACL) dataset (n=2,824) revealed that women 
were approximately three times more likely to experience depression in response to a stressful life event 
compared to men.52 Similarly, a prospective female twin-study (n=1,898) found that stressful life-events 
over a one-year period had a marked causal relationship with depression onset.53 In addition, a recent 
Swedish study (n=587) which examined the prevalence of perceived stress in patients from a working-
age population who visited primary care physicians (PCPs), demonstrated that women reported higher 
stress levels compared to men, and that such stress was accompanied by symptoms indicative of 
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anxiety (64% of patients) and depression (33% of the patients).54 Rojo-Moreno et al. reported similar 
results (n=100) from a study that examined depressed patients in relation to healthy controls and found 
that the risk of developing depression was 9.7 times greater in subjects who had experienced severe, 
stress-inducing events.55 These findings support the view that chronic stress is related to the 
development of affective disorders in women. 
Additionally, high rates of comorbid anxiety and depressive disorders have been reported in 
some studies, including population level studies.56-58 Lamers, et al. reported that 75% of those with 
depression met criteria for an anxiety disorder and 79% of those with an anxiety disorder met criteria for 
depression.58 These findings are consistent with those from Kessler et al. who reported that 45.7% of 
those who experienced depression in their lifetime also had one or more lifetime anxiety disorder 
events.59 Surveys among community dwelling adults (n=72,933) investigating affective disorders in 15 
countries in the World Health Organization Mental Health Survey Initiative (WHOMHSI), revealed that 
across all cohorts and countries women experienced higher rates of these disorders.60, 61 These results 
have suggested that depression and anxiety are often experienced together and that stress may be the 
underlying causative mechanism linking them. 
Affective disorders have also been associated with reported antecedent psychosocial factors 
such as symptomatic distress, diminished social support and more past-year distressing life events as 
revealed in a community sample of mid-life women (n=915).62 These women also reported more 
childhood abuse or neglect, (classified as an ELS), compared to women with a history of either affective 
disorder alone.62 Therefore, women may be at higher risk of developing stress-related affective 
disorders, which may partly explain the increased prevalence of such among women. However, there 
are further consequences to experiencing chronic stress. 
An additional consequence of chronic stress includes Allostatic load. Defined as the ‘wear and 
tear imposed upon the body’ by physiological processes, Allostatic load has been previously associated 
with chronic stress exposure (p. 30).40 The link between chronic stress and physiological disease states 
is well established and the explanation for such includes an increased vulnerability to inflammatory 
processes due to decreased tissue sensitivity to cortisol, an inflammatory-response regulator.63 In 
support of Selye’s early findings, a large meta-analysis of 293 studies examined 30 years of study 
(n=18,941), which concluded that there is an important link between chronic stress and inflammatory 
response dysregulation.11, 12, 64 However, this physiological inflammatory response also impacts 
neurobiological functioning. 
Heightened inflammatory responses have been linked to depression in both clinic- and 
community based samples as evidenced by three systematic reviews, which found inflammatory 
markers were positively associated with such.65-67 In addition, Köhler-Forsberg et al. reported that 
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among 36 RCT’s, that included approximately 10,000 patients, five out of six anti-inflammatory drugs 
improved depression scores compared to placebo.68 Heightened inflammatory activity may signal 
neuronal activity changes in brain regions responsible for mood regulation, such as the limbic system.69, 
70 Therefore, high rates of comorbid depression and anxiety among women suggests that anxiety and 
inflammation may also be related. 
Inflammation has also been associated with anxiety as revealed in a study that examined post-
traumatic stress disorder (PTSD), in 12 women with childhood abuse related PTSD and 24 healthy 
controls.71 Results revealed that PTSD sufferers demonstrated higher concentrations of inflammatory 
activity in blood samples versus controls.71 Similarly, inflammatory markers in the blood of 48 individuals 
diagnosed with PTSD or panic disorder (PD) was compared to 48 healthy controls.72 Eighty-seven 
percent of those with either anxiety disorder had six or more inflammatory markers compared to 25% of 
the controls (p<0.0025). In addition, the impact of chronic stress on inflammation may partly explain the 
mechanisms linking stress, anxiety and depression, as suggested in a review that examined 
mechanisms underlying these three phenomena, one of which includes poor dietary choices.73 Figure 
1.2 summarizes the relationship between the factors predisposing women to chronic stress and possible 
negative outcomes, including depression, anxiety and inflammatory responses. 
Results from a year-long study in which subjects (n=516) were randomly assigned to three 
intervention dietary groups, one of which comprised a Mediterranean diet, suggests that diet and 
inflammation are related, as lowered inflammatory markers on the Mediterranean diet were noted.74 It is 
suggested that multiple factors, including nutrient intake, may link chronic stress, inflammation, 
depression and anxiety.75 For women, managing chronic stress via diet may contribute to preventing the 
onset of affective disorders and accompanying inflammation. However, it is presently unknown whether 
it is possible to ameliorate the effects of chronic stress via the consumption of specific nutrients. 
1.5 Factors related to the proliferation of chronic female stress: 
A number of different mechanisms may contribute to women’s increased experience of stress globally in 
comparison to men, including psychosocial, neurobiological and hormonal mechanisms and ELS. 
Figure 1.2 lists these mechanisms. 
 Psychosocial factors 1.5.1
Psychosocial factors, such as ongoing time constraints imposed by increasingly complex and competing 
societal roles coupled with unchanging traditional roles and culture-specific stressors may contribute to 
the discrepancy between men and women in relation to reported levels of stress.61, 76-81 In relation to 
health generally, Leineweber et al. reported on a Swedish study (n=6,580), which found that women 
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who experienced work-family conflict were at greater risk for self-reporting diminished health.82 
Diminished health may thus be related to stress, as results from another Swedish study (n=60) revealed 
that women’s levels of stress remain high after work, as evidenced by cortisol levels remaining high, 
compared to men’s levels which decreased.79 This result is possibly due to traditional domestic and 
childcare responsibilities following daily paid work outside the home for women, which has been called 
their ‘second shift’ (p. 4).83 Indeed, household labour studies a decade apart reveal that women still 
perform more housework and childcare activities compared to men.84-86 It is estimated that women on 
average do 1.6 times the amount of housework as men and married mothers average 1.9 times the 
housework of married fathers.85  
Other comparable data further highlights gender differences. Regarding paid work, household 
duties and childcare, a Swedish population survey (n=1,180) found that the presence of children 
impacted the workload for women, but not men.81 The total workloads of men and women with no 
children were approximately 60 hours per week, whereas in families with three or more children, 
women’s workload increased to almost 90 hours per week compared to men’s 70 hour per week.81 This 
amounts to a mean gender difference of 2.5 hours per day.81 Therefore, married, working mothers may 
be more vulnerable to experiencing chronic stress compared to married, working women without 
children. In support of this hypothesis, Luecken et al. reported that working mothers had higher cortisol 
levels than childless women and women with at least one child at home excreted significantly more 
cortisol over a 24-hour period (p<0.01).87 In addition, levels of strain at home were also significantly 
higher among mothers with live-in children (p<.001).87 Similarly, the risk of developing affective 
disorders was higher among working mothers, as revealed by a Netherlands study (n=3,857).88  
However, non-traditional family structures may also impact mother’s psychological health. For 
example, in a German cross-sectional study that analysed questionnaires about psychological problems 
from similar groups of mothers, Franz et al.89 reported that single mothers (n=531), when compared to a 
control group of married mothers (n=278), experienced higher rates of psychological distress. Similarly, 
Canadian single mothers (n=236) reported experiencing higher rates of psychological distress 
compared to partnered mothers (n=438), while a survey in the same country over 1996-97 found 
depressive symptoms were higher among single (n=3,030) versus married mothers (n=10,195).90, 91 In 
support of this data, two American surveys reported that the prevalence of anxiety disorders was higher 
in single compared to married mothers (n=1,534 and n=2,956).92, 93 In further support of these results, 
mood disorders were significantly more prevalent among single mothers (p<0.01) in a Singaporean 
survey.94 A systematic review of 11 studies from six countries, which used secondary data from 
household surveys in which sample sizes ranged from 375 – 53,292 participants, also revealed that 
single mothers experienced lower levels of health compared to partnered mothers.95 Single mothers 
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may therefore be more vulnerable to chronic stress, stress-related affective disorders and diminished 
health than married mothers. 
Moreover, because of the ‘unequal status of women in most societies across the world,’ 
cultural stressors such as sex-specific socialisation and victimization, subordinate social rank and 
violence may also contribute to increased stress vulnerability among women (p. 40).96 Therefore, 
female-specific psychosocial factors such as competing work and family roles, ongoing and unequal 
distribution of domestic tasks, single motherhood and women’s social position may all contribute in 
varying ways to women experiencing more stress than men. 
 Neurobiological factors 1.5.2
A number of neurobiological factors may contribute to women experiencing increased levels of stress 
compared to men. A growing body of evidence supported by advances in the development of imaging 
technologies reveals gender differences in relation to brain function, neurochemistry and hormonal 
influences.97-101 A review that examined neurological sex differences using magnetic resonance imaging 
(MRI), functional magnetic resonance imaging (fMRI), positron emission tomography (PET), and single 
photon emission computed tomography (SPECT), found important differences that distinguish male and 
female brains.97, 98 These differences may combine and underlie specific mechanisms that contribute to 
increased levels of stress among women in the presence of psychosocial stressors. 
A review of neurological sex differences concluded that a lower cortisol response to 
psychological stress in women compared to men may be a reflection of HPA hyporeactivity, wherein 
there is a reduced reaction to the stressor.30 Viewed in this light, the consistently higher rates of female 
stress reported globally may be as a result of less-adaptive HPA activity in the presence of stress. This 
suggestion is supported by an in vivo study using fMRI to investigate cognitive down-regulation of 
stressful, negative sensations in both genders (n= 20men and n=23 women), which found that women 
reported higher subjective stress ratings versus men and higher limbic system activity was observed in 
women compared to men.102 These results are indicative of the women in the study engaging in 
emotional responses via the limbic system more strongly than men when exposed to stress.102 Wang et 
al. also reported heightened limbic system activation in response to mild to moderate stress in women 
(n=16) compared to men (n=16) in a similar fMRI study.103 Therefore, ongoing limbic system activation, 
present during chronic stress, coupled with dysregulated cortisol release via HPA hyporeactivity, may 
contribute to women’s heightened response to stress versus men. Specific mechanisms within the 
limbic system may contribute to this female-specific response. 
The limbic system contains high levels of the neurotransmitter serotonin, which is involved in a 
number of critical processes within the brain, including the regulation of mood by facilitating flexible 
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responses and adaptations to environmental challenges, with ‘distinct responses mediated by distinct 
serotonergic pathways’ (p. 1092).104, 105 Serotonergic pathways, or systems, are groups of neurons that 
collectively respond to this neurotransmitter and are found in the hippocampus, amygdala and pre-
frontal cortex.51 These systems all have roles to play in stress responsivity, with serotonin playing an 
important role in regulating GC feedback to maintain homeostasis within the HPA axis.46 Furthermore, 
animal and human studies demonstrate that high levels of GCs are linked to decreased serotonin-
mediated responses, leading to a hypofunctional serotonin state.106-108 Anomalies in serotonin status 
and functioning, either in the presence of stress or not, may thus lead to both an increased susceptibility 
to stress and an inability to return to homeostasis after stress exposure.107, 109, 110 Although specific 
nutrients are required for serotonin synthesis, it is unknown at present whether increasing the 
consumption of such may improve stress-responsivity. 
 Hormonal factors 1.5.3
Sex hormones impact neurotransmitters and steroid receptors, and large fluctuations in levels of sex 
hormones, such as progesterone and estrogen, which occur throughout women’s reproductive life span, 
may impact receptors for these hormones which are highly expressed in the limbic system, making it 
sensitive to these fluctuations.111, 112 In addition, such fluctuations may increase the potential for 
neurochemical system dysfunction in some women due to hormonal effects on serotonin, glutamate and 
gamma amino butyric acid (GABA) as suggested by animal and small human studies and reviews.46, 112 
For example, Altemus et al. reported that during the luteal phase of the menstrual cycle HPA 
responsiveness increased in relation to stress in a small study (n=9).113 Another small study, using 
proton magnetic resonance spectroscopy (H-MRS), compared brain GABA levels in healthy women 
(n=14) with those experiencing pre-menstrual dysphoric disorder (PMDD) (n = 9), and found decreased 
GABA levels in the PMDD group during the follicular menstrual phase and an increase from this phase 
to mid- and late luteal phases, while in the healthy group it declined across the cycle.114 These results 
suggested that hormone fluctuations may influence HPA responsiveness and that the GABAergic 
system may be modulated by hormone fluctuations in both healthy women and those with PMDD. 
Therefore, a subgroup of women experiencing normal physiological hormone changes may be 
vulnerable to neurotransmitter fluctuation anomalies, which being expressed in the limbic system, may 
account for mood dysregulation and possibly also influence stress coping mechanisms.51, 115  
A number of studies suggest a relationship between hormone fluctuations and stress. For 
example, De Weerth et al. reported that during pregnancy, cortisol and HPA axis stress responses were 
supressed, as identified using salivary cortisol data.116 The study compared healthy pregnant women 
(n=120) exposed to psychological stressors using the TSST to a control group of healthy women (n=31) 
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who were not pregnant.116 In addition, lactation also produces a change in hormonal state, and using 
similar stressors, Heinrichs et al. reported that the stress response, identified using blood and salvia 
sampling, was suppressed in lactating women (n=43) who were randomly assigned to either breast-feed 
or hold their infants for 15 minutes before stress exposure.117 Furthermore, two small PET studies 
revealed that estrogen and progesterone levels impacted serotonin receptor density in the cortex in 
postmenopausal women (n=5) and similar results were found in similar women (n=10) following 
estrogen replacement therapy.118, 119 Although small, these studies suggested that recurring hormone 
fluxes across the lifespan may impact brain function and mood modulation via hormone-
neurotransmitter interaction and may, in as yet unexamined ways, contribute to an increased 
vulnerability to experiencing chronic stress.30, 46, 51, 98, 109 
 Early Life Stress (ELS) 1.5.4
Although not specific to females, the neurological effects of ELS may also be a risk factor for increased 
sensitivity to stress later in life.120-126 A review of recent longitudinal human studies revealed that 
exposure to ELS, comprised of one or a variety of negative events, which may include events in utero, 
childhood abuse, parental loss or prolonged separation and/or severe poverty or neglect, are 
psychosocial risk factors for the development of mental health disorders in later life.122 Neurobiological 
changes during specific stages of brain development may partly explain this phenomenon, as some 
researchers suggest, with increased amygdala volume resulting from ELS leading to limbic system 
changes and heightened stress sensitivity.122, 123 When exposed to the TSST, in the early 2000s, 
subjects that were separated from both caregivers as children during World War 2 (WW2) evacuations  
(n=68) all had higher average salivary cortisol and plasma ACTH concentrations versus the non-
separated group (n=85).127 Women also responded with higher baselines of both compounds compared 
to men.127 Increased pituitary-adrenal reactivity, possibly related to altered HPA axis responsiveness 
initiated during childhood, 60 years earlier, may partly explain these results.127  
However, ELS may include stressful events prior to birth, as stated by Babenko et al.: ‘Being 
exposed to stress in utero and in early life may increase the risk of neurological and psychiatric 
disorders via altered epigenetic regulation’ because ‘epigenetic mechanisms are prone to changes in 
response to stressful experiences and environments perceived as hostile,’ (p. 70).128 Researchers 
suggest that ELS induces changes in the functional development of the amygdala and striatum, which 
impact the ability of animal and human offspring to evaluate and respond appropriately to a variety of 
stimuli.129, 130 The amygdala reaches an earlier peak volume in women compared to men, so women 
may be more vulnerable to heightened stress responses in adulthood as a result of the effects of ELS 
on amygdala development.122 These factors may partly explain how ELS contributes to stress sensitivity 
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in adulthood and why women may be more vulnerable to ELS, as their subordinate social rank and sex-
specific socialisation and victimization may expose them to ELS more frequently than men.96  
Figure 1.2 summarises the predisposing factors discussed thus far, some of which may 
interact and heighten women’s susceptibility to experiencing chronic stress.51, 97, 109, 131 A combination of 
these factors may also partly explain the 50% greater prevalence of affective disorders in women versus 
men.47-51  
 
Figure 1.2: Predisposing factors that may contribute to chronic stress and possible negative outcomes. Predisposing factors 
(or moderators) can combine and lead to negative outcomes, such as depression and anxiety, which are often 
co-morbid, and have a bi-directional relationship with increased inflammatory responses. HPA hyporeactivity, 
limbic system sensitivity, serotonin anomalies and recurring sex hormone fluctuations may combine, possibly 
compounding their effects in the presence of psychosocial stress. ELS may also be a predisposing factor to a 
heightened stress response in the presence of psychosocial stress, and inflammatory responses may contribute 
to limbic system sensitivity. 
1.6 Metabolic or Physiological processes whereby chronic stress 
may lead to nutrient deficiencies 
The previous sections have identified a variety of predisposing factors that may impact the experience 
of and ability to manage chronic stress (Figure 1.2.). In addition, a variety of pathways to chronic stress 
have also been discussed, which include ongoing psychosocial stress, anticipatory cortisol reactivity 
leading to ongoing HPA and SNS activation and post stress rumination (Figure 1.3). However, nutrient 
deficiencies may be an additional pathway to chronic stress via ongoing stress hormone synthesis. For 
example, high nutritional needs are imposed due to increased metabolic activity required to generate 
energy aimed at survival strategies, including mobilizing energy from storage and diverting energy away 
from non-essential processes.1, 2, 30 In addition, gastro intestinal (GI) challenges, sleep deprivation and 
appetite changes may also contribute to nutrient status. Possible mechanisms underpinning how 
nutrient deficiencies manifest are now addressed. Figure 1.3 summarizes possible pathways to chronic 
stress including these mechanisms. 
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Figure 1.3: Pathways that may contribute to chronic stress. Pathways to chronic stress may combine in a number of ways 
that could lead to an inability to return to homeostasis. For example, ongoing psychosocial stress, anticipatory 
cortisol reactivity, ongoing HPA and SNS activation and post stress rumination may contribute to nutrient 
deficiencies via either one of the five, or any combination of the five mechanisms listed. Nutrient deficiencies may 
contribute to an inability to return to homeostasis because specific neurotransmitters, possibly lacking, are 
required for such to occur. 
Amygdala activation via sensory perception, and hippocampal input, triggers the flight-or-flight 
response, prompting a biochemical cascade of activity that includes the synthesis of stress hormones 
(Figure 1.1).1, 30, 36 In addition, the synthesis of neurotransmitters, including serotonin, which facilitates 
emotional equilibrium, requires many of the same nutrients as those required for stress hormone 
synthesis.132, 133 Being a survival mechanism, the synthesis of stress hormones may take precedence 
over the synthesis of neurotransmitters that regulate mood because, as Ames stated: ‘natural selection 
favours short-term survival at the expense of long-term health’ (p. 17589).2 Chronic stress may therefore 
negatively impact the synthesis and equilibrium between excitatory and inhibitory neurotransmitters and 
contribute to the development of affective disorders. In support of this hypothesis, Bitterlich et al. 
reported chronically stressed subjects stress states improved after supplementing with an amino acid-
containing DS.134 Therefore, the disequilibrium between neurotransmitters may be partly explained by a 
lack of nutrients with which to sustain neurobiological equilibrium in the presence of chronic stress, 
which may also prevent a return to HPA homeostasis.2 Indeed, chronic stress, which triggers the 
survival response, may increase the already high metabolic needs of the brain. 
The brain competes with the body for energy resources due to the critical role it plays in 
survival.135 For example, Tomasi et al. assessed brain energy requirements in a human study of glucose 
metabolism using PET and MRI in healthy volunteers at rest (n=54) and found that basal metabolism, in 
the absence of connectivity, accounted for 30% of brain glucose utilization.136 This led the researchers 
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to suggest that spontaneous brain activity accounted for 70% of the brains energy consumption and that 
higher energy demands of brain activity, which hinge on higher connectivity, may lead to vulnerability in 
specific areas that are vulnerable to energy deficits.136 Reporting on such higher cognitive functions, 
Lennie reported that over 40% of whole-brain energy utilization accounts for such functions, as 
evidenced by electrophysiological recordings of neuronal neo-cortex activity which analysed energy 
demands and resources.137 Therefore, spontaneous brain activity, which includes higher cognitive 
functioning and increased brain processing and increased connectivity between brain regions, may, in 
the presence of chronic stress, demand higher energy and nutrient usage. 
As the brain and gut have an ongoing, bi-directional exchange which impacts digestion and 
absorption, the availability of nutrients may impact capacity for increased brain activity. For example, 
chronic stress has been previously related to digestive challenges via inflammatory mechanisms.138 
Bennett et al. have also reported that chronic life stress threat was a predictor of irritable bowel 
syndrome (IBS) symptom severity and no patient exposed to a high stressor improved clinically, while 
all the patients who improved did so in the absence of such.139 Similarly, a prospective study which 
assessed perceived stress, depressive symptoms and stressful life events over 45 months in patients 
with ulcerative colitis found that acute stress did not trigger symptoms but long term perceived stress 
increased the risk of symptom exacerbation.140 Yin et al. reported that stress inhibited normal gastric 
myoelectrical activity (GMA) in healthy human subjects (n=10).141 Finally, GI motility was altered in the 
presence of chronic stress, as evidenced by a review that summarized the literature on this topic from 
animal and human studies.142 Therefore, in the presence of chronic stress, optimal digestion and 
nutrient absorption may be hampered, which will consequently impact the availability of nutrients for 
brain function. 
Behavioural factors associated with stress may also negatively impact nutrient availability, one 
such being sleep deprivation, which is associated with chronic stress in women. Hall et al. reported on a 
nine-year prospective, four-site, cohort study (n=330), which examined stress-inducing life events and 
sleep.143 Furthermore, Vgontzas et al. reported a stimulatory effect on the HPA axis with sleep 
disturbance in a small group of men (n=10).144 However, apart from being related to chronic stress and 
stimulating the HPA axis, sleep deprivation has other effects, including appetite changes, weight gain, 
and comfort, or emotional eating, defined as eating with the aim of relieving negative emotions or affect, 
such as anxiety or depression.145-148 These sleep-deprivation induced physiological and behavioural 
changes occur via adaptations in energy and appetite regulation, which are influenced via activation of 
the SNS and HPA axis.145, 146, 149 These adaptive changes have a number of consequences that may 
lead to nutrient deficiencies. 
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A systematic review of 17 studies (n=496) revealed that partial sleep deprivation led to 
increased energy intake, while a 14-day laboratory sleep study linked sleep deprivation to an increased 
intake of calories from snacks versus meals.150, 151 Similarly, but specific to women (n=27,983), Kim et 
al. found that shorter sleep duration was associated with a greater propensity for high-fat and sweet 
snacks versus meals.152 In terms of weight gain, a small controlled intervention with women (n=14) 
revealed that sleep deprivation led to an increase in energy intake of 20% and a body weight increase of 
0.4 kg over eight days.149 Supportive of these results, data from the Nurses Health Study (n=80,000) 
revealed that the lowest body mass index (BMI) was observed in participants sleeping seven to eight 
hours per night.153 The interaction between emotional eating and short sleep duration was investigated 
in a one-year follow-up mixed gender study (n=911 men and n=553 women).146 Results revealed that 
emotional eating and weight gain were significantly higher among women compared to men 
(p=0.005).146 In addition to supporting the evidence that women have higher levels of stress than men, 
these studies suggest a relationship exists between chronic stress, sleep deprivation, appetite shifts and 
emotional eating. 
In an attempt to understand the cognitive processes underlying appetite shifts, a mixed gender 
study assessed brain mechanisms responsible for the increased desire of calorie-dense foods in states 
of sleep-deprivation. Greer et al. reported on data gathered via fMRI for twenty three participants (n=10 
men and n=13 women) which suggested that sleep deprivation results in reduced activity in cortical 
regions responsible for food stimulus evaluation, thus increasing the appetite shift towards, and 
desirability of, high-calorie foods.154 However, ongoing sleep deprivation, unlike induced sleep 
restriction, may have a greater impact on food choices and appetite, and consequently nutrient 
deficiencies, over time, via the establishment of new neural pathways supporting habitual nutrient-
deficient food choices. In addition, the intake of calorie-dense, nutrient-deficient foods, in the presence 
of chronic stress, may provide emotional comfort via the release of opioids that temporarily lower the 
stress response via dampened HPA activity.155 Indeed, in support of this explanation, apart from being 
influenced by sleep deprivation, research suggests appetite is influenced directly by chronic stress. 
A cross-sectional, longitudinal analysis of self-reported data from a population-level survey of 
Australian women (n=1,382), found an association between stress and frequent fast food 
consumption.156 Similar trends and gender disparities have been observed in American surveys 
conducted between 2007 and 2015.20, 27 Similarly, Kandiah et al. reported that in the presence of stress, 
81% of female college students experienced a change in appetite and 62% experienced an increase in 
appetite, coupled with an increase in the consumption of sweet food and fast food.157 Furthermore, Epel 
et al. found that pre-menopausal women exposed to the TSST who had high cortisol levels consumed 
more calories and sweet foods than low cortisol reactors and increases in negative mood were also 
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associated with greater food consumption.158 Another laboratory stress study found similar results about 
which the researcher commented: ‘stress may compromise the health of susceptible individuals through 
deleterious stress-related changes in food choices’ (p. 853).159 Therefore, regardless of how stress is 
induced, either via a laboratory stressor or via other pathways (see Figure 1.3), consequent appetite 
changes lead to women favouring high calorie, low nutrient foods. 
Appetite changes may also be related to serotonin, a neurotransmitter that plays a role in 
regulating appetite.160 In addition, serotonin is also the precursor to melatonin, which is necessary for 
deep, restorative sleep.161 Both these compounds are reliant on a number of nutrients for synthesis.132, 
133, 161, 162 Therefore, a lack of nutrients may hamper serotonin’s appetite-regulating function and 
melatonin’s sleep inducing function, both of which may lead to the over-consumption of calorie dense, 
quick energy release, nutrient deficient foods.145, 146, 149 A complex relationship may therefore exist 
between serotonin, sleep deprivation, and nutrient deficiencies. 
 Thus far, evidence suggests that appetite changes in the presence of chronic stress and sleep 
deprivation may over time lead to poor dietary choices, and possibly nutrient deficiencies, further 
contributing to the inflammatory responses associated with stress, depression and anxiety.74, 75 (See 
Figures 1.2 and 1.3.) These factors may combine with the previously described pathways to chronic 
stress, thus preventing a return to homeostasis and the amelioration of chronic stress. Whether specific 
nutrients consumed via food and/or DSs can improve the experience of chronic stress for women is 
presently unknown although a growing body of research suggests that specific nutrients are important 
for mental wellbeing and their absence is linked to stress-associated disorders.163-172  
1.7 The neurobiological role of specific nutrients in relation to 
chronic stress 
The absence of specific nutrients have been associated with the presence of affective disorders, 
however, despite the relationship between stress and affective disorders, there is a dearth of evidence 
to support the importance of specific nutrients in relation to stress.163-167 Due to the roles nutrients play 
in neurobiological functioning, a number of nutrients may indeed impact the stress response.162, 172 For 
example, many vitamins function as cofactors of key enzymes in a variety of pathways including amino 
acid metabolism and neurotransmitter synthesis.132 Some minerals also have important roles to play in 
maintaining normal brain function including neurotransmitter synthesis, and are involved as co-factors in 
energy metabolism and in the synthesis of stress hormones.132, 133, 172 Inadequate dietary intake of 
nutrients may therefore impact the brains ability to manage chronic stress effectively due to the 
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association with higher metabolic activity and the increased demands imposed by chronic stress. Table 
1.1 summarizes the neurobiological role of specific nutrients. 
The brains metabolic requirements suggests that it may be ‘sensitive to fluctuations in the 
nutrient state of the rest of the body’ (p. 271).173 Brozek et al. reported that thiamine (B1) and riboflavin 
(B2)-induced deficiency over 161 days resulted in psychological symptoms, such as depression, in a 
group of healthy men (n=10), who used self-rated questionnaires to report sensory and motor functions 
along with intelligence and personality and in whom irritability and depression appeared after anorexia 
and muscle weakness.174 Similarly, Sterner et al. investigated B2-induced deficiency in a group of 
healthy male conscientious-objectors (n=6) over 56 days, which resulted in depression and hysteria 
among other physical and behaviour-specific effects.175 Other mental wellbeing and B vitamin 
interventions have revealed similar results. 
Aybak et al. reported that 300mg of pyridoxine (B6) supplemented daily over four weeks was 
effective as an anti-stress strategy leading to significant decreases in systolic (p<0.01) and diastolic (p 
<0.005) blood pressure measurements for hypertensive patients along with reductions in noradrenaline 
(18%) and adrenalin (16%).176 McCarty hypothesized that this effect was likely due to a reduction in 
SNS activity along with serotonin modulation in the presence of this nutrient, which may dampen 
corticosteroid response and therefore be a useful clinical approach in the presence of psychological 
stress.177 Indeed, as vitamin B6 is also a co-factor in serotonin synthesis, a deficiency may negatively 
impact stress levels. 
In addition, folate (B9) deficiency may predispose or exacerbate depression in humans.178 
Furthermore, early studies of copabalamin (B12), found that a wide range of psychiatric symptoms, 
including anxiety, depression, confusion, psychosis and mania were reversed with B12 
supplementation.179 A more recent randomized double-blind, placebo-controlled (RCT) study which 
examined the effect of a-90 day, high dose, vitamin B-complex administration on work stress in sixty 
participants (n=19 men and n=41 women) reported significantly lower personal strain (p=0.02) from 
week 4 to week 12 and a reduction in depression.180 Thus, evidence has suggested that either a 
deficiency, or supplementing with B vitamins, impact mood states, although whether these nutrients can 
ameliorate chronic stress levels is as yet unknown. (See Table 1.1 for a summary of B vitamin roles in 
the brain.) 
In addition to the B vitamins, vitamin C also has a significant role to play in healthy brain 
function, with the concentration of such (ascorbic acid (AA)) being higher in the brain than in any other 
organ (besides the adrenal glands).181 This suggests that vitamin C also has a role to play in the stress 
response. Furthermore, vitamin C plays a number of other roles in the brain (see Table 1.1), some of 
which are of particular importance due to the high oxidative metabolic rate of neurons (10-fold over 
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supporting glia (animal studies)).182, 183 Brody et al. examined stress, cortisol and AA levels in relation to 
the administration of the TSST using a high dose sustained-release vitamin C supplement (1000 mg) on 
a mixed gender group of young adults (n=60) over 14 days.184 A statistically significant reduction in 
anxiety in the supplement compared to the placebo group was noted at 14 days (p=0.0096) along with 
the same reduction in stress between the supplement group at baseline compared to 14 days 
(p≤0.0004).184 The researchers suggested that supplementing with this nutrient rather than using dietary 
sources yielded anxiety and stress-lowering effects.184 Reporting on a similar RCT, de Oliveira et al. 
found that the effects of 14 days of vitamin C supplementation (500mg) on anxiety scores in a mixed 
gender group of students (n=42) yielded significantly lower scores and plasma vitamin C status after the 
intervention period versus the placebo group (p = 0.010; p=0.001) and the heart rate of the supplement 
group was also significantly reduced compared to the placebo group (p=0.032).185 These results have 
suggested that supplementing with either forms of this nutrient may be effective at reducing 
psychological stress. However, minerals also play a role in mental health. (See Table 1.1.) 
In addition to the vitamins addressed, magnesium and zinc also impact affect states. A review 
examining the role of magnesium in affective disorders suggests this nutrient influences several 
systems related to such disorders which include a reduction in HPA axis activity.186 In support of this 
review, Jacka et al. reported on a Norwegian survey (n=5,708) that found higher magnesium intake via 
food was associated with significantly lowered depression (ß=-0.11, 95%CI=-0.16 to -0.05) and lowered 
anxiety scores.187  
Amani et al. reported on a controlled study that examined depression in relation to serum zinc 
levels in young women with moderate-to-severe depression (n=23) and healthy matched controls 
(n=23).188 Significantly lower zinc intake and serum zinc concentrations were noted in the depressed 
group (p<0.01).188 Similarly, an American survey revealed that women (n=2,163) with a low food-derived 
zinc intake were more likely to have depressive symptoms, whereas the same association was not 
found in relation to men (n=1,545).189 This result suggested a gender-specific relationship between zinc 
and depression. In addition, some research suggests that zinc has a non-uniform distribution in the 
brain with high concentrations in specific areas, such as the cerebral cortex, which is associated with 
emotion and learning.190 Zinc deficiency may therefore negatively impact the ability to cope with stress, 
as stress assessment and emotion regulation occur in these areas. However, there is no evidence to 
suggest that either magnesium or zinc supplementation alone, or combined, reduces anxiety or chronic 
stress. 
Unlike B vitamins, vitamin C, magnesium and zinc, EFAs are not directly involved in the 
synthesis of neurotransmitters or the stress regulation process, although they are critically important 
nutrients required for optimal neurological functioning, (see Table 1.1) which suggests they may have a 
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role to play in ameliorating the stress response.191, 192 Research has suggested that this may be the 
case in both genders. For example, Kiecolt Glaser et al. reported on a 12-week, RCT trial that examined 
omega 3 supplementation (2.5g/day) versus placebo in medical students, via blood samples that 
measured inflammatory markers, during low stress and high stress (exam days).193 Validated 
measurement instruments assessed anxiety and food intake and a significant supplementation effect on 
anxiety was reported (p=0.04).193 A similar RCT assessed responsiveness to mental stress (mental 
arithmetic) before and after eight weeks of omega 3 supplementation compared to placebo, and found a 
significant reduction in heart rate (HR) (p=0.002) in the supplement group versus the placebo group 
(p=0.756).194 The dietary intake of the omega 3, docosahexaenoic acid (DHA), has also been 
associated with lower anxiety scores.195 In addition, a lowering of test anxiety in men was found in a 
small three-week study using EFAs.196 Conversely, Bradbury et al. reported on a RCT (n=90) that found 
no effect on chronic psychological stress using another omega 3, eicosapentaenoic acid (EPA).197 
Combined, these results suggest a gender response to anxiety, detected via physiological markers or 
psychological measurement instruments that are ameliorated in the presence of omega 3, in contrast to 
using the same for chronic stress. 
Table 1.1: A summary of the neurobiological roles of specific vitamins, minerals and EFAs 
Nutrient Function  
Vitamin B1 
(Thiamin) 
Enzyme cofactor for acetylcholine synthesis;132, 133 facilitates nerve conduction functioning; 
facilitates glucose metabolism.133  
Vitamin B2 
(Riboflavin) 
Facilitates glucose metabolism.133  
Vitamin B3 
(Nicotinamide) 
Enzyme cofactor for serotonin synthesis;132, 133 facilitates glucose metabolism.133  
Vitamin B5 
(Pantothenic acid) 
Facilitates glucose metabolism.133  
Vitamin B6 
(Pyridoxine) 
Enzyme cofactor for noradrenaline, dopamine, serotonin, GABA, adrenaline synthesis;132, 133 
modulates binding of neurotransmitters at postsynaptic receptors;198 protects cerebral blood flow.199  
Vitamin B9 
(Folic acid) 
Enzyme cofactor for Noradrenaline, dopamine, adrenaline synthesis;132, 133 maintains myelin sheath 
integrity; protects cerebral blood flow.199 
Vitamin B12 
(copabalamin) 
Enzyme cofactor for noradrenaline, dopamine, adrenaline synthesis;133 maintains myelin sheath 
integrity; protects cerebral blood flow.199 
Vitamin C 
(Ascorbic acid) 
Enzyme cofactor for Noradrenaline, adrenaline, dopamine synthesis; antioxidant.133, 181, 182  
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Nutrient Function  
Magnesium Cofactor for over 325 enzymes; inhibits excitatory neurotransmitter release; facilitates glucose 
metabolism;133 increases brain-derived neurotrophic factor (BDNF) expression;200 enzyme cofactor 
for Glutamate, Serotonin synthesis.39, 133, 201  
Zinc Cofactor for over 300 enzymes; inhibits excitatory neurotransmitter release; cellular metabolism; 
increases brain-derived neurotrophic factor (BDNF) expression;200 enzyme cofactor for glutamate 
and serotonin synthesis.2, 133, 188, 202, 203  
EFAs Involved in all neurotransmitter synthesis and release; improves oxygen and nutrient assimilation 
facilitating energy production and neuronal functioning; improves membrane and synaptic flexibility 
and permeability; optimal cognitive functioning relies on EFAs to compose 20% of brain dry weight; 
eicosanoid precursors.191, 192  
 
Overall, there is a paucity of evidence to support the role that B-vitamins, vitamin C, 
magnesium, zinc and EFAs play in CNS functioning specifically related to chronic stress among women. 
However, deficiencies in certain B vitamins can lead to poor mental health, while others suggest 
supplementing with them can ameliorate stress.174-176, 178-180 Vitamin C supplementation has been 
associated with a reduction in physiological and psychological determinants of stress and magnesium 
has been associated with lowered depression and anxiety scores.184-187 Zinc meanwhile has been 
associated with lowered depression scores and omega 3s with lowered anxiety scores.188, 189, 193-195 
Although few studies have examined the role of these nutrients in relation to chronic stress among 
women, the myriad of roles they play in both general metabolic and CNS functioning, and because 
chronic stress may pre-date the development of affective disorders, these nutrients may play a role in 
ameliorating chronic stress. Increased neural metabolic activity, gastrointestinal challenges, and 
changes in sleep and appetite as induced by chronic stress, coupled with an insufficient supply of these 
nutrients, may lead to an inability to concurrently synthesize stress hormones and neurotransmitters 
required for the maintenance of emotional equilibrium. Furthermore, the presence of these health 
challenges may lead to women using DSs in the belief that they can ameliorate the experience of 
chronic stress. 
1.8 Stress management strategies including the use of DSs 
As discussed, appetite is influenced by feelings of stress, but research has also suggested that eating 
may be used as a stress-management strategy among women. For example, an Australian survey 
(n=1,537) found that significantly more women than men reported ‘turning to food’ to manage stress (p. 
8).204 Although alcohol was also reported as being a support mechanism, gender differences are 
unclear.17, 204 Similar support strategies were reported in a 2010 American survey (n=530 men and 
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n=604 women).27 Appetite changes due to stress may therefore not be entirely due to changes in 
energy and appetite regulation systems but may also be due to women using food to manage stress. 
However, it is not known whether this strategy is used along with others, for example, visiting PCPs. 
Although not gender segregated, a twenty-year survey which concluded in the 1980’s, 
undertaken by an American managed-health care company, found that an estimated 60%-90% of visits 
to PCPs are related to stress.205 In addition, more recent data (1997 to 2004) from the American 
National Health Interview Survey (NHIS), the samples of which represent 25,618,369 adults, found that 
healthcare expenditures and outpatient visits increased significantly as psychological distress 
increased.206 Furthermore, more women than men tend to visit hospitals and PCPs in the US and the 
UK.207, 208 Australian data supports this trend with a survey over 2017-18 that revealed women (14%) 
were twice as likely to be admitted to a hospital versus men (6%).209 A Canadian survey also reported 
that chronic health conditions were 40% higher for women than for men as reported over a ten-year 
period (1994-2003; n=3,522).210 This data suggests that, similar to stress levels, more women 
experience chronic ill health globally than men, which may be related to these high stress levels. 
A Danish survey found women accounted for 69% of stress-related cases reported by a 
general practitioner (GP).211 A 2018 Australian online survey of women (n=15,262) found that close to 
half of the respondents (46.1%) had been diagnosed with anxiety or depression by a doctor or 
psychologist.212 Furthermore, this sample size increased by 49% from 2017 (n=10,377), suggestive of 
increased awareness among women regarding health and mental wellbeing.212 These results suggested 
increased stress may drive more women to visit PCPs and be diagnosed with anxiety and/or 
depression. Given the relationship between stress and affective disorders and the increased prevalence 
of such among women, differences in health-seeking behaviour between genders may be expected. A 
population level UK survey (n=15,222) investigated such behaviour among men and women with 
common mental–health problems with women more likely to report that they would (and did) seek 
help.213  
Help seeking behaviour may result in the use of psychotropic medications, such as anxiolytics, 
which are prescribed by PCPs to reduce symptoms of anxiety, which accompany feelings of stress.214 
An early study by Baker et al. reported on the use of anxiolytic/sedative medication over a 12 month 
period from the USA and 10 Western European countries wherein past year prevalence rates were 
much higher for women than for men in every country surveyed, with a ratio close to 2:1 in favour of 
female anxiolytic use.215 In support of these findings, Ashton et al. revealed that throughout the USA 
and Europe, women were prescribed approximately twice as many psychotropic drugs as men.214 In 
addition, Agarwal et al. reported on a recent large USA cross-sectional study (n=386,457) which 
examined data over 2003 – 2015 regarding benzodiazepam outpatient prescribing, and found that the 
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use of such anxiolytics had increased over this time period and that women were more frequently 
prescribed compared to men.216 Data regarding antidepressant (AD) use also suggested higher use 
among women versus men. For example, Pratt et al. (n=13,951), reported that over 2011-2014, women 
were twice as likely to use such medication versus men.217 Similarly, Mars et al. reported on a 
retrospective UK study over 1995-2011 that found that AD prescribing was about two times higher for 
women.218 Similarly, Australian women were more likely to use a mental-health related treatment 
(18.2%) than men (11.7%) and that women (9.9%) were more likely than men (5.6%) to have an AD 
prescription filled.219 In addition, the self-reported prevalence of taking either ADs or anxiolytics among 
Australian women (n=48,359) increased from 9.1% in 2001 to 10.3% between 2004-2005.220 These 
results have suggested that women use more psychotropic medications than men globally, although 
whether this is the preferred method of managing affective mood states is unknown. 
Research investigating stress management counselling in primary care, versus non-
pharmacological interventions, is sparse. For example, O’Donnell et al. reported on a Canadian survey 
(n=2,916) that investigated mood and anxiety disorders and revealed that 47.6% of patients took 
medication, 6.9% received counselling and 27.3% were taking medication and had received 
counselling.221 No significant differences were found between treatment type and gender.221 In addition, 
Nerurkar et al. reported on an American survey that only 3% of office visits included stress management 
counselling from PCPs despite 34,065 visits to 1,263 physicians being related to stress, although this 
survey did not separate data by gender.222 These results have suggested that either patients prefer 
medication or that few PCPs offer alternate stress-management strategies. Furthermore, research is 
also sparse regarding people who do not choose medical help for mental ill health challenges and may 
instead turn to what they believe are effective, alternative sources of support, such as DSs and 
complimentary alternative medicine (CAM), which includes DSs and dietary changes. 
Three American surveys, totalling over 107,000 participants, reporting on data over 2007-
2011, found that women used more DSs than men, with the difference ranging from between 10% to 
16% more.223-225 In addition, two recent Australian studies (n=14,000) reported a similar trend.226, 227 
Vatanparast et al. reported similar findings from a Canadian survey (n=35,107), with higher reported DS 
use among women (47%) compared to men (34%).228 Overall, these findings have suggested that the 
use of DSs globally have been more prevalent among women than men. Although it is not possible to 
ascertain what percentage of such DS purchases are aimed specifically at stress-reduction among 
women, a number of studies have reported on the use of CAM and DSs for some mental health 
challenges. 
Kessler et al. reported on a population level American survey (n=2,055) about the use of CAM 
wherein 9.4% of respondents reported suffering from anxiety attacks in the last 12 months and 7.2% 
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reported suffering from depression.229 Results revealed that over half of these respondents used CAM 
and that over 60% of those who had visited a conventional provider also used CAM.229 Similarly, 
reporting on a cross-sectional study in Switzerland (n=2,937 men and n=3,249 women) Marques-Vidal 
et al. found that the prevalence of multi-vitamin and mineral (MVM) and DS use increased in subjects 
who reported a personal history of anxiety and/or depression, among other health challenges.230 
Although these studies were not gender segregated and did not report on the use of MVMs and DSs in 
relation to stress, some gender segregated studies did report on such. 
Two mixed gender studies have reported on stress and DS use. Firstly, a Japanese study 
(n=375) revealed that as daily stressors increased so did the consumption of DSs.4 An Italian study 
(n=1,723) additionally revealed that the use, or non-use, of DSs was associated with self-assessed 
stress levels, wherein 48% of users reported no stress, 63% of users reported low stress levels and 
57% of users reported high stress levels.5 In addition, specifically related to women, data from a French 
study (n=83,058) found an association between DS use in 57.7% of those who reported work-related 
stress, and 26.4% among those who reported work being very stressful, although 59% of non-users also 
reported work-related stress.6 These mixed results have suggested that increased stress does not 
necessarily accompany the increased use of DSs. However, regardless of motivations for use, DS use 
is more prevalent among women compared to men and is used by some women in the presence of 
stress, although what prompts the use of DSs requires examination. 
The Pew Internet and American Life Project examined the extent of Internet use for health-
related matters in 2000 using data from a representative population sample (n=521) wherein 26% 
reported looking for information about mental health including anxiety or depression while data from 
another Pew survey (n=12,751) revealed that 73% of users were women.231 More recent Pew Research 
findings (n=3,014) found that 72% of American adults used the Internet for health information and 
distinguished between Internet health-seekers, revealing that women are more likely (40%) to look 
online to diagnose a health condition than men (30%).232 Similar results from an Australian online poll 
(n=1,000) found that 78% of adults used the Internet for health-related information in 2015, with women 
reporting more Internet use than men on each of five criteria, including using social media (SM) for 
health related information.233 Thus, Internet health seeking is a global behaviour that more women 
engage in than men. However, how this behaviour relates to DS purchasing is presently unknown. 
Self-directed use of DSs occurs widely, as evidenced by the money spent on them.9 For 
example, Nahin et al. reported on data for 2012 from the American National Institute of Health (NHIS; 
n=44,743), which revealed total out-of-pocket expenditures for DSs was US$30.2 billion.9 Specifically 
related to DS use prevalence in the Australian market for 2018, expenditure was calculated at AU$2.77 
billion.234 However, global expenditure is expected to reach US$278.02 billion by 2024 for general DSs 
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and US$16.7 billion by 2025 for stress-targeted DSs despite a dearth of evidence to support their use as 
a health promotion or stress management strategy, respectively.8, 235 
Thus far, the evidence has suggested that more women experience chronic stress than men, 
more women investigate health matters online and more use DSs, including to manage stress. The 
methods used by women to manage stress also include emotional eating, PCP visits, the use of 
psychotropic medication and DSs may be the result of female-specific pathways to chronic stress. (See 
Figure 1.4.) Although emotional eating (and PCP visits, resulting in psychotropic use), may provide 
improvements in mental health, the evidence to support measurable improvements in chronic stress 
from DS use is sparse.10 Women’s increased use of online health resources may expose them to 
convincing DS marketing strategies that may contribute to the prolific use of such for stress 
management. Figure 1.4 provides a conceptual framework, of the interaction between factors and 
pathways that women may use to manage stress including DS use. 
 
Figure 1.4: The conceptual framework linking predisposing factors and pathways to chronic stress, possible negative 
outcomes and methods for managing stress among stress. This conceptual framework links factors that may 
contribute to, and combine in a variety of ways to lead to intractable chronic stress. Predisposing factors may 
alone lead to negative outcomes, but may combine with pathways to lead to negative outcomes, because over 
time, in the presence of chronic stress, predisposing factors may lead to habitual or entrenched behaviours and 
thus support these pathways. Bi-directional relationships may exist between HPA hyporeactivity, limbic system 
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sensitivity, serotonin anomalies and recurring sex hormone fluctuations. Depression and anxiety have a bi-
directional relationship with inflammatory responses and may contribute to limbic system sensitivity while ELS 
may lead to depression and anxiety. Pathways and possible negative outcomes may both lead to any of the 
methods for managing stress. Emotional eating may be used as a way to manage stress and be a consequence 
of chronic stress in the form of appetite changes and both may lead to nutrient deficiencies. Within pathways, 
ongoing psychosocial stress, anticipatory cortisol reactivity, ongoing HPA and SNA activation and post stress 
rumination may either alone, or in a variety of combinations, contribute to nutrient deficiencies via ongoing stress 
hormone synthesis, increased metabolic needs, gastro-intestinal challenges, sleep deprivation and appetite 
changes. 
Despite women experiencing high levels of stress;17, 20-26, 28 suffering more from stress-
associated affective disorders than men;47, 52, 60, 61 and consuming more DSs than men,223, 225, 226, 228, 236, 
237 there is a dearth of research investigating whether such interventions produce a measurable 
outcome.10 Using an evidence-based approach to investigate this phenomenon may provide clarity for 
clinicians and prevent the ongoing use of ineffectual interventions among women. With this in mind, the 
following section discusses the origin, and the strengths and weaknesses of the evidence based 
medicine (EBM) approach to clinical care. A variety of initiatives that have arisen from this approach are 
considered along with a brief discussion regarding evidence based mental health and reasons for 
positioning this thesis within the Joanna Briggs Institute (JBI) Model of Evidence Based Health Care 
(EBHC). 
1.9 The strengths and weaknesses of the EBM model and reasons 
for situating this thesis in the JBI model of EBHC 
The concept of ‘evidence-based medicine’ (EBM) was introduced in 1991 when Guyatt coined the term 
in an editorial where he suggested that this new idea was a necessary and important advance required 
for the future practice of medicine.238, 239 This approach to EBM proposed a hierarchy of knowledge in 
which randomised trials and meta-analyses were placed at the top of a linear ordering system and the 
‘pathophysiological understanding of disease processes and clinical experience occupied successively 
lower positions’ (p. 892).239 In this form EBM focused primarily on critical appraisal and the development 
of systematic reviews and clinical practice guidelines (CPGs). However, a comprehensive definition of 
EBM was not yet proposed. 
Sackett, an original member of The EBM Working Group, proposed such a definition later in 
the same decade: ‘Evidence-based medicine is the conscientious, explicit and judicious use of current 
best evidence in making decisions about the care of individual patients’ (p. 71).240 The use of the word 
‘current’ in this definition implies that the clinical approach will be modified according to increased 
empirical knowledge, so that recent research will take precedence over older evidence.241  
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This approach to clinical care included a number of important features, including combining 
‘individual clinical expertise with the best available external evidence from systematic research’ (p. 71). 
240 This perspective placed a value on the judgement and proficiency that individual clinicians acquire 
through both clinical experience and practice. More effective and efficient diagnoses, coupled with the 
recognition of, and empathetic use of individual patients’ preferences and rights, when making clinical 
decisions about their care were additional features. The use of clinically relevant research from medical 
science and patient centred clinical research that focused on the accuracy and precision of diagnostic 
tests, including clinical examinations, prognostic markers and the efficacious and safe use of preventive, 
rehabilitative and therapeutic regimens were key expectations of working to an EBM approach. The use 
of external clinical evidence, which will at times invalidate previously accepted diagnostic tests and 
treatments, leading to their replacement by new tests that are more accurate, powerful and safer, is 
another feature of this approach.240 These features combine the use of individual clinical expertise with 
the best available external evidence as neither is considered individually sufficient for the practice of 
EBM.240  
The EBM approach has also made a marked contribution to improvement in the quality of 
research via the documentation of challenges in current research, such as risks of bias, which has 
driven the development of improved research design and publication standards.242 Indeed, more than 
two decades ago, Altman suggested that most medical research was flawed for a number of reasons, 
which included ‘inappropriate designs, unrepresentative, and small, samples, incorrect methods of 
analysis and faulty interpretation’ (p. 283).243 Schulz et al. added to this criticism by highlighting the 
effects of systematic bias on research outcomes.244 These realisations led to the suggestion that 
specific principles rather than categories established by research design should serve as the foundation 
for assessing the quality of evidence because researchers realised that assessing the quality of the 
research was more important than categorising research design.244, 245 Therefore, the hierarchies of 
evidence used when EBM was in its infancy were replaced by robust classification systems with which 
to categorise evidence by quality (risk of bias) rather than design. 
The Grading of Recommendations, Assessment, Development and Evaluation (GRADE) 
methodology is an example of an EBM informed classification system that addresses important 
concepts related to the credibility of guidelines and systematic research and evidence, such as 
consistency of results across studies, strengths and limitations of studies, publication bias, applicability 
of research, study design, significance of effect and dose-response gradients, all of which provide 
guidance for clinicians in assessing evidence.242 The pursuit of EBM has also encouraged the 
development of checklists and other tools to guide the design, conduct and reporting of research, such 
as the Consolidated Standards of Reporting Trials (CONSORT) and the Preferred Reporting Items for 
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Systematic Reviews and Meta-Analyses (PRISMA) checklists, which guide researchers on the reporting 
of RCTs and Systematic Reviews and Meta-Analyses, respectively. 242, 246, 247  
Despite these contributions and initiatives, this approach has been criticised for a number of 
reasons. Holmes’ polemic against the EBHC approach focused on its reliance on a specific method of 
knowledge production, based on privileging RCT’s, and was therefore dismissive of other designs, 
leading to an exclusionary and rigid paradigm. Holmes suggested that EBHC had become ‘a regimented 
and institutionalised version of the ‘truth’ (p. 181).248 Although less extreme, others have argued that 
EBM may foster a ‘formulaic’ perspective to clinical practice, which dissuades deliberation and clinical 
reasoning, possibly leading to ‘cook book’ or robotic decision-making, (p. 1141).249-252 Further to this 
criticism, other researchers have suggested this approach may encourage a rule-based reasoning 
technique, which may discourage intuitive, experience-based, person-centred care, which is the 
essence of expert opinion and judgement.251  
Given the reliance on external evidence in EBHC, failure to publish research results, or 
suppression of negative results, is a practical problem that continues to challenge the EBM 
movement.242, 253 The exclusion of negative results is a form of systematic bias which can lead to 
clinicians making uninformed decisions because positive results are more frequently published than 
negative or equivocal results. The initiative ‘Alltrials,’ is an attempt by a group of highly motivated EBM 
researchers and practitioners to address the suppression of, and failure to publish negative results.254 
This group advocates for the registration of all past and present clinical trials and the full reporting of all 
their methods and summary results, regardless of research outcome.254 However, whether researchers 
or clinicians access this registry to guide evidence based clinical decision making is unclear.253  
Another practical challenge to the use of EBM by clinicians relates to the time available to 
practitioners to access, select, appraise, extract and inform practice with the best available evidence. 
Timely access has become a barrier to best practice. This challenge is evidenced by the results of a 
2014 cross-sectional study which analysed a sample of systematic reviews and found that 
approximately 8,000 systematic reviews were indexed in MEDLINE annually, which was a three-fold 
increase over a sample taken the previous decade when the total was 2,500.255 In an attempt to 
address this challenge, electronic platforms such as BMJ Best Practice, Dynamed Plus and JBI-
COnNECT+ were created to provide pre-processed information which clinicians can use to become 
informed about current best clinical practice in their fields of interest.256-258 However, an evaluation of 26 
existing point-of-care information sources found that they were not all equally reliable, suggesting that 
the onus remains on individuals and organisations to assess the quality of EBM information.259  
A further ongoing challenge that may limit the practice of EBM is the need for more efficient 
research production, not just improved quality.242, 253 Besides using reporting guidelines manually while 
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designing and writing up research, such as those provided by CONSORT and PRISMA, technology-
driven solutions may facilitate increased rigor and efficiency of research generation. A number of 
options are already existent, and include software programs that encourage comprehensive research 
reporting and more recently, two that check manuscripts for missing information, one of which is the 
result of an EQUATOR network initiative.260-263  
Sackett et al. once stated that over time the EBM movement would evolve and adapt, 
suggesting that the EBM model envisaged by the original team had the capacity to be responsive to 
medical advances, expanding human knowledge and understanding.240 The EBM model has increased 
in scope and complexity and is now broadly known as evidence-based health care (EBHC), having 
expanded to include other disciplines such as nursing, dentistry, health policy and public and mental 
health.242, 264 Furthermore, as evidenced by the initiatives above, this movement has also grown to 
encompass checks and balances that support its evolution and primary goal of providing the best 
evidence for clinical care. 
However, it is challenging to generate evidence in complex settings, such as those in settings 
aimed at improving mental health, and the general EBM model falls short of providing an overarching 
framework within which to generate and assess diverse forms of evidence. Therefore, the primary 
studies undertaken as part of this thesis are better positioned within the Joanna Briggs Institute (JBI) 
model for EBHC (Figure 1.5) due to this models ability to support various forms of evidence. 
Furthermore, the flexibility and sensitivity inherent in this model is also supportive of a body of work that 
calls upon research from multiple disciplines. 
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Figure 1.5: The JBI model for evidence-based healthcare (EBHC). Jordan Z, Lockwood C, Aromataris E, Munn Z. The 
updated JBI model for evidence-based healthcare. Adelaide: The Joanna Briggs Institute; 2016, p. 4 
1.10 The role of the JBI Model of EBHC in this thesis 
The JBI model of EBHC represents the complexity of EBHC and provides a clear and succinct 
conceptualisation of the major components related to EBHC, namely evidence generation, evidence 
synthesis, evidence transfer and evidence implementation.265 Each of these ‘inner’ components 
represent the higher-order, conceptual steps involved in ‘the process of achieving an evidence-based 
approach to clinical decision-making’ while each of the actionable components are represented by three 
linked outer sections, (p. 3).265 Arrows depict a natural ‘flow’ between the components along with 
smaller arrows which acknowledge that the process of moving between components is not necessarily 
always a linear process.265 This illustration of ‘iterative, bi-directional movement’ between the 
components showcases the models flexibility and adaptability, constructs especially important when 
researching complex topics. 
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The centre of the model, the ‘pebble of knowledge,’ summarises the foundation of evidence 
and how it informs practice via the FAME scale: Feasibility, Appropriateness and Meaningfulness of the 
activity or intervention and the Effectiveness of the intervention. The broad conceptualisation of FAME 
reflects the variety of research approaches undertaken by health researchers, such as the degree to 
which an activity or intervention is practical within a specific context (Feasibility), the degree to which an 
activity or intervention fits within a specific context (Appropriateness), the degree to which an 
intervention is meaningful and experienced positively by individuals or groups (Meaningfulness), and the 
degree to which an intervention achieves the intended result (Effectiveness).265 The FAME scale takes 
diverse research and clinical practice into account by supporting a variety of research approaches 
undertaken by health researchers, which are informed by the specifics of the research question.265  
Due to the complexity inherent in social interventions, evidence based on both experimental 
and non-experimental methods can be useful.266 Indeed, the FAME scale acknowledges that answering 
complex research questions may require diverse research approaches. The JBI model therefore 
provided a conceptual framework that guided the design and implementation of the projects within this 
thesis and has the ability to further guide the research results in relation to evidence transfer and 
implementation. This program of research started with a systematic review of effectiveness that clearly 
identified a knowledge gap in the field under investigation, and was followed by a cross-sectional 
research project. A qualitative project followed, which used focus groups within a methodology of 
participatory action research (PAR) to explore the lived experience of stress and the use of DSs to 
manage stress in a group of women. 
Using multiple research methodologies to investigate the overarching research questions in 
these three projects provided a broad and deep perspective to this thesis. This mixed-model approach 
is well situated within the framework of the JBI model, due to the complex nature of mental health, 
because ‘evidence that addresses the multifarious questions, concerns and interests of clinicians ... will 
need to utilize a wide range of knowledge development approaches and varied research traditions’ (p. 
86).267, 268  
The position of the ‘Global Health’ component at the top of the model underpins the primary 
reason and motivation for EBHC as suggested by the researchers when they originally developed the 
model, stating that ‘the achievement of improved global health is conceptualised as both the goal and 
the endpoint of any or all of the model components, (p. 209).269 Including mental health improvement in 
this conceptualization situates research aimed to this end comfortably within this model because similar 
variables apply to its pursuit, which can be operationalized in comparable ways. 
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1.11 Conclusions 
As previously examined, few studies have explored nutritional factors in relation to women’s 
experience of, and management of chronic stress, and these have predominantly focused on stress 
accompanying a hormonal state.10 Some studies have investigated stress in relation to DSs in both 
genders. For example, Schlebusch et al. reported on a double blind, multi-centre, placebo-controlled 
intervention study (n=300) in the general population of two South African cities where stress is 
recognised as being high.270 Across 30 days, participants used either a MVM or a placebo and 
experienced a significant reduction in stress as measured by all four self-report rating scales (p=0.0344; 
p=0.0148; p=0.0001; p= 0.0136).270 Rucklidge et al. reported on results from an RCT (n=116) that 
investigated stress levels over a one-month period in relation to the consumption of MVM’s, after an 
earthquake.271 Results revealed that MVM users had better outcomes compared to controls. Another 
study found that a year after MVM supplementation was initiated using a double blind study (n=129) an 
improvement in mood in female students was noted.272 These researchers suggested that providing 
higher levels of vitamins promoted long-term changes because short-term marginal deficiencies, 
addressed at three months, did not result in mood changes.272 Furthermore, as discussed in section 1.7, 
‘The neurobiological role of specific nutrients in relation to chronic stress,’ a few studies have 
investigated the effectiveness of vitamin C, and EFA supplementation on anxiety or stress in both 
genders, with mixed results, over shorter periods of time. 184, 185, 193-197 Examining the impact of dietary 
nutrients reveals similar results. 
Indeed, results from a cross-sectional study of adult Iranians (n=3,846) who completed a FFQ 
and validated anxiety measurement instruments revealed that psychological distress increased 
significantly in women as their consumption of fast food increased (p=0.02).273 Regardless of gender, 
but in support of these findings Banta et al. reported on a recent American population level study 
(n=245,891) that found moderate and serious psychological distress was associated with lower intakes 
of healthy foods and higher intakes of the opposite.274 Mujcic et al. reported on data from a longitudinal 
study over 2007 – 2009 (n=5,949) and revealed that the probability of being diagnosed with anxiety or 
depression in 2009 was inversely related to the consumption of fruit and vegetables in 2007.275 
Conversely, Jacka et al. found no correlation between women’s diets and their anxiety levels (n=1,494), 
assessed via a validated FFQ and a clinical interview.276 However, Jacka et al. later reported on an 
Australian 12-week, parallel group, single-blind, RCT (n=67) which examined whether adherence to a 
specific diet (ModiMedDiet) impacted this mood state, and found a significant improvement between 
baseline and endpoint in the intervention group (p=0.001).277 However, none of these studies compared 
the nutrient intakes of men and women in relation to chronic stress. 
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An interesting anomaly was revealed between men (n=272) and women (n=291) in relation to 
mental health and dietary patterns in a recent American cross sectional, Internet based survey.278 
Begdache et al. reported that men were more likely to experience mental wellbeing until severe nutrient 
deficiencies arose while women were less likely to experience the same until a balanced diet and 
healthy lifestyle were followed.278 The authors propose that dietary sufficiency may potentiate 
heightened limbic system regulation in women, which is suggestive of nutrients impacting mental 
wellbeing more in women than men.278 In support of this result, Firth et al. reported on a recent 
systematic review and meta-analysis of 16 RCTs (n=45,826) that examined the effects of dietary 
interventions on symptoms of depression and anxiety.279 The results showed female subjects with 
significantly greater benefits from dietary interventions for symptoms of these affective disorders.279 
Combined, these results suggested that women may benefit uniquely from improved nutrient intake via 
food and as per the Benton et al. study, in which women alone benefited from a year-long MVM 
intervention, this may be the case for DSs too.272 Although most of these studies suggested that specific 
nutrients in the form of DSs or food impact mental wellbeing, none of them examined women’s 
experience of chronic stress in relation to specific nutrients. 
As discussed, globally women report experiencing higher levels of stress and also experience 
higher rates of stress-related affective disorders than men. 17, 20-26, 28, 47, 52, 60, 61 A combination of factors 
may be responsible for this disparity including specific psychosocial, physiological and neurobiological 
differences. A variety of mechanisms related to the experience of chronic stress may lead to nutrient 
deficiencies due to the role that specific nutrients play in the stress response and the maintenance of 
emotional equilibrium. In addition, the consequences of chronic stress, including appetite changes, may 
further lead to nutrient deficiencies. In an attempt to manage chronic stress, women may use a number 
of approaches including the consumption of DSs, which they consume in greater quantities than men, 
despite insufficient evidence to support this behaviour. Figure 1.4 provides the conceptual framework 
linking the predisposing factors and pathways to chronic stress, possible negative outcomes and 
methods for managing stress. 
This thesis is positioned within the JBI model of EBHC because the complex nature of this line 
of enquiry fits a model that supports diverse forms of evidence and takes into account that a number of 
factors contribute to the experience of health which include the role that society, culture and personal 
values play in such.265, 269 As the objective of this study was to investigate the relationship between 
perceived stress and specific nutrients consumed in the daily diet and/or in DSs in a group of women, 
the first step in answering this research question was to investigate the present state of evidence. The 
author accessed, selected, appraised and extracted research that examined this relationship in a 




THE IMPACT OF ESSENTIAL FATTY ACID, 
B VITAMINS, VITAMIN C, MAGNESIUM AND 
ZINC SUPPLEMENTATION ON STRESS LEVELS IN WOMEN: 
A SYSTEMATIC REVIEW 
2.1 Introduction 
This chapter is a modified version of the Systematic Review that was published (February 2017) as part 
of my PhD qualification, investigating stress and nutrient intake in women.10 This review was conducted 
according to an a priori published protocol.280 
2.2 Introduction to Systematic Review 
The use of dietary supplements (DSs) fuels a global multibillion-dollar industry, with the figure estimated 
to reach $60 billion by 2020.281 Furthermore, according to Goldstein Research, the global stress 
management DS market is expected to reach USD16.7 billion by 2025.8 General DS usage is 
widespread, although some studies suggest use of vitamin and mineral supplements increases in 
people with a history of anxiety and/or depression.4-6, 229, 230 Complementary or alternative therapies, 
which include DSs, were used by over half of the individuals diagnosed with an anxiety or mood 
disorder in a population level survey (n=2,055).229 Prevalence of supplement usage has also been found 
to be higher among women compared to men.223-228, 236, 237 Furthermore, evidence suggests women are 
50% more susceptible to depression, generalized anxiety disorder, panic disorder, phobias and 
insomnia compared to men and this may influence the uptake of supplement usage among women and 
contribute to the global rise of DSs aimed at reducing stress.47-51, 96  
Stress and anxiety not only appear to influence supplement usage, they are associated with 
nutritional deficiencies, which are thought to compound anxiety and stress.2, 172 Biochemical evidence 
indicates that nutrients play a critically important role in CNS functioning.133, 172, 282 In addition, 
subclinical nutrient deficiencies may influence psychological wellbeing and potentially precede physical 
or emotional/affective disorders.172 Chronic stress leads to a cascade of negative physical and mental 
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sequelae such as cardiovascular disease, lifestyle-related diabetes, metabolic and immune dysfunction 
along with cognitive decline and depression.2, 283, 284 
2.3 Objectives 
The objective of this systematic review was to identify the impact of essential fatty acids (EFAs), B 
vitamins, vitamin C, magnesium and zinc, consumed as supplements to the daily diet, on stress levels in 
women. 
2.4 Inclusion criteria 
 Types of participants 2.4.1
The systematic review considered studies that included all women over the age of 18 years, who had 
been included in a study where stress and/or anxiety was being assessed.  
• Studies that included pregnant women were also considered. 
• Studies that included both genders were considered where it was possible to extract data 
for female participants. 
• Studies that included women taking prescription medication for anxiety or depression were 
excluded, as were hospitalized women or women suffering from eating disorders. 
 Types of intervention(s)/phenomena of interest 2.4.2
This review considered studies that evaluated the impact of supplementation with EFAs, B vitamins, 
vitamin C, magnesium and zinc at any dose/frequency on stress or anxiety being experienced by 
women. Supplements delivered in any form, including capsules, tablets, caplets, chewables, powders 
and liquids, at any dosage and for a duration of 14 days or longer were considered. The 
supplementation of these nutrients was investigated whether used individually, or in any combination. 
 Types of studies 2.4.3
This review considered experimental studies, including randomized controlled trials (RCTs), non-
randomized controlled trials, and quasi-experimental studies. The review also considered observational 
studies, case series and case control studies and descriptive cross sectional studies. 
 Types of outcomes 2.4.4
The systematic review considered studies that included the following outcomes: 
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• Stress, as measured by any validated tool or measure, for example the Perceived Stress 
Scale (PSS) or the Perceived Stress Questionnaire (PSQ). Self- or observer reports were 
considered. 
• Anxiety, as measured by any validated tool or measure, for example, the Beck Anxiety 
Inventory (BAI) or the State-Trait Anxiety Inventory (STAI). Self- or observer reports were 
considered. 
• Physiological measures of stress, such as increased blood pressure or cortisol levels in 
blood or saliva were considered. The presence of stress-related symptoms, including, but 
not limited to, insomnia, irritability, headaches, fatigue, tense muscles, frequent upper 
respiratory tract and other infections, weight gain, weight loss, gastrointestinal disorders, 
such as irritable bowel syndrome (IBS) and loss of sexual desire were considered. Self- or 
observer reports were considered. 
2.5 Search strategy 
The search strategy aimed to find both published and unpublished studies. The review author 
conducted a preliminary search of the JBI COnNECT+ database, Embase, Prospero, CINAHL and 
PubMed, using the keywords below, and no prior or progressing systematic reviews addressing the 
effectiveness of EFAs, B vitamins, vitamin C, magnesium and zinc on stress levels in women were 
found. The search strategy aimed to find both published and unpublished studies. A three-step search 
strategy was utilized in this review. An initial limited search of MEDLINE via PubMed and Embase was 
undertaken, followed by an analysis of the text words contained in the title and abstract, and of the 
index terms used to describe the article. A second search using all identified keywords and index terms 
was then undertaken across all included databases. Thirdly, the reference list of all identified studies 
and articles was searched for additional studies. 
Studies published in English were considered for inclusion in this review. 
No date limits were stipulated in this review. 
The following databases were searched: 





In addition, the search for unpublished studies included the following databases: 




National Institute of Mental Health 
International Association for Women's Mental Health. 
One unpublished paper was found in the CINAHL database. 
Initial keywords used were: 
Women, stress, psychological stress, mental fatigue, resilience, burnout, anxiety, omega 3 
fatty acids, polyunsaturated fatty acids, micronutrients, dietary supplements, vitamins, B 
vitamins, Vitamin C, magnesium, zinc. 
The full search strategy is provided in Appendix A. 
2.6 Method of the review 
Quantitative papers selected for retrieval were assessed by two independent reviewers for 
methodological quality prior to inclusion in the review using standardized critical appraisal instruments 
from the Joanna Briggs Institute Meta Analysis of Statistics Assessment and Review Instrument (JBI-
MAStARI) (Appendix B). Any disagreements that arose between the reviewers were resolved through 
discussion, or with a third reviewer. 
2.7 Data collection 
Quantitative data were extracted from papers included in the review using the standardized data 
extraction tool from JBI-MAStARI (Appendix C). All included papers were RCTs/pseudo-RCTs, and 
therefore only the JBI data Extraction Form for Randomized and Pseudo-randomized Controlled Trials 
was used. The data extracted included specific details about the interventions, such as the populations, 
study methods and outcomes of significance to the review question, such as anxiety or stress scores 
and the interaction of specific nutrients with such. The authors of four of the selected studies that 
included both male and female participants provided the reviewer with gender-disaggregated data upon 
request, which facilitated data analysis and commentary.184, 285-287  
2.8 Data synthesis 
Statistical pooling was not possible due to the heterogeneity of the papers included. The data is 
therefore presented narratively, inclusive of tables, organised according to the outcomes of interest, 
stress, anxiety and physiological measures of stress. Means and standard deviations provided in 
  Chapter 2 
37 
studies were used to compare treatment and placebo groups at baseline and endpoints using the 
independent t-test, with the online statistics calculator, graphpad 
(http://graphpad.com/quickcalcs/ttest2/) as raw data was not present to perform paired t-tests. 
Independent t-test results are more conservative than the results from paired t-tests.  The disaggregated 
data provided for some studies was used in the same way. One study author provided raw 
disaggregated data, which was analysed in the statistical software program SPSS 23 (IBM Corp. 
Released 2013. IBM SPSS Statistics for Windows, Version 23.0. Armonk, NY: IBM Corp.), where 
means and standard deviations were extracted allowing comparisons between groups using 
independent and paired t-tests and analysis of variance (ANOVA) statistical tests.286  
2.9 Results 
 Study selection 2.9.1
A total of 24,739 papers were identified through database searching, including a further two from other 
sources. A total of 154 papers were considered relevant to the review based on assessment of the title 
and abstract and were retrieved in full for further evaluation. From these, 15 papers were selected and 
included for final assessment and methodological evaluation, although one of these papers was 
excluded when final methodological analysis was performed (Appendix D). References of the 14 papers 
were analysed but no papers met the protocol requirements for inclusion. Of the 14 research studies 
included for the review, 13 were published papers and one was an unpublished thesis. See the study 
selection flow chart for details. 
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Figure 2.1: PRISMA Flow Diagram of selection and filtering process 
All the included papers measured levels of stress or anxiety in females, using a variety of 
measurement tools, at specific points in time, related to hormonal phase or regardless of it. A total of 
2,193 participants were assessed, and participant age ranged from 18 – 70 years. Out of the 14 
selected papers, 13 mentioned the recruitment process utilised, with university students and/or 
graduates being volunteers in five of the papers,286, 288-291 one paper using volunteers from a medical 
practice, the surrounding urban centre and local university,285 one using respondents from an 
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advertisement in a local newspaper,292 and one from the local university and urban area.184 One used 
volunteers from the local metropolitan electoral roll,293 while four mentioned the use of volunteers but 
provided no further detail,287, 294-296 and one did not mention recruitment.297 The participants represented 
a diverse range of socio-economic and cultural backgrounds. 
All 14 included studies were RCTs or pseudo-RCTs. Four studies investigated the use of 
specific nutrients, namely magnesium, vitamin B6, or omega 3 fatty acids for the management of a 
variety of premenstrual symptoms, including anxiety.290-292, 297 Three studies investigated the 
relationship between EFA supplementation and either peri- and post-menopausal symptoms, including 
anxiety and psychological distress during menopause,295, 296 and prenatal stress,294 while one 
investigated the role of vitamin B6 alone, or in combination with magnesium, in feelings of stress 
accompanying dysmenorrhea.289 Of the six remaining papers, two investigated the relationship between 
the supplementation of the EFA (DHA) and cognitive and psychological functioning in young adults,286, 
288 one assessed mental wellbeing in older subjects who were taking a fish oil supplement,287 and one 
investigated cognitive functioning and mood with DHA and eicosapentaenoic acid (EPA) 
supplementation.285 The final two studies investigated the effects of vitamins and minerals, with the first 
one investigating the possible role of folate, vitamin B6 and vitamin B12 on memory and mood, which 
included anxiety, in women of various ages293 and the final paper investigated the effect of high dose 
sustained-release vitamin C on subjective responses to psychological stress in young women.184 
Two of the included studies used the TSST to induce stress in participants.184, 294 The TSST is 
a standardised psychological laboratory-based stress induction procedure, which consists of specific 
instructions starting with the directive that participants will give a 5-minute speech to an unknown panel 
consisting of both genders, on their personal suitability for a job in the participants’ field of interest. This 
is followed by a 5-minute mental arithmetic task, which consists of serial subtractions of 17, starting with 
2023, with errors resulting in the participant being directed to start at the beginning of the arithmetic 
task. This test is performed in front of an audience and may also be recorded using a video camera.  
Sample size varied between these 14 papers, with the smallest sample sizes being present in 
the hormonal phase studies, and the larger sample sizes being present in the studies that examined the 
outcome of interest regardless of hormonal phase. The participants in nine of the studies provided 
written consent.184, 285-288, 290, 295-297 Four studies did not mention consent,291-294 and although it was 
mentioned in another, no detail was provided.289  
Although vitamin E was not one of the stipulated nutrients for study inclusion in the protocol, it 
is a commonly used antioxidant that acts as a preservative in EFA supplements, due to the sensitivity of 
the fatty acids to light, heat and oxygen.298 Therefore, studies where it was included in the EFA 
supplement were included in this review. 
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The included studies were published between 1987 and 2015, with the majority being 
conducted during the last decade. The included studies were conducted from across a wide 
international range, namely Australia (1), Britain (5), Canada (1), Germany (1), Iran (2), the Netherlands 
(1) and the United States of America (3). A summary of each of the studies, including the participants, 
population, interventions and results can be found in Appendix E. 
 Methodological quality 2.9.2
All the papers selected for retrieval were critically appraised using the JBI Critical Appraisal Tool for 
RCTs or pseudo-RCTs (Appendix C). Table 2.1 is a summary of the methodological quality of all the 
included studies, where U=unclear, Y=yes, N=no and N/A =not applicable. 
As summarised in Table 2.1, question one, eight of the 14 selected papers specified the 
specific randomization process used, with four of these studies using computer-generated stratified 
randomization lists to assign women to either an active treatment, or an identical placebo,285-287, 296 and 
the other four used either a dynamic randomized algorithm,295 a random number list,184 a Latin square 
design to ensure randomization to four groups,292 and a two-to-one ratio to randomly assign women to 
receive either active treatment or placebo, as the researchers expected greater variability in the 
dependant stress assessment.294 Therefore, to optimise power, they chose to enrol a higher number of 
participants in the experimental group versus the placebo group. Although this randomization procedure 
has been criticised, it may have offered some benefits, as the women participating were pregnant and 
this randomization procedure does confer some benefits in statistical power for adverse event 
monitoring.299 The other six papers stated that randomization was used to allocate participants to active 
and control groups but did not provide any detail regarding how this occurred.288-291, 293, 297 The possible 
lack of randomization in these studies introduces the risk of allocation bias, which limits the internal 
validity of the studies and the conclusions that can be drawn from the interventions. 
Participants were blinded to treatment allocation in 13 of the studies (Q2),184, 285-291, 293-297 
leading to the potential for performance bias in the paper where participant blinding did not occur.292 Ten 
of those studies (Q3)184, 285-287, 289, 293-297 concealed allocation to treatment groups from the allocator, and 
from those assessing outcomes (Q5), which introduced the potential for observation bias in the four 
papers where this did not occur.288, 290-292  
Intention to treat (ITT) analysis was only adhered to in four of the studies (Q4),285, 287, 293, 294 
which introduces the potential for attrition bias in the 10 studies where ITT was not followed,184, 286, 290-
292, 295-297 as groups being measured at outcome may no longer be similar to the groups measured at 
baseline. The control and treatment groups were comparable at entry in 11 of the studies (Q6),184, 285-289, 
291, 292, 294, 296, 297 leaving the remaining three studies290, 293, 295 open to potential risk of selection bias. All 
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of the studies, bar one, treated the groups identically apart from the named intervention, where 
participants were supplied with intervention on different days, where different instructions and participant 
differences in terms of hormone phase calculations may have impacted outcome measurement (Q7)297 
and only one study measured the outcomes differently for the two groups (Q8).288 The potential for 
measurement bias is therefore high in these two studies. 
All of the papers selected for this review used specific outcome measures to measure the 
stress or anxiety of the participants, with a number of the papers using a combination of measures to 
assess these psychological states. The outcome measures used ranged from high to low in terms of 
reliability, with 10 studies using reliable outcome measures (Q9),184, 285-289, 293-296 while four used self-
assessment methods based on diagnostic criteria in diaries, possibly introducing recall or recording 
bias.290-292, 297 A full list of these 14 outcome measures can be found in Appendix 4 with references 
pertaining to test reliability. 
All of the included papers used appropriate statistical analysis (Q10) and the disaggregated 
data was analysed by the reviewer using appropriate statistical tests, although a lack of raw data led to 
the use of independent t-tests in a number of studies where paired t-tests would have been more 
appropriate.184, 285, 287, 289, 290, 294, 296, 297  
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Table 2.1: Assessment of methodological quality 
Citation Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 Q9 Q10 
Benton D et al.288 N Y U N U Y Y N Y Y 
Brody S et al.184 Y Y Y N Y Y Y Y Y Y 
Bryan J et al.293 U Y Y Y Y U Y Y Y Y 
Cohen LS et al.295 Y Y Y N Y N Y Y Y Y 
Davis LS.289 U Y Y N Y Y Y Y Y Y 
De Souza MC et al.292 Y U U U U Y Y Y U Y 
Jackson PA et al.286  Y Y Y U Y Y Y Y Y Y 
Kashanian M et al.291 U Y U N U Y Y Y U Y 
Keenan K et al.294  Y Y Y Y Y Y Y Y Y Y 
Lucas M et al.296 Y Y Y N Y Y Y Y Y Y 
Rogers PJ et al.285  Y Y Y Y Y Y Y Y Y Y 
Sohrabi N et al.297  U Y Y N Y Y N Y U Y 
van de Rest O et al.287 Y Y Y Y Y Y Y Y Y Y 
Walker AF et al.290  U Y U N U U Y Y U Y 
% 64.29 92.86 71.43 28.57 71.43 78.57 92.86 92.86 71.43 100 
Q1: Was the assignment to treatment groups truly random? 
Q2: Were participants blinded to treatment allocation? 
Q3: Was allocation to treatment groups concealed from the allocator? 
Q4: Were the outcomes of people who withdrew described and included in the analysis? 
Q5: Were those assessing outcomes blind to the treatment allocation? 
Q6: Were the control and treatment groups comparable at entry? 
Q7: Were groups treated identically other than for the named interventions? 
Q8: Were outcomes measured in the same way for all groups? 
Q9: Were outcomes measured in a reliable way? 
Q10: Was appropriate statistical analysis used? 
2.10 Findings of the review 
The review findings are presented according to the outcomes stress or anxiety, or a combination of 
stress and anxiety, and physiological measures of stress assessed. Due to the heterogeneity of the 
included papers, which employed a wide variety of outcome measures (14 in total), it was not possible 
to perform a meta-analysis. (See Appendix F for details regarding the stress and anxiety outcome 
measures used in the studies.) The participants of the included studies also differed significantly in 
terms of age, as well as hormone cycle, and the nutrients used for supplementation differed in terms of 
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type, dosage, specific ingredients and nutrient combination. (See Appendix G for supplementary 
statistical data extracted for included studies not displayed in narrative or tables.) 
 Key findings related to the outcome stress 2.10.1
Both of the studies that examined the use of specific nutrients to reduce stress levels did so for women 
during a specific hormonal phase. Keenan et al. examined the association between EFA 
supplementation, perceived stress and cortisol response to a laboratory stressor, the TSST, during 
pregnancy in 64 African American women living in low-income environments.294 The study ran for a 
maximum of 14 weeks with women being recruited from between 16 and 21 weeks of gestation. The 
treatment and placebo comprised two gel capsules to be taken daily, with treatment containing 450 mg 
DHA, 40 mg docosapentaenoic acid (DPA), eicosatetranoic acid (ETA) and EPA, with 15 international 
units of vitamin E. The placebo was matched in size, colour and smell and contained corn and soya oils. 
The ITT protocol was adhered to in this study. Cortisol response via saliva was collected at three time 
points during baseline, and at 24 and 30 weeks of gestation, 20 minutes after arrival at the laboratory, 
and 20 and 45 minutes post-TSST. Participants completed two outcome measures at these times, the 
Difficult Life Circumstances Scale (DLCS) which requires 28 either yes or no responses to present life 
challenges, with a score of 6 or less associated with increased stress and poor outcome, and the PSS-
14 with a possible range of 0 – 56, with higher scores reflecting higher levels of stress.300, 301 The 
reviewer used independent t-tests, due to a lack of raw data, to compare PSS scores at baseline, 24 
and 30 weeks in the treatment group. There was no statistically significant difference in perceived stress 
in the EFA group at either 24 or 30 weeks gestation. In addition, statistical significance was not reached 
when comparing the stress scores of the EFA group at 24 weeks gestation or 30 weeks gestation with 
placebo stress scores (Appendix G). However, when controlling for negative life events and depression 
scores using ANOVA, perceived stress scores were significantly lower among the EFA group (mean 
27.4) compared to placebo group (mean 29.5) at 30 weeks (F[1,47} 5.06, p=0.029, with Cohen’s 
d=0.65). The reviewer used independent t-tests to compare circumstance stress at baseline and 24 
weeks gestation for the EFA group. There was no statistically significant reduction in circumstance 
stress in the EFA group at baseline compared to 24 weeks. There was a statistically significant 
reduction in circumstance stress between the EFA group at baseline (5.16±3.4) and 30 weeks 
(3.91±0.6; (t(52)=2.1, p≤0.040) (Table 2.2). There was no statistically significant reduction in 
circumstance stress in the EFA group compared to the placebo group at follow up (Appendix G). The 
effect of EFA supplementation only had a significant effect on perceived stress and circumstance stress 
scores after 30 weeks gestation, suggesting that the length of time the participants were on the 
treatment influenced their subjective responses to stress and their challenging life circumstances. 
  Chapter 2 
44 
Davis investigated the effects of vitamin B6 and magnesium supplementation on symptoms of 
stress and dysmenorrhea (very painful menstrual cramps).289 Forty-seven women with dysmenorrhea 
were assigned to one of four dietary supplement groups: group 1) 500 mg magnesium per day; 2) 200 
mg vitamin B6 per day; 3) 500 mg magnesium + 200 mg vitamin B6 or placebo. The supplements were 
to be consumed daily for four consecutive menstrual cycles, and stress response was measured at 10 
and 14 days after commencement of study and during each of the four menstrual periods. The 
Symptoms of Stress Inventory (SOS) was used to assess participant stress levels, with higher scores 
reflecting higher levels of stress.302 The reviewer used independent t-tests to compare SOS scores at 
baseline and endpoint for magnesium and vitamin B6 alone, and in combination, and to compare 
treatment against placebo. There was a trend towards decreased stress between baseline magnesium 
treatment (98.8±36.3) and endpoint (70.2±35.0, t(24)=2.04, p≤0.052) and between baseline vitamin B6 
treatment (67.7±26.6) and endpoint 45.1±21.9, t(18)=2.07, p≤0.052). In addition, there was a 
downward trend with the combination of vitamin B6 and magnesium, between baseline (99.5±45) and 
endpoint (66.8±29.7; t(20)=2.01, p≤0.057) suggesting that there may have been a synergistic effect of 
combining magnesium and vitamin B6. In addition, there was a downward trend with the use of vitamin 
B6, between endpoint (45.1±21.9) compared to placebo (73.6±39.5; t(20)=2.03,p=0.055) (Table 2.2). 
However, the use of magnesium alone and the combination of magnesium and vitamin B6 did not lead 
to a statistically significant reduction in stress at endpoint compared to placebo (Appendix G). 
In summary, over time, the EFA treatment significantly lowered the pregnant participants’ 
perceived stress levels and improved their perception of their difficult life circumstances.294 Although 
there was a downward trend towards decreased stress levels using magnesium and vitamin B6 in 
isolation, and in combination, with women suffering from dysmenorrhea, statistical significance was not 
reached.289  
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Keenan K et 
al.294  
DHA + DPA 
+ ETA + 
EPA  
Placebo None None DLCS Scores 
Baseline treatment (N=20) 5.16±3.4 
versus endpoint (N=34) 3.91±0.6 
(t(52)=2.1;p=0.040*) 
PSS Scores 
ANOVA: controlling depression scores 
and negative life events 
At 30 weeks treatment (mean 27.4) 
versus placebo (mean 29.5) 
(F[1,47} 5.06, p=0.29, Cohen’s d=0.65) 
Outcome measures: DLCS + PSS + 
cortisol (saliva) 
Davis LS.289  Magnesium Vitamin B6 Magnesium 
+ vitamin B6 
Placebo SOS Scores 
Baseline (Mg) treatment (N=13) 
98.8±36.3 versus endpoint 70.2±35.0 
(t(24)=2.04, p=0.052*) 
Baseline (vitamin B6) treatment (N=10) 
67.7±26.6 versus endpoint 45.1±21.9 
(t(18)=2.07, p=0.052*) 
Baseline (Mg + vitamin B6) treatment 
(N=11) 99.5±45 versus endpoint 
66.8±29.7 (t(20)=2.01, p=0.057*) 
Endpoint vitamin B6 (N=10) (45.1±21.9) 
versus placebo (N=12) (73.6±39.5; 
t(20)=2.03,p=0.055*) 
No statistically significant differences 
between magnesium alone or in 
combination with vitamin B6 at endpoint 
versus placebo 
Outcome measure: SOS 
* p≤0.05 
 Key findings related to the outcome anxiety 2.10.2
Ten studies examined the effect of specific nutrients on anxiety levels, six of which did so for women 
experiencing a specific hormonal phase. Van de Rest et al. assessed the impact of omega 3 fish oil 
(DHA and EPA) supplementation on mental well-being in 139 women aged 65 ≥ years, over 26 
weeks.287 The EFA treatment was provided in six soft gelatine capsules daily, at either a high or low 
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dose, or placebo, all indistinguishable in appearance. The high dose active supplement contained a 
mean daily intake of 1093 mg EPA and 847mg DHA, and the low dose contained a mean daily intake of 
226mg EPA and 176mg DHA, while the placebo group took oil capsules that contained oleic acid (olive 
oil). A subscale of the Hospital Anxiety Depression Scale - Anxiety (HADS-A) was used to identify 
anxiety symptoms, with higher scores reflecting higher levels of anxiety.303 The reviewer used the 
means and standard deviations to perform independent t-tests on the disaggregated data and 
compared the HADS-A scores at baseline and three months for both the 400 mg and the 1800 mg 
groups. There was no statistically significant difference in anxiety in either the 400 mg or the 1800 mg 
EFA groups at baseline compared to three months or six months. There was no statistically significant 
difference in anxiety between the 400 mg group at three months compared to six months and no 
statistically significant difference in anxiety between the 1800 mg group at three months compared to six 
months. There was also no significant difference in anxiety comparing the 400 mg groups and the 1800 
mg groups at six months. In addition, there was no statistically significant difference in anxiety between 
either the 400 mg or the 1800 mg groups compared to placebo at six months (Appendix G). 
Benton et al. examined the effects of a DHA supplemented high oleic acid (omega 9) 
sunflower seed oil supplement over 50 days on the psychological functioning of a group of young female 
university students, aged between 21 and 28 years, with anxiety being a subscale of interest.288 There 
was no detectable EPA, or other EFA in the mixture. Four 250mg capsules per day provided 400mg of 
DHA, while the placebo provided maize-soya oil, and was identical in colour, size and smell to the active 
capsules. The study was conducted in two phases, with two groups of 150 women each being recruited, 
three months apart. The data generated by these two groups of women was combined and statistics 
were employed to rule out the possibility that the time of the year could have influenced the results. 
Baseline testing used visual analogue scales (VAS) based on the Profile of Mood States (POMS) 
questionnaire, with higher scores related to greater frequency of distressed mood.304 Benton et al. used 
a repeated measure ANOVA to assess the interaction between the outcome variable (composed-
anxious dimension), the treatment (DHA versus placebo) and the study time period. Controlling for time, 
the authors examined the association between the anxiety score and DHA intake and found no 
significant association (F=2,566, p=0.38) (Table 2.3). Therefore, in this study DHA had no effect on 
anxiety among participants. Although the researchers mention that the dose of omega 3 may have been 
too small to introduce change, the presence of omega 6 in the placebo may have influenced this result. 
Sohrabi et al. examined the impact of EFA supplementation over a three-month period on 
anxiety during premenstrual syndrome (PMS), according to the American College of Obstetricians and 
Gynecologists (ACOG) diagnostic criteria for PMS.297, 305 The researchers prescribed 2g of omega 3 
(comprised of 12% DHA and 18% EPA), found in two 1 g pearls, as a single daily dose, to be used for a 
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total of 30 days, while the placebo group were prescribed identical pearls containing no oil. Over the 
next two months the participants consumed their stipulated dose only on the 8 days preceding, and the 
2 days after the onset of menstruation. A visual analogue score (VAS) was used to assess the severity 
of the symptoms, both at the start of the study, at 45 days and at 90 days from intervention, which were 
made up of 6 mood subscales, including the outcome of interest, anxiety. As the researchers 
commented on the significance of the results of a t-test, but did not specify these results, the reviewer 
used independent t-tests to calculate the mean differences between treatment and placebo groups 
using the means and standard deviations of the results at 45 and 90 days. There was a statistically 
significant reduction in anxiety severity in the EFA group (1.53±1.04) compared to the placebo group 
(4.07±0.91) at 45 days (t(122)=14.45;p=0.0001). There was however a statistically significant increase 
in the duration (days) of anxiety in the EFA group (9.81±1.43) compared to the placebo group 
(8.23±2.12) at 45 days (t(122)=4.87;p=0.0001). There was a statistically significant reduction in anxiety 
severity in the EFA group (0.79±1.04) compared to the placebo group (3.89±0.91at 90 days 
(t(122)=17.64;p=0.0001). There was a statistically significant reduction in duration (days) of anxiety in 
the EFA group (4.45±1.02) compared to the placebo group (8.23±1.94) at 90 days 
(t(122)=13.64;p=0.0001). There was a statistically significant reduction in anxiety in the EFA group at 45 
days (1.53±1.04) compared to 90 days (0.79±1.04; t(122)=3.96;p=0.0001) (Table 2.3). Using a Chi-
Square test, the authors examined the association between two binary variables, namely treatment or 
placebo and sedative use, either yes or no. On day 90, sedative use in the treatment group (15 cases 
25%) compared to the placebo group (44 cases 73.3%) was significantly lower (p=0.001), suggesting 
that reduced sedative use may have been a result of reduced anxiety. The use of EFAs in this study 
reduced the severity of anxiety symptoms at 45 and 90 days, although anxiety duration was only 
reduced at 90 days, suggesting that this treatment became effective at reducing the duration of anxiety 
over time. 
Cohen et al. used a multi-centre 12-week trial to determine the efficacy of EFAs in reducing 
anxiety, as a secondary outcome, in peri- and post-menopausal women.295 Anxiety was measured using 
the Generalised Anxiety Disorder-7 (GAD-7) outcome measure, with higher scores related to higher 
levels of anxiety (range 0 – 21).306 Either a 1.8 g/day EFA supplement (three pills per day), composed of 
425 mg EPA, 100 mg DHA and 90 mg other EFAs, was used for treatment, or a matching olive oil-
containing placebo. The reviewer used the means provided and the standard deviations calculated from 
the 95% Confidence Intervals provided in the paper to compare the mean differences of GAD-7 scores 
at 12 weeks treatment with the placebo group using an independent t-test. There was not a statistically 
significant difference in anxiety in the EFA group (-0.2±3.32) compared to the placebo group (-
0.85±3.64) at 12 weeks (t(335)=1.71;p=0.087) (Table 2.3) although there was a downward trend 
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towards decreased anxiety. The use of EFAs in this study did not reduce anxiety significantly in the peri- 
and post-menopausal women, although there was a downward trend. 
Lucas et al. compared the use of enriched ethyl-EPA with placebo for the treatment of 
psychological distress (PD) associated with menopause in 120 middle-aged women over an eight week 
period.296 Twenty four % of the participants (29) experienced major depressive episodes (MDE). The 
Psychological General Well-Being (PGWB) outcome measure, which included anxiety among 22 items 
was used to assess PD, with lower scores related to higher rates of anxiety (range: 0 – 110).307 
Treatment and placebo consisted of a 500 mg capsule to be consumed three times a day for the study 
period, containing either 350 mg EPA and 50 mg DHA in the form of ethyl esters (the other 100mg is not 
mentioned) while placebo consisted of sunflower oil combined with 0.2% regular FO of which 18% was 
EPA and 12% was DHA for better matching of possible fish-oil taste, which was present in the treatment 
capsules. Assessing the data using independent t-tests, the reviewer calculated the difference in anxiety 
scores between the ethyl-EPA group at baseline and at eight weeks for all women. There was a 
statistically significant reduction in anxiety in the ethyl-EPA group between baseline (55.9±12.1) and 
eight weeks (68.3±15.9, t(112)=4.7;p=0.0001) regardless of the presence of MDE or not. There was a 
statistically significant reduction in anxiety in the ethyl-EPA group between baseline (42.5±13.0) and 
eight weeks (52.3±10.4; t(23)=2.06;p=0.049) for women who experienced MDE. There was a 
statistically significant reduction in anxiety in the ethyl-EPA group between baseline (59.8±8.8) and 
eight weeks (72.7±14.2; t(87)=5.18;p=0.0001) for women without MDE. There was a statistically 
significant reduction in anxiety in the ethyl-EPA group at eight weeks (72.7±14.2) compared to the 
placebo group (63.3±18.1) in women without MDE (t(78)=2.6;p=0.011) (Table 2.3) but there was no 
statistically significant difference in anxiety in the ethyl-EPA group at eight weeks compared to the 
placebo group in the presence of MDE (Appendix G). These results suggest that the effect of EFAS on 
anxiety in menopausal women may be reduced in the absence of MDE. 
Walker et al. used the Menstrual Health Questionnaire (MHQ) and a self-report menstrual diary 
(MD) based on the Moos Menstrual Distress Questionnaire (MDQ) to investigate the effect of a daily 
supplement of 200 mg of magnesium oxide (MgO), or placebo, for two menstrual cycles on PMS 
symptom severity, including anxiety, among 41 women.290, 308, 309 The menstrual diary symptoms had a 
range of 0 – 66, with higher scores reflecting more severe symptoms. Volunteers were assigned to two 
groups and for the first two cycles the first group took the supplement, and the second group took the 
placebo, and at the beginning of the third cycle, the groups crossed over for two cycles, thereby 
eliminating between group variance. The reviewer used independent t-tests to compare the mean 
anxiety scores at baseline treatment and endpoint, and treatment and placebo. There was no 
statistically significant difference in anxiety between the magnesium group at baseline compared to 
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endpoint and there was no statistically significant difference in anxiety between the magnesium group at 
endpoint compared to placebo (Appendix G). However, the scores were lower for anxiety after one 
month of magnesium treatment and the MHQ symptom scores indicated that the most prevalent 
symptom among the women was anxiety at 76%. 
De Souza et al. examined the effect of 200 mg of magnesium and 50 mg vitamin B6, either 
alone or in combination or placebo, for the relief of anxiety-related PMS symptoms over a five-month 
period.292 The authors used the MHQ to assess baseline pre-menstrual symptoms and a MD comprised 
of 30 symptoms, including anxiety, to assess anxiety over the study time period.308 Participants were 
instructed to consume one of the three types of supplements or placebo, for one menstrual cycle, 
commencing on the first day of the second cycle, which meant that each participant changed to a 
different supplement according to this design on day one of her next cycle, until each of the four options 
had been completed, thereby eliminating between group variance. The reviewer was unable to perform 
any statistical tests. The researchers used a multivariate ANOVA to assess differences among the 
treatment group related to the dependant variable, anxiety, and the covariates, namely magnesium and 
vitamin B6. Using ANOVA, the authors state that there was a statistically significant interaction effect of 
magnesium and vitamin B6 for reducing PMS-related anxiety symptoms (p=0.040; mean scores of 
magnesium (22.0), vitamin B6 (21.8), magnesium + vitamin B6 (16.3), and placebo (19.8) (Table 2.3). 
Anxiety-related symptoms were the most prevalent symptom reported by women in both the MHQ and 
the MD, with 64% of the women reporting having stressful lives and 66% of them scoring the maximum 
scores for anxiety on the MHQ, which is a similar trend noted in participants in Walker et al’s paper, 
above.83 These results suggest that the combination of magnesium and vitamin B6 may be useful for 
reducing PMS related anxiety. 
Kashanian et al. examined the effects of vitamin B6 on anxiety experienced during PMS. Forty-
six women took 80 mg of vitamin B6 daily for two menstrual cycles, while 48 women took an identical 
looking and tasting placebo.291 A recording sheet based on the American Psychiatric Association (APA) 
questionnaire was used to assess the presence of PMS (including anxiety) during the first three 
menstrual cycles without treatment.310 The symptoms recorded during the first three cycles were 
compared to the symptoms recorded after the second cycle of treatment. The reviewer used an 
independent t-test to calculate the mean differences between the treatment and placebo groups. There 
was a reduction in anxiety in the vitamin B6 group (-0.22±0.35) compared to the placebo group at 
endpoint (-0.15±0.35) but the difference did not reach statistical significance (t(92)=0.969;p=0.3349) 
(Table 2.3). 
Bryan et al. examined the effects of 35 days of using folate (vitamin B9), vitamin B12, vitamin 
B6 or placebo, on cognition and mood, including anxiety, in 211 healthy younger (20 – 30 years), 
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middle-aged (45 – 55 years) and older women (65 – 92 years).293 Anxiety was measured using the 
POMS outcome measure at baseline and endpoint, with higher scores reflecting higher levels of 
anxiety.304 The women were allocated to one of the four treatment groups, and consumed either 750 µg 
of folate (vitamin B9), 15 µg of vitamin B12, or 75 mg of vitamin B6, or a placebo, daily, for 5 weeks. All 
treatment groups’ capsules were identical in shape and colour and the placebo contained calcium and 
magnesium. Each quartile constituted a sub-population within each age group, based on the intake of 
nutrients assessed by a food frequency questionnaire (FFQ), which was administrated to both the 
treatment and placebo groups prior to treatment. The researchers used either a 2-way ANOVA or 
repeated measures ANOVA to assess anxiety scores. No effect of treatment on anxiety scores over 
time within the three age groups was reported. However, independent t-tests performed by the reviewer 
to assess the differences between the endpoint treatment groups, for all ages, and the placebo groups, 
found a statistically significant reduction in anxiety at 35 days for the older age group using vitamin B6 
(12.33±2.23) compared to placebo (14.70±3.42, t(36)=2.53;p=0.015). This result suggests that vitamin 
B6 may be effective at reducing anxiety in older women. The authors suggest that the general lack of 
effects of short-term B vitamin supplementation may be due to the short duration of supplementation. 
In summary, EFA treatment was effective at reducing anxiety in one group of women 
experiencing premenstrual tension,297 and one menopausal group in the absence of depression.296 EFA 
treatment was ineffective at reducing anxiety in two groups of women experiencing no specific hormonal 
phase287, 288 and one menopausal group.295 A combination of magnesium and vitamin B6 was shown to 
be effective at reducing premenstrual anxiety in one group,292 although the use of vitamin B6 alone was 
not shown to be effective at reducing anxiety in another premenstrual group,291 and the use of 
magnesium in another premenstrual group was ineffective.290 Regardless of hormonal phase, older 
women benefited with a significant reduction in anxiety from using vitamin B6, but not folate or vitamin 
B12, while folate, vitamin B12 or vitamin B6 used alone was ineffective at reducing anxiety in younger or 
middle aged women.293  











van de Rest O et 
al.287  
High dose 
EPA + DHA  
Low dose 
EPA + DHA  





Outcome measure: HADS-A 












Benton D et 
al.288 
DHA Placebo None None No statistically significant interaction 
(p=0.38) between treatment and 
time; 3-way ANOVA (F=2,566), 
p=0.38) 
Outcome measure: VAS dimensions 
based on the POMS 
Sohrabi N et 
al.297  
DHA + EPA Placebo None None VAS scores of ACOG criteria for 
PMS 
45 days treatment - severity of 
anxiety (N=63) 1.53±1.04 versus 
placebo (N=61) 4.07±0.91 
(t(122)=14.4;p=0.0001*) 
45 days treatment - duration of 
anxiety (N=63) 9.81±1.43 versus 
placebo (N=61) 8.23±2.12 
(t(122)=4.8;p=0.0001*) 
90 days treatment - severity of 
anxiety (N=63) 0.79±1.04 versus 
placebo (N=61) 3.89±0.91 
(t(122)=17.64;p=0.0001*) 
90 days treatment - duration of 
anxiety (N=63) 4.45±1.02 versus 
placebo (N=61) 8.23±1.94 
(t(122)=13.64; p=0.0001*) 
Mean difference between treatment 
at 45 days versus 90 days (t(124) = 
3.99, p=0.0001*) 
Sedative use in treatment versus 
placebo groups: Chi-Square test 
(p=0.0001*) 
 
Outcome measure: VAS of ACOG 
PMS diagnostic criteria 
Cohen LS et 
al.295 
EPA + DHA 
+ other 
omega 3’s 
Placebo None None GAD-7 Scores 
Endpoint treatment (N=169) -
0.2±3.32 versus placebo (N=168) -
0.85±3.64 (t(335)=1.71;p=0.087) 
Outcome measure (secondary 
outcomes - including anxiety): GAD-
7 












Lucas M et al.296 EPA + DHA 
(ethyl esters) 
Placebo None None PGWB Scores 
Baseline treatment (Combined MDE 
and no MDE) (N=59) 55.9±12.1 
versus endpoint (N=55) 68.3±15.9 
(t(112)=4.7;p=0.0001*) 
Baseline treatment (MDE) (N=13) 
42.5±13.0 versus endpoint (N=12) 
52.3±10.4 (t(23)=2.06;p=0.049*) 
Baseline treatment (no MDE) 
(N=46) 59.8±8.8 versus endpoint 
(N=43) 72.7±14.2 
(t(87)=5.18;p=0.0001*) 
Endpoint treatment (no MDE) 
(N=43) 72.7±14.2 versus placebo 
(N=37) 63.3±18.1 
(t(78)=2.6;p=0.011*) 
Outcome measure: PGWB 








None None No statistically significant difference 
between treatment baseline and 
endpoint or treatment endpoint and 
placebo group 
 
Outcome measures: MHQ; MDQ  
De Souza MC et 
al.292 
Magnesium Vitamin B6 Magnesium 






to the next 
treatment 




MD anxiety scores 
MANOVA 
Statistically significant (p=0.040*) 





Outcome measure: MD 












Kashanian M et 
al.291  
Vitamin B6 Placebo None None Anxiety scores 
Endpoint treatment (N=46) -
0.22±0.35 versus placebo (N=48) -
0.15±0.35 (t(92)=0.969;p=0.3349*) 
No statistically significant difference 
in anxiety scores between treatment 
baseline and placebo (p=0.3349*) 
Outcome measure: APA 
questionnaire 
Bryan J et al.293  Folate Vitamin B12 Vitamin B6 Placebo POMS anxiety scores 
Endpoint treatment (Vitamin B6) 
12.33±2.23 versus placebo 
14.70±3.42 (t(36)=2.53; p=0.015*) 
Authors note: No effect of treatment 
on anxiety scores in any groups 
over time 
Outcome measure: POMS 
* p≤0.05 
 Key findings related to the outcomes of stress and anxiety 2.10.3
Rogers et al. evaluated the effects of EPA and DHA supplementation on stress and anxiety as 
secondary outcomes in a group of mild to moderately depressed individuals over a 12-week period, 
using the Depression, Anxiety and Stress Scales (DASS) outcome measure, which is a 42-item 
instrument.285, 311 Low scores indicate normal or mild levels of stress or anxiety and higher scores 
indicate moderate to severe levels. With the aim of maximising the participation of individuals with low 
mood who hadn’t been labelled as such in a clinical setting, this study recruited people from a wide 
variety of places in an urban centre. Both the treatment and placebo groups were instructed to consume 
three capsules per day, which in the treatment group contained 630 mg EPA, 850 mg DHA, 870 mg 
olive oil, 7.5 mg mixed tocopherols and 12 mg orange oil, while the placebo group consumed 2360 mg 
olive oil, with an equal amount of tocopherols and orange oil. Using the disaggregated data, the 
reviewer calculated the differences between the baseline and endpoint scores, as well as the 
differences between treatment and placebo scores for the same time period using independent t-tests 
as raw data was not available with which to perform paired t-tests. There was a statistically significant 
reduction in stress in the EFA group between baseline (15.6±8.1) compared to 12 weeks (12.3±7.8; 
t(168)=2.70;p=0.0075). However, the comparative reduction in stress between the EFA and placebo 
groups at 12 weeks was not significant. There was a statistically significant reduction in anxiety in the 
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EFA group between baseline (5.9±5.6) compared to 12 weeks (4.2±4.6; t(168) =2.16, p=0.032) 
(Table 2.4). However, the comparative reduction in anxiety between EFA and placebo groups at 12 
weeks was not significant (Appendix G). These results indicate that the EFAS used in this study may 
have had an effect on both the stress and anxiety levels of the participants in the treatment group over 
the 12-week period. However, there was no reduction in stress or anxiety when comparing EFA 
treatment to placebo group, as the placebo group also showed a reduction in stress and anxiety levels. 
Apart from the treatment, there may therefore have been another unknown variable that impacted both 
groups. 
Jackson et al. aimed to examine the effects of two types of fish oil (FO) on healthy young 
adults using the DASS outcome measure, over 12 weeks.286, 311 Each of the treatment groups were 
assigned a 1g daily dose, which was provided by 2 X 500 mg capsules, comprising 497.5 mg of 
deodorised FO with 2.5 mg mixed tocopherols (vitamin E). The first treatment group would be 
consuming DHA-rich FO, made up of 450 mg of DHA combined with 90 mg of EPA in a ratio of 5:1 
DHA:EPA. The second group would be consuming EPA-rich FO, made up of 300 mg EPA and 200 mg 
DHA in a ratio of 3:2 EPA:DHA and the third group received 1 g of olive oil as placebo. The ratio of the 
DHA and EPA contained in the active treatments are a reflection of the range that exists naturally in fish 
consumed by the general population. Outcomes were measured at baseline and endpoint, using the raw 
disaggregated stress and anxiety DASS scores supplied to the reviewer. The means and standard 
deviations for the three groups were calculated and independent and paired t-tests were used to 
compare the DHA, EPA and placebo groups at baseline and after treatment. There was no statistically 
significant difference in stress or anxiety scores in either the DHA or the EPA groups between baseline 
and at 12 weeks. There was no statistically significant difference in stress or anxiety between either the 
DHA or the EPA groups compared to the placebo group at 12 weeks. Using ANOVA, there was no 
statistically significant difference found in stress (P value=0.686) or anxiety scores (P value=0.747) 
between the DHA, the EPA or the placebo groups (Appendix G). The use of EFAS for 12 weeks had no 
effect on the stress or anxiety scores of the female participants in this study. 
Brody et al. examined the impact of supplementation on stress and anxiety by assessing the 
effects of a high dose sustained-release vitamin C (1000 mg) supplement, made up of two capsules, 
three times per day, in a group of 60 young adults over 14 days.184 The treatment formula has a half-life 
of 19h unlike the conventional formula, which has a 2h half-life. Psychological stress was assessed 
using the German version of the Spielberger State Anxiety Scale (SSAS), also known as the State-Trait 
Anxiety Inventory (STAI) with higher scores reflecting higher levels of anxiety.312 The researchers also 
assessed subjective stress responses with another outcome measure developed by the primary 
researcher, which measured stress on a scale from 0 (the least stress imaginable) to 10 (the worst 
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stress imaginable), although the details of this outcome measure were not provided in the research 
paper. During the pre-trial session, a brief medical examination was followed by a cannula being 
inserted into participants right forearm vein to enable assessment of cortisol and vitamin C levels in 
blood plasma. In addition, plasma cortisol response to an injection of 1µg of adrenocorticotrophic 
hormone (ACTH) was assessed after 45 and 60 minutes. During this time, participants completed the 
questionnaires and were then provided with the vitamin C supplements, and advised to consume them 
with ample fluid, which included two doses on the day of the post-trial session. During the endpoint 
laboratory session, participants again completed the questionnaires, and participated in the TSST. 
Subjective stress ratings were taken, at -10, -1, +10, +20, +30 and 40 minutes relative to the TSST. The 
reviewer performed independent t-tests using the disaggregated data to compare STAI scores at 
baseline and at endpoint after the TSST, and between treatment and placebo groups. There was a 
statistically significant reduction in anxiety in the vitamin C group at baseline (36.55±7.32) compared to 
14 days (43.63±9.23), t(74)=3.7, p≤0.0004). There was also a statistically significant reduction in 
anxiety in the vitamin C group (43.63±9.23) compared to the placebo group (50.34±11.95) at 14 days 
(t(69)=2.66;p=0.0096). There was a statistically significant reduction in stress between the vitamin C 
group at baseline (3.71±2.02) compared to 14 days (2.25±1.35; t(74)=3.70, p≤0.0004) (Table 2.4). 
However the reduction in stress between the vitamin C and placebo groups at 14 days was not 
significant (Appendix G). These results suggest that vitamin C may be more effective at lowering anxiety 
than stress. Plasma vitamin C levels increased significantly over the course of the trial (F=3.9, p=0.002) 
for the treatment group (from mean of 1.55 to 2.65 mg/dl [88.0 to 150.5  mol/l]) but not for the placebo 
group (from a mean of 1.36 to 1.40 mg/dl [77.2 to 79.5  mol/l]). The researchers suggest that the use of 
high dose sustained-release vitamin C supplementation, rather than vitamin C from normal dietary 
sources, yields anxiety and stress-lowering effects. These results suggest that high dose sustained-
release vitamin C may be effective at reducing induced psychological stress. 
In summary, although stress and anxiety levels decreased significantly between baseline and 
endpoint for the EFA treatment groups in the Rogers et al. study,285 they did not do so between 
treatment and placebo groups and there was no statistically significant difference between the treatment 
groups and placebo for stress and anxiety scores in the Jackson et al. study.286 The use of high dose 
sustained- release vitamin C was effective at reducing anxiety when comparing treatment with placebo, 
but only reduced stress levels in the treatment group in the Brody et al. study.184  
  Chapter 2 
56 









Rogers PJ et 
al.285  
EPA + DHA Placebo None DASS stress scores 
Baseline treatment (N= 85) 15.6±8.1 versus 
endpoint 12.3±7.8 (t(168)=2.70;p=0.0075*) 
DASS anxiety scores 
Baseline treatment (N=85) 5.9±5.6 versus 
endpoint 4.2±4.6 (t(168)=2.16;p=0.032*) 
Outcome measure: DASS 
Jackson PA et 
al.286  
High dose 
DHA + low 
dose EPA 
Low dose 
DHA + high 
dose EPA 
Placebo No statistically significant difference for any t-test 
or ANOVA 
Outcome measures: Bond Lader VAS and the 
DASS 
Brody S et al.184  High dose, 
sustained- 
release 
vitamin C  
Placebo None STAI Scores 
Baseline treatment (N=38) 36.55±7.32 versus 
endpoint (N=38) 43.63±9.23 
(t(74)=3.7;p=0.0004*) 
Endpoint treatment versus placebo 
(50.34±11.95), t(69)= 2.66;p=0.0096*) 
Subjective Stress Scores 
Baseline treatment (N=38) 3.71±2.02 versus 
endpoint 2.25±1.35 (t(74)=3.70; p=0.0004*) 
Outcome measures: STAI 
* p≤0.05 
 Key findings related to the physiological stress measurement outcomes 2.10.4
Keenan et al. examined the cortisol levels of pregnant women both before and after the TSST.294 
(Please see section 2.9, ‘Results,’ for details regarding the TSST.) Cortisol levels did not change as a 
function of EFA treatment at 24 weeks gestation, but at 30 weeks gestation, cortisol levels upon arrival 
at the laboratory were significantly higher in the placebo group. The authors state that they differed 
significantly as a function of EFA supplementation (mean 0.35 compared with 0.27; F [1.74, 74.63] 
3.51,p=0.041) (Table 2.5). The placebo group had cortisol levels that were 20% higher than the EFA 
group at 30 weeks gestation following TSST; (active: placebo 1.86:2.24). The cortisol lowering effect of 
EFA supplementation was greater than its stress lowering effect over the 30 weeks of treatment, 
suggesting that EFA treatment may elicit physiological benefits but may not produce any noticeable 
psychological improvements in stress perception. The researchers suggest that EFA treatment may 
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influence the HPA axis by modulating the response to a social stressor as indicated by the significant 
differences in cortisol output over time. 
Changes in systolic and diastolic blood pressure (SBP and DBP) in the presence of an acute 
psychological stressor, the TSST, were examined in relation to high dose sustained-release vitamin C 
treatment by Brody et al.184 At baseline, participants supplied blood to assess cortisol levels, and saliva 
cortisol samples, blood pressure readings, and subjective stress ratings were taken, at -10, -1, +10, 
+20, +30 and 40 minutes relative to the TSST at endpoint. Upon completion of the last measurement, 
participants’ blood was drawn to assess vitamin C and plasma cortisol levels, and the ACTH 
provocation procedure was repeated. There was no statistically significant difference in mean SBP 
measurements for the vitamin C group between baseline compared to 14 days, although there was a 
significant reduction in SBP measurements in the vitamin C group (111.28±11.41) compared to the 
placebo group at 14 days (118.72±9.44; t(69)=2.96;p=0.0041). There was a statistically significant 
increase in DBP in the vitamin C group at baseline (67.15±6.71) compared to 14 days (88.64±9.53; 
t(74)=11.36;p=0.0001). There was a statistically significant decrease in DBP in the vitamin C group 
(88.64±9.53) compared to the placebo group (95.21±11.64) at 14 days (t(69)=2.6;p=0.0011) 
(Table 2.5). These conflicting results suggest that there may have been an unknown variable impacting 
the vitamin C group, which led to increased DBP measurements between baseline and 14 days. 
In summary, EFA treatment significantly reduced saliva cortisol over time294 and SBP and DBP 
reduced significantly using high dose sustained-release vitamin C treatment in the presence of 
laboratory-induced stress.184  





B Results (Mean±SD) 
Keenan K et 
al.294  
DHA + DPA  
+ ETA + EPA  
Placebo Cortisol (saliva) 
(Mean 0.35 compared with 0.27; F [1.74, 74.63] 3.51,p=0.041*) 






B Results (Mean±SD) 






Placebo Plasma vitamin C levels increased significantly during trial (F=3.9, 
p=0.002*) for treatment group (from mean of 1.55 to 2.65 mg/dl [88.0 to 
150.5  mol/l]) but not for placebo (from a mean of 1.36 to 1.40 mg/dl 
[77.2 to 79.5  mol/l]) 
Blood Pressure Measurements 
SBP: Endpoint treatment (N=38) (111.28±11.41) versus placebo 
(N=33) (118.72±9.44) (t(69)=2.96;p=0.0041*) 
DBP: Baseline treatment (N=38) 67.15±6.71 versus endpoint 
88.64±9.53 (t(74)=11.36;p=0.0001*) 
Endpoint treatment versus placebo 95.21±11.64 (t(69)=2.6;p=0.011*) 
* p≤0.05 
2.11 Discussion 
The findings of this review have demonstrated that EFA treatment was effective at reducing stress in 
pregnant women294 and a combination of vitamin B6 and magnesium may lower stress in women 
suffering from dysmenorrhea.289 High dose sustained-release vitamin C was effective at reducing 
anxiety regardless of hormonal phase, but only reduced stress levels in the treatment group.184 EFA 
treatment was effective at reducing anxiety in one group of women experiencing premenstrual 
tension,297 and one menopausal group in the absence of depression296 but was ineffective at reducing 
anxiety in another menopausal group,295 and in two groups of women experiencing no specific hormonal 
phase.287, 288 The use of vitamin B6 alone was ineffective at reducing anxiety in a group of premenstrual 
women,291 and the use of magnesium in another group of anxious premenstrual women was also 
ineffective.290 However, in combination, magnesium and vitamin B6 was shown to be effective at 
reducing anxiety in one group of premenstrual women.292 Regardless of hormonal phase, older women 
benefited with a reduction in anxiety from using vitamin B6, but not folate or vitamin B12, while the same 
nutrients used alone were ineffective at reducing anxiety in younger or middle aged women.293 Two 
studies that investigated both stress and anxiety found no significant reduction in either mental state 
from EFA treatment.285, 286 Pregnant women’s salivary cortisol was reduced with EFA treatment294 and 
high dose sustained-release vitamin C treatment reduced the blood pressure of stressed women.184  
A large proportion of the research conducted on supplementation and mental well being thus 
far has focussed on the relationship between nutrient supplementation and mood state, such as 
depression, cognitive functioning, memory or mental well being during old age, or during various stages 
of female hormone fluctuation, such as prenatal, pre-menstrual or menstrual phases, as clearly 
evidenced by the studies in this review. In addition, a small group of male and mixed gender studies 
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have investigated the effects of EFA or vitamin B or vitamin C or magnesium or multivitamin and mineral 
supplementation on stress and anxiety.185, 193, 194, 196, 270, 313-318  
Studies wherein EFAs have been used primarily to treat female psychological stress and 
anxiety, regardless of hormonal phase, are not available for comparison with these review findings. 
However, there are some mixed gender and male studies that have investigated the use of these 
nutrients to treat stress and anxiety. A lowering of test anxiety in men was found in a small three-week 
study using EFAs196 and anxiety was also reduced in a mixed gender study in which EFA treatment was 
used over a period of 12 weeks.193, 297 These results are in agreement with the findings of this review 
where anxiety was reduced in PMS using EFAs over a 3-month period.297 Another small male study 
conducted over three weeks using EFAs also resulted in reduced mental stress, possibly due to impacts 
on the central nervous system (CNS) according to the researchers.313 Using physiological outcome 
measures of stress in an eight-week mixed gender study, EFAs significantly reduced heart rate and 
muscle sympathetic nerve activity (MSNA) reactivity to mental stress, supporting the hypothesis that 
EFA treatment may impact the CNS and thereby reduce mental stress.194 This is in agreement with the 
findings of this review where pregnant women experienced a reduction in saliva cortisol after EFA 
treatment.294 These studies were conducted over a significantly shorter period of time than any of the 
studies in this review that addressed stress or anxiety in women regardless of hormonal phase,285-288 
suggesting that gender may play an important, but currently overlooked role, in addressing the 
effectiveness of EFA treatment for stress and anxiety. A longer, two-month trial, analysing EFA 
treatment effects in a mixed gender study resulted in reduced plasma adrenaline and noradrenaline 
levels following treatment.314 The researchers suggest that decreased HPA axis activation produced an 
anxiolytic effect, supporting Delarue et al.313 and Carter et al’s.194 hypotheses relating to EFA activity in 
the CNS, and supporting the findings of this review. Biochemical, physiological and clinical findings, 
although sparse, support the hypothesis that EFAs may be useful in the treatment of stress and anxiety, 
although gender and length of study need to be taken into account when analysing results.319-321 
Studies are not available wherein the use of the specific vitamins and minerals of interest to 
this review have been used to address female stress and anxiety regardless of hormonal phase. 
However, there are a few studies wherein the use of multivitamins (which include the review nutrients of 
interest) was examined in relation to stress and anxiety in both genders. In a mixed gender study that 
investigated the effect of a multivitamin on stress levels in a sample of people experiencing on-going 
social stress, a statistically significant difference was found between the treatment and placebo groups 
after 30 days.270 Furthermore, two studies that examined subjective stress experienced by men found 
that a reduction in stress followed four weeks of multivitamin supplementation.315, 316 Haskell et al. 
investigated the effect of multivitamin supplementation on cognitive functioning, mental fatigue and 
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mood in women, over a nine-week period and although supplementation improved cognitive function, it 
did not improve mental wellbeing, including anxiety.317 A possible suggestion for the lack of treatment 
effectiveness is a gender-specific response distinction and the short duration of the study, a finding 
which is supported by a year long supplementation research project that yielded results in women’s 
mood after 12 months, and supports the study comments in this review where a 35-day B vitamin 
supplementation program did not produce significant differences in all three age groups involved.272, 293 
In addition, the study in this review that examined the effect of vitamin B6 and magnesium on anxiety 
related to PMS found a significant difference after five months of treatment, again supporting the idea 
that the length of time that the nutrient is consumed impacts effectiveness.292 Two studies wherein 
vitamin C was used to treat anxiety are available, and in agreement with the findings of this review, 
anxiety was effectively reduced using this form of treatment. In a 14-day study conducted by de Oliveira 
et al. anxiety was significantly reduced using vitamin C with a mixed-gender group, and anxiety was also 
reduced using the same nutrient, compared to vitamin E, in a study with mixed gender Type-2 diabetic 
patients conduced by Mazloom et al. over six weeks.185, 318 These study comparisons suggest that the 
effectiveness of vitamin C in reducing anxiety is realized over a shorter period of time compared to 
possible B vitamin or EFA treatment effectiveness. 
2.12 Limitations of the studies 
Six studies used physiological measures of compliance to the interventions, leading to increased 
reliability in assessing treatment compared to placebo. To assess magnesium intake the magnesium-
creatinine urine ratio analysis was used in two studies290, 292 and EFA blood plasma assessment was 
used in three studies.285-287 One study assessed levels of vitamin C in blood plasma.184 The other eight 
studies used either capsule count,289, 296 or self report,293, 294 or a combination of self-report and capsule 
count,295 while three of the papers did not mention compliance.288, 291, 297 A lack of compliance evidence 
introduces the possibility that the placebo effect was responsible for any observed changes, leading to a 
lack of confidence in assessing outcomes related to treatment. 
The use of olive oil alone in four studies,285-287, 295 or in combination with maize and soya oil288 
may have acted as a confounding variable in these studies, rather than as placebos, which should be 
inert substances, due to a possible active effect of these oils. Sunflower oil alone,296 and a combination 
of corn and soybean oil294 were used for the same purpose in two other studies, and may have acted as 
confounding variables in these studies too. 
The presence of antioxidants and plant sterols in olive and sunflower oil, and pro-inflammatory 
eicosanoids that are derivatives of the omega 6 EFAs used in these studies, found in sunflower oil, may 
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have acted as treatment confounders. Antioxidants inhibit damage caused by reactive oxygen species 
(ROS), which may improve neuronal membrane integrity, function, and neurotransmitter synthesis322, 323 
and plant sterols may lower high cholesterol and improve fat digestion,324, 325 influencing the efficacy of 
essential fats being consumed as part of the participant’s diet, consequently influencing membrane 
function and neurotransmitter synthesis.191, 193, 325, 326 This may have been beneficial for the participants 
in the placebo group, thereby limiting the reliability of conclusions that can be drawn between the 
treatment and placebo groups in these studies, none of which reported significance between treatment 
and placebo.285-287, 295 Inflammatory prostaglandins promote neuronal membrane inflammation and 
cytokine production which has been linked to increased anxiety322, 327 and may have limited the reliability 
of the conclusions drawn between the treatment and placebo groups in these studies,294, 296 with the 
longest running study showing no significant difference between treatment and placebo.288 Only one 
study used an inert substance as a placebo, where significance was reached over time.297  
The EFA manufacturing process, which introduces light, heat and oxygen to the fats being 
processed, leads to fatty acid degradation and the transformation of EFAs into a variety of peroxidation 
products, such as trans, polymerized, cyclised and cross-linked fats. 298, 325, 328-331 The presence of these 
damaged fats in neuronal cell membranes may lead to disturbances in membrane and neurotransmitter 
synthesis and function,298, 325, 332 but was not mentioned in any of the studies. Two of the three studies 
that mentioned the form of magnesium used,290, 292 made use of magnesium oxide, which has a limited 
range of bioavailability (0 – 4%) and may therefore have limited treatment efficacy.39, 333 The use of a 
variety of compounds in placebos such as pressed lactose289 with possible effects on lactose-intolerant 
participants, or calcium and magnesium293 with magnesium’s anxiolytic effects39 or amino acids289 or 
sedative use among participants297 may have acted as confounding variables in these studies, limiting 
the reliability of their results. The presence of a variety of genetic polymorphisms may influence folate, 
(vitamin B9), vitamin B6 and vitamin B12 synthesis334 and may have influenced the efficacy of these 
nutrients in the participants in the Davis, Kashanian et al., De Souza et al., and Bryan et al. studies.289, 
291-293 A polymorphism on the methylenetetrahydrofolate reductase gene (MTHFR) which influences the 
breakdown of vitamin B9 (folic acid) into methionine, an important amino acid which facilities protein 
synthesis and antioxidant utilization, and which has been implicated in a number of mental health 
challenges may have been present in an unknown number of participants that took part in the Bryan et 
al. study, and participants were not tested for this genetic variation.293, 334, 335 The presence of this 
polymorphism may have influenced treatment outcome, as 10-20% of the worldwide population may 
possess this gene variant, although these percentages do vary according to ethnicity and geographical 
location.334-337 These confounding variables introduce variance between the treatment and placebo 
groups that is not due to the treatment, thereby limiting the reliability of the results. In other words, the 
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active placebo ingredients act as extra independent variables, possibly having a hidden effect on the 
dependant variable, stress or anxiety, or, genetic variations inhibit the efficacy of the nutrient, also 
limiting result reliability. 
The choice of participants as well as the size of the sample, can lead to limited generalizability 
of results. Five of the 14 papers recruited student volunteers as participants, introducing selection bias, 
and limiting the generalisability of the results.286, 288-291 Recruiting stressed or depressed volunteers may 
have led to confounding due to very high levels of stress influencing treatment outcome or 
effectiveness294 and depressed people may experience less stress or anxiety reduction from treatment 
than people who are not depressed.285 Wide variation between study participants as indicated by the 
inter-quartile variation within age groups293 does not facilitate a meaningful comparison between the 
groups, and variations in baseline nutrient intake as measured by FFQ analysis, may have introduced 
further confounding, although this phenomena was likely not limited to this study alone. 
Sample size varied from just over 40 to 355 participants, leading to uncertainty regarding the 
generalizability of the results from the small samples. Four of the researchers reimbursed participants, 
leading to possible confounding,184, 288, 295 with one using an accelerated schedule of reimbursement, 
where an increase in payments occurred for each subsequent visit, which may have influenced 
compliance reporting, especially as participants were drawn from a low income population. 184, 288, 294, 295 
Eight of the selected papers assessed the use of specific nutrients during a particular 
hormonal phase, limiting the generalizability of the results.289-292, 294-297 The longest study that 
investigated the impact of EFA treatment on anxiety lasted for 26 weeks,287 while the longest time 
period for any of the other nutrients investigated was five months.292 Long-term studies may be required 
to adequately assess the impact of nutrients on mental wellbeing, with a study by Benton et al. showing 
a beneficial response in terms of mental composure only after 12 months, for female participants 
consuming a multivitamin and mineral supplement.272 De Souza et al’s. study supports this suggestion, 
as it was the longest running included study and significance was reached at five months.292  
The wide variety of outcome measures used to assess outcomes, notwithstanding the fact that 
the majority possessed reasonable reliability, makes it challenging to compare results between studies. 
The use of outcome measures that have not been tested for reliability, such as a menstrual diary in four 
of the studies, within which participants recorded feelings of anxiety and stress, may introduce recall 
bias and a lack of consistency over time.290-292, 297 Recording bias may also be a challenge in this type of 
measurement, with participants or researchers inaccurately deciphering responses.338 Repeat testing 
bias may have been introduced when participants were exposed to the same outcome measure on both 
training and testing day, possibly limiting the results that can be drawn from this study.286 
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2.13 Limitations of this review 
A significant challenge in attempting to compare the studies that used EFAs as treatment was that the 
actual amounts and combinations of EFAs consumed by the participants varied significantly. Clearly, 
comparing the use of these EFAs in differing doses, coupled with placebo’s that contain substances with 
potentially confounding effects leads to an inability to adequately comment on the impact of treatment. 
In addition, none of the studies assessed the impact of any of the nutrients on participants’ levels of 
perceived stress, but instead induced stress via the TSST.184, 294 Eight of the 14 studies investigated 
stress or anxiety during specific hormonal phases,289-292, 294-297 reducing generalizability, with six of 
these only investigating anxiety or stress as a secondary outcome, or as a small sub-scale of an 
outcome measure or self-report diary.290-292, 295-297 The large range of outcome measures used to 
measure stress and anxiety, with varying rates of reliability, also make comparisons between these 
studies challenging. Due to a lack of raw data for the majority of the studies it was not possible for the 
reviewer to use any other statistical tests besides the independent t-test, which limited conclusions to be 
drawn from study results. No studies examining the impact of vitamin B1, B2, B3, B5 or zinc on female 
stress were identified during the systematic literature search. Due to the possible population variability in 
nutrient intake, as evidenced by Bryan et al. it may not be possible to assess the effect of 
supplementation on levels of stress or anxiety unless the baseline nutrient status is comparable, which 
was only established in the afore mentioned study.293 Individual differences in age, body weight, nutrient 
and specific fat content of diet, metabolic rate, nutrient absorption, hormone phase, and/or the 
presence, absence or balance of specific hormones at the time of treatment, as well as general mental 
health, including the ability to manage stress and the perception of stress, and inborn errors of 
metabolism, such as gene polymorphisms, may all influence the impact of nutrient treatment on 
participants. The gathered evidence in this review is therefore conflicting, as there is no consensus as to 
whether the treatments were effective for reducing stress and/or anxiety in either non-hormonal or 
hormonal phases. 
2.14 Conclusion 
Stress and anxiety are common mental health challenges that affect women regardless of age. Within 
the specific nutrient treatments examined, no consensus was reached as to the effectiveness of the 
nutrients at reducing perceived levels of stress or anxiety. Using the best available evidence, this review 
suggests that EFA treatment may be effective at reducing stress during pregnancy and reducing anxiety 
during premenstrual syndrome, and during menopause in the absence of depression. Magnesium and 
vitamin B6 may be effective in combination at reducing stress in premenstrual women and vitamin B6 
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may lower anxiety in older women. Salivary cortisol may be reduced using EFA treatment and anxiety 
and blood pressure may be reduced using high dose sustained-release vitamin C. 
 Implications for practice 2.14.1
The use of EFAs may be useful at reducing prenatal stress levels and cortisol levels, as well as 
premenstrual anxiety or menopausal anxiety in the absence of depression (Grade B).339 Magnesium 
and vitamin B6 in combination may be useful in reducing premenstrual stress (Grade B).339 Vitamin B6 
may be effective at reducing anxiety in older women (Grade B).339 High dose sustained-release vitamin 
C may be effective at reducing anxiety and high blood pressure (Grade B).339  
 Implications for research 2.14.2
This review highlights the lack of research into the role that specific nutrients may play in reducing 
stress and anxiety in women regardless of hormonal phase. The use of EFA, B vitamin, vitamin C, 
magnesium and zinc treatment to address female stress requires further investigation using long-term 
studies, regardless of hormonal phase. Future research should take into account the complex interplay 
of daily life with its ongoing inherent stressors, coupled with individual differences, including nutrient 
status at baseline. 
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A dearth of evidence to support the use of specific nutrients to reduce stress in the general female 
population was evident from the results of this systematic review. The knowledge gap thus identified led 
to the design and implementation of two primary research projects, a quantitative and a qualitative 
project. Firstly, a cross-sectional survey was conducted that examined perceived stress and nutrient 





THE RELATIONSHIP BETWEEN SPECIFIC NUTRIENTS 
CONSUMED VIA THE DIET AND/OR DSS AND STRESS LEVELS 
AMONG A GROUP OF WOMEN: 
A CROSS SECTIONAL PROJECT 
3.1 Introduction 
The purpose of this chapter and research project was examine the relationship between perceived 
stress scores (PSS) and specific nutrients consumed in the diet and/or via DSs among a group of 
women in Queensland (Gold Coast), Australia. This project included three questionnaires, which 
gathered data about the perceived stress of the participants, the types of DSs used and associated 
variables, and food choices. The data was analysed to ascertain whether there was a relationship 
between any of these variables. The position of this project within the JBI EBHC model is also 
addressed in this chapter. 
Although a growing body of evidence suggests that nutrients have an important role to play in 
mental health and specific dietary patterns (DPs) have been associated with such, the impact of 
nutrition and nutrient deficiencies on the experience of stress in women is presently underexamined.163, 
164, 170 The use of stress-targeted DSs is prolific, evidenced by the global expenditure on these products, 
which is estimated to reach USD16.7 billion by 2025.8 However, the efficacy of these products, 
particularly in relation to women is currently unknown. The few experimental studies that have 
investigated this phenomenon used a combination of nutrients despite the prolific use of stress-targeted, 
nutrient-specific DSs.180, 270, 317  
Stress hormone synthesis takes precedence over the synthesis of neurotransmitters that 
regulate mood, such as dopamine and serotonin, and the synthesis of all these compounds require 
many of the same nutrients.2, 132, 133, 340 Whether a lack of specific nutrients has a role to play in the 
development of affective disorders is unknown at present, however, it is well recognized that chronic 
stress has the potential to lead to the development of depression and anxiety.46-51 Nutrient sufficiency 
may therefore provide neurobiological support in the prevention of affective disorders. As women report 
higher levels of stress than men,17, 18, 20-26, 28 are more likely than men to become depressed following 
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stressful life events,52, 53, 284, 341-343 and use more DSs than men, research into whether the consumption 
of specific nutrients is related to lower stress levels among women is warranted.223-225, 229 
3.2 Situating Quantitative Research Evidence Within The JBI 
Model of EBHC 
As discussed in Chapter one, the JBI Model of EBHC takes into account that a wide variety of 
methodological approaches to health research may be useful because different approaches answer 
different questions (Figure 1.5, Section 1.9). The JBI model comprehensively facilitates the discovery of 
knowledge gaps, supports the generation of new knowledge and provides expertise in sharing 
knowledge by providing a useful framework to support researchers focused on producing EBHC.344 This 
model therefore incorporates and supports a variety of approaches to evidence generation, synthesis, 
transfer and implementation, which in the case of this exploratory research project and as a first step, 
led to the identification of a knowledge gap, which resulted in a systematic review. (Chapter 2)10, 265  
The centre of the JBI model, the ‘pebble of knowledge,’ summarises the foundation of 
evidence and how it informs practice via the FAME scale.265 The broad conceptualisation of JBI-FAME 
clearly and simply reflects the variety of research approaches that health researchers may use, such as 
the degree to which an activity or intervention is practical within a specific context (Feasibility), the 
degree to which an activity or intervention fits within a particular context (Appropriateness), the degree 
to which an intervention is meaningful and experienced positively by individuals or groups 
(Meaningfulness), and the degree to which an intervention achieves intended results (Effectiveness).265 
JBI-FAME acknowledges that there is a need for diverse forms of evidence to support complex 
knowledge needs when investigating complex clinical questions including mental health challenges. 
This framework is therefore supportive of research that is informed by the specifics of the research 
question, such as is the case with this cross-sectional survey aimed at investigating the unexamined 
relationship between a psychological construct and a specific behaviour.265 
3.3 Methods 
 Introduction 3.3.1
Questionnaires are a frequently used form of data collection, as they can collect large volumes of data 
about participants, including their knowledge, opinions, values, behaviour and attitudes, and can be 
either specific and narrow in scope, or more global and generalized.345, 346 Three questionnaires were 
used in this cross sectional survey. The PSS is a validated measurement instrument that is used 
globally.14 The dietary questionnaire for epidemiological studies (DQES) is an Australian validated food 
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frequency questionnaire.347 The supplement use questionnaire (SUQ) was developed by the researcher 
and details regarding the piloting and testing of face validity for this instrument are addressed in section 
3.3.12.2. 
Combining the quantitative results from this survey with those from the qualitative project 
(Chapter 4) revealed a deeper understanding of the phenomena under investigation.348  
 Ethics approval 3.3.2
Ethics approval for this project was received on the 6th of May 2016 (H-2016-090) (Appendix H). 
Participants provided consent on two occasions. SurveyMonkey, an online tool that allows for 
the design of surveys and the gathering of data was used for such, wherein the first page of the online 
survey form advised participants that by clicking the ‘continue’ button they were providing consent to the 
use of their data for the research project.349 Secondly, an email was sent to participants with a unique, 
numerical Internet-based (URL) identification (ID) code providing access to the online DQES survey 
developed by the Cancer Council of Victoria (CCV) and advised them that by linking to the DQES they 
were providing consent to the use of their data. Appendix I contains the survey introductory page from 
the SurveyMonkey online form.  
Participant data was anonymized after data cleaning when all the data from all three survey 
questionnaires were merged into an excel spreadsheet ready for upload and data analysis in Stata 
(version 15, Stata Corp, College Station, Texas, USA). 
Appendix J contains the study timeline. 
 Population of Interest 3.3.3
Women living on the Gold Coast, in Queensland, Australia. 
3.3.3.1 Sample size 
Eighty-seven women were recruited to the project. A total of 74 women completed all three surveys. 
3.3.3.2 Sampling and Recruitment Procedure 
Recruitment was initially scheduled to occur over a 12 week period, from the 25th May 2016 to the 10th 
August 2016, and was initiated via information flyers at three locations on the Gold Coast, a medical 
practice, a pharmacy and a health store, with the aim of investigating whether women visiting these 
locations differed in their experience of stress and nutrient and DS use. The uptake of information flyers 
from the three locations was poor and it was therefore decided to change the recruitment strategy at 
week ten, as only four women contacted the researcher to take part in the research project and only 
from the health store flyers. All the flyers were removed from all the centers during week 12. 
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As a result of these poor recruitment results and with approval from the ethics board, it was 
decided to implement a combination of convenience and snowball recruiting, starting from the 12th of 
August, to run for four weeks, until the 9th of September 2016. The researcher wrote a blog post for a 
radio station inviting participation, sent an invitation to council workers via the council e-newsletter and 
invited female friends to participate and share details about the project with other interested women 
face-to-face and via Facebook. This is therefore a non-probabilistic sample. 
All recruitment channels provided the researcher’s email address, a telephone number 
dedicated to this project and a link to a Facebook page. Respondents expressed their interest to the 
researcher via any of these methods. (See Appendix K and L for details regarding the blog post and 
Facebook page respectively.) 
Participants were aged between 21 and 65 and representativeness of age in this sample was 
assessed using the census data from the Australian Bureau of Statistics (ABS). The only available age 
related data for people living on the Gold Coast, Australia, related to both genders and reported that the 
median age was 38 as at 2016.350 
A dedicated Facebook page, ‘Female Stress and Nutrition – Research Project,’ was created 
prior to recruitment to provide respondents with information about the project and as a means to contact 
the researcher via private message, email or telephone (Appendix L). The same options were available 
to women who did not use Facebook. Women were offered a free e-book about skin care via the 
Facebook page as an incentive for completion of all three surveys. 
 Response Rate 3.3.4
A total of 87 women responded to the invitation to participate in the study, 13 of which failed to complete 
all three surveys, for an 85% completion rate. 
 Eligibility and exclusion criteria of participants 3.3.5
Participants were deemed to be eligible to participate in the research project if they were female 
residents of the Gold Coast at the time of recruitment, aged from 18 years, and could provide informed 
consent. Participants were deemed ineligible if they did not live on the Gold Coast, did not fall within the 
age range, or were unable to provide informed consent. 
 Power Analysis 3.3.6
This research project was an exploratory research project aimed at gathering preliminary data to inform 
hypothesis generation and support further research.346, 351 No formal sample size calculations were 
performed. 
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 Procedures 3.3.7
SurveyMonkey was used to deliver the questionnaires to, and collect the data from participants. 
Delivering the surveys via SurveyMonkey enabled the participants to complete them when convenient 
and communication via the Internet allowed the researcher to send email reminders about completing 
the surveys and allowed for the verification of supplement brands, which was necessary on occasion, 
prior to data anonymization. 
 Contacting participants 3.3.8
Respondents provided their email address to the researcher who sent them two emails, one containing 
the ID link to the DQES and the second email was sent via SurveyMonkey where the PSS and SUQ 
were available for completion. See Appendix M for an example of these emails. 
3.3.8.1 Participant information sheets and recruitment cover letter 
The first email contained two documents: a recruitment cover letter, which was a two-page information 
document that explained in detail the nature of the project, including data anonymization and the contact 
details of all involved researchers, and a one-page participant and survey information sheet which 
briefly explained the aim of the research project with instructions to complete the questionnaires. See 
Appendix N and O for examples of these documents. 
3.3.8.2 Researcher follow-up and reminders 
The researcher sent a reminder email or Facebook message a week after the respondent received the 
initial emails. The respondent was reminded of the surveys and asked whether they had any questions 
related to the survey. On occasion a respondent required the survey links again, which the researcher 
supplied. Two weeks after sending the previous reminder email the researcher again sent a reminder 
about the survey. A final reminder was sent two weeks prior to the conclusion of the study, 12 weeks 
after the initial email was sent. Completes were thanked via email or Facebook and were sent the skin 
care e-book. 
 Data Collection 3.3.9
Data from the PSS and the SUQ was captured online via a SurveyMonkey form and exported into a 
spread sheet. Anonymous data from the DQES was captured online and analysed by the CCV after 
which it was sent to the researcher. All the data was held on the researchers private computer with two 
separate backups taking place every day, which the researcher alone had access to. The de-identified 
data was shared with a statistician for data analysis. 
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3.3.9.1 Data Cleaning 
Data cleaning was undertaken by checking all the data to ensure no data was missing, incomplete or 
unusable and data quality was improved where necessary by correcting detected errors and omissions. 
3.3.9.2 Merging Data 
A spread sheet containing data for each participant was updated daily as completion of the surveys 
occurred, which allowed for follow up with participants who had not completed all three surveys. The 
DQES ID link was the code used to link participant data from all three questionnaires and simplified de-
identification after the recruitment for the PAR project (Chapter 4) was complete. Nutrients not of 
interest to this project were removed from the data set supplied by the CCV before a final merged 
spread sheet was ready for upload into Stata (version 15, Stata Corp, College Station, Texas, USA). 
3.3.9.3 Data Analysis 
Participant characteristics and nutrient intakes were reported using frequencies and percentages for 
categorical items, and descriptively summarized using means and standard deviations for continuously 
measured items. Associations between categorical variables of interest were assessed using Fisher’s 
Exact tests, and differences between continuously-measured outcome variables between participant 
sub-groups of interest were explored using the Wilcoxon Rank-Sum test and the student t-test. The 
relationships between specific nutrients and PSS scores were examined using Spearman’s correlations 
and multivariable linear regression. In light of previous research the effect of particular nutrient 
combinations was analysed.292, 352  
Analyses were carried out using Stata (version 15, Stata Corp, College Station, Texas, USA). 
The two-tailed level of significance was set to 0.05. Corrections for multiplicity were made using the 
Sidak-adjustment. 
3.3.9.4 Instrumentation 
Three questionnaires were used to gather data in this project, the PSS, the DQES, and the SUQ, the 
development of which was necessitated prior to data collection.14, 347 (Appendix P and Q.)   
 Assessment of Perceived Stress using the Perceived Stress Scale (PSS) 3.3.10
Cohen et al. designed a self-report perceived stress measurement tool, the PSS-14, in 1983 as a 
means to measure the degree to which life situations were perceived as being stressful and how they 
may impact physical health.14 Items were designed to account for how uncontrollable, unpredictable and 
overwhelming respondents experience their lives over a one-month time period, all central elements 
related to the experience of stress.14  
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In 1988 Cohen et al. shortened the PSS to a 10-item measurement tool, which was used in 
this survey.353 The PSS-10 has been validated and used widely in a variety of English speaking, 
European and Asian countries, and in a number of fields, including business and health, to assess the 
degree of global stress being perceived in a given situation, the effectiveness of an intervention on 
psychological stress and the effect of perceived stress on quality of life.354  
The PSS is not a diagnostic or screening tool but rather a self-administered tool to measure 
changes in perceived stress over time. There are no categories and only comparisons are made of total 
scores between people within the sample of interest.14, 353 The minimum score representing no 
perceived stress is 0 and the maximum score representing the highest perceived stress is 40. See 
Appendix P for an example of the PSS-10. 
The tool is self-administered and uses a matrix-style answering grid, with five response options 
for each of the ten questions, namely ‘Never,’ ‘Almost never,’ Sometimes,’ Fairly often,’ and ‘Very often.’ 
The scaling responses for each response option are 0, 1, 2, 3, and 4 respectively. Questions four, five, 
seven and eight are positively stated items, and scores are obtained by reversing these scores and then 
summing across all 10 items. This was added to a SurveyMonkey template and software logic made it 
possible to automatically score the responses yet keep them hidden from the participant which provided 
the researcher with the total PSS-10 score for each participant.  
The PSS does not tie the appraisal of questions to specific situations and is therefore sensitive 
to the non-occurrence of events, which may also be perceived as stressful. This is of importance to this 
project because chronic stress may not be related to specific events. In addition, the PSS-10 is a short, 
one-page questionnaire that is simple to administer and score. Furthermore, the PSS-10 was designed 
for use in community samples with at least a high school education and the questions are of a general 
nature and therefore free of content that is specific to any subpopulation group.353 
 Assessment of Nutrient Intake via Food using the Dietary Questionnaire 3.3.11
for Epidemiological Studies (DQES) 
The DQES was originally developed by the CCV to measure dietary intake of people participating in the 
Melbourne Collaborative Cohort Study (MCCS).347 The DQES version 3.2 (DQES v3.2) is an updated 
version of the DQES v2 designed to cover dietary intake over a period of 12 months.347  
This FFQ reports on participant’s usual intake of 152 foods and six alcoholic beverages using 
37 questions; responses are guided by food portion images and beverage consumption guides. A 
combination of food frequency, multiple responses to a variety of foods, portion size, seasonal fruit 
intake and alcoholic beverage intake are used to calculate the approximate daily equivalent of nutrient 
intake for each participant. Nutrient intakes are computed using the Nutrient Tables for use in Australia 
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(NUTTAB) and Australian Food, Supplement and Nutrient (AUSNUT) reference and survey databases 
respectivly.355-357 Intakes are expressed in gram/serves or g/mg of nutrients per day. Most food item 
questions use a 10-point scale and questions move from simple to complex.  
This FFQ is a comprehensive, computer-based tool that can be self- or interviewer 
administered and was validated for assessing habitual dietary intake in the Australian population.358 The 
first page of the DQES provides instructions about completing the survey along with details about the 
survey aims. Three options are present in the form of ‘buttons’ at the bottom of each screen ‘page’ 
facilitating a move to the previous page, to stop and save the survey, or move to the next page. 
The researcher received 100 ID links from the CCV and sent a link to each participant via 
email. For this project, the CCV checked for FFQ completes each week, which allowed the researcher 
to prompt completion via an email. 
The CCV generated four excel output reports for all the completes when data collection was 
complete (23 September 2016), and included raw data, nutrients from food excluding alcoholic 
beverages, nutrients from alcoholic beverages and food intakes in grams per day. 
The FFQ made provision for all the nutrients of interest to this project and may yield data more 
valid to this project versus a 24-hour recall questionnaire because long-term, not short-term, nutrient 
intake or deficiency may be associated with mental health and a wide combination of nutrients may 
impact mood.172, 272 In addition, as this tool was self-administered, participants could save their answers 
if unable to complete the FFQ in one sitting, which made it ideal for the sample of interest 
 Supplement Use Questionnaire (SUQ) 3.3.12
3.3.12.1 Introduction 
A comprehensive search of relevant studies for an instrument to assess DS use was conducted. Three 
questionnaires were found, the Dietary Supplement Questionnaire (DSQ), the Supplement Frequency 
Questionnaire (SFQ) and the VITAL questionnaire.359-361 None of these questionnaires were suitable for 
this project as none provided for the reporting of specific quantities of nutrient per supplement, which 
precluded examining a dose-response and only commonly used, American DSs were listed. In addition, 
motives for supplementation, perceptions of effectiveness, who/what prompted use and where DSs 
were purchased was also not addressed. Furthermore, the majority of the questions provided close-
ended response options, limiting the possibility of collecting a wider range of associated data. Due to the 
nature of these limitations and the requirement for gathering specific data in line with the research 
questions, the design of a SUQ was completed in April 2016, prior to recruitment commencement 
(Appendix Q). 
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3.3.12.2 Design, Reliability and Validity of the SUQ (Methods) 
The questions and design format of the DSQ, SFQ and VITAL questionnaires were examined, which 
provided examples of questions that did provide the scope required for the SUQ. Next, the researcher 
examined the labels of approximately 100 DSs, comprising MVMs and single nutrient DSs, which, 
combined with appropriate questions from the three questionnaires, resulted in a comprehensive list of 
the contents, form, dosage and frequency instructions for DSs. Questions were developed to provide 
data on perceptions and behaviour associated with DS use, for example, whether the DS was perceived 
as being useful and who/what prompted use. Using this data, a list of possible draft questions was 
compiled with which to answer the research question. These questions were separated into groups that 
informed specific data end points such that all the questions related to type of DS and nutrients were 
grouped together, as were those related to dosage, frequency and duration of use. Establishing these 
groups supported a simple design format and logical question flow from the beginning to the end of the 
SUQ. Next, comprehensive response options that made provision for a variety of possible responses 
were developed. A screening question, with which to establish respondent eligibility was developed, as 
was an introduction to the questionnaire and instructions to guide completion. Overall, specific 
characteristics, underpinned by questionnaire design research, were utilised throughout the 
questionnaire development process. For example, clear and direct phrasing in the introduction and 
instruction sections and clearly articulated questions and response options were used, as was design 
format aimed at increasing completion, such as logical question and group flow, and aesthetic appeal. 
Finally, two forms of the questionnaire were designed for dissemination; a pen-and-paper and an online 
form using SurveyMonkey, and the relevant logic and parameters. However, regardless of questionnaire 
dissemination, the presence of specific characteristics can improve validity and reliability, and hence, 
the quality of the data gathered.362 Appendix R contains a list of questionnaire design characteristics 
that supported the development of the SUQ. 
Three tests were performed to assess face and content validity and administration techniques. 
Firstly, the authors pretested the questionnaire among their peers to ensure the questions were clearly 
articulated, appropriate and relevant to the research question. Feedback suggested that these 
characteristics were present, which was indicative of both face and content validity. In addition, 
administration of the pre-test questionnaire was undertaken using both forms of the questionnaire, using 
the same techniques that were to be used for the survey.363  
Secondly, the authors conducted a pilot test (feasibility study) wherein ten women were 
purposively sampled, provided with the SUQ, asked to complete it and provide feedback. The subjects 
ranged in age from 18 – 60 years and included a dietician and a pharmacist. Subjects completed the 
SUQ online after receiving the survey link via email, after which they completed a pen-and-paper form, 
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and then provided feedback on both forms. Two changes were made to the SUQ after feedback 
following this test, which included adding a question about multiple uses of DS per day and a clearer DS 
definition in the introduction. In addition, none of the respondents consumed more than 10 DSs, so this 
number was not increased in either forms of the questionnaire. Responses from this pilot test were 
suggestive of both face and content validity, which was further supported by the expert analysis of the 
instrument by the dietician and pharmacist, who have experience in DS use, dosage, recommendations, 
motivations for use and purchasing.364 Test-retest reliability was informally assessed by using two 
different forms of the questionnaire, the results of which suggested a high degree of agreement with 
these two administrations of the SUQ. Furthermore, the possibility of systematic error due to the 
learning effect was reduced as different forms of the questionnaire were completed and compared.365 
Although informally assessed, these results suggest that reliable data can be generated using either 
forms of the SUQ.366 Inclusion in this pilot study precluded participation in the research project. 
The pilot test also provided an opportunity for the authors to test the administration and data 
collection procedure and the response rate, as the same administration procedure was to be used in the 
study. Some of the respondents required a reminder follow-up email to complete the survey. The 
response rate was 100%. Thirdly, a test to ascertain face validity was administered, using two groups of 
purposively sampled women, one of who had seen the SUQ before (n=20) and another who had not 
seen it previously (n=20). Both groups were provided with the questionnaire online, accompanied with 
one question and four possible response options. The question was: ‘In your opinion does the 
Supplement Use Questionnaire (SUQ) look like it is assessing your supplementary use of dietary 
nutrients?’ The four response option were: ‘Yes, definitely;’ ‘Yes, I think so;’ ‘No, I don't think so’ and 
‘No, definitely not.’ The results of both respondent groups are in Table 3.1, which reflect a high 
percentage of positive responses, suggestive of face validity. The response rate was 100%. 
Table 3.1: Face Validity percentage results of new and previous questionnaire respondents 
 Yes, definitely Yes, I think so No, I don't think so No, definitely not 
New respondents 55 35 10 0 
Previous respondents 50 45 5 0 
 
Although confirming face and content validity is not possible using a statistical test because these 
concepts are primarily subjective in nature, the pre-test, the pilot test and the SurveyMonkey test all 
confirmed that the SUQ seemed to be measuring the concepts it was aimed at measuring and included 
the right sort of content, which included expert opinions in the field of dietary supplementation. Both 
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forms of the SUQ were made available for dissemination, a pen-and-paper form and an electronic form 
in SurveyMonkey, although only the electronic form was used in the survey (Appendix Q). 
3.3.12.3 Calculation of nutrient intake via supplementation 
The ingredients of each reported DS were examined to establish the amount of the nutrients of interest, 
then the total amount of the nutrient consumed at each serving was determined and used in data 
analysis. This resulted in the development of a DS database that totalled 96 items (Appendix S).  
Effect estimates were presented as meaningful increments of increase, according to the 
recommended daily allowances (RDAs) for each nutrient of interest. For example, the RDA for plant-
sourced Omega 3 (ALA) is 1000mg, while that of B12 is 2.4mg.367, 368 
3.4 Results 
 Participant Characteristics 3.4.1
The participant cohort comprised 74 women who ranged from 21 to 70 years of age with a mean age of 
42.7 years (SD: 13.8 years). Fifty-eight of the participants reported using DSs (78.4% of the sample), 16 
reported no use of DS (16/74; 21.6%) and five (5/74; 6.76%) reported the use of DSs that were not of 
interest to this study. The total number of DSs containing nutrients of interest reported per participant 
ranged from one (n=22 participants) to five (n=3 participants). (See Appendix T for a summary of the DS 
combinations cited by participants.) PSS scores ranged from 10 to 36 with a mean score of 19.66 (SD: 
5.90) and a median score of 19. Table 3.2 summarizes this data. 
Table 3.2: Description of survey participants, total number of DS used and summary statistics 
for PSS scores 
Participant characteristics   
N 74 
Age in years (mean ± SD) 42.7 ± 13.8 
Supplement use   
Yes (n, %) 58  (78.4) 
Total number of supplements used (n, %)   
1 22 (29.7) 
2 16 (21.6) 
3 10 (13.5) 
4 2 (2.7) 
5 3 (4.1) 
N/A (No DS used or nutrients not of interest) 21 (28.4) 
Summary statistics for PSS scores    
Mean ± SD 19.66 ± 5.90 
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Participant characteristics   







PSS scores ranged from 10 – 36. The mean score was 19.66 (standard deviation of 5.90 units) 
and the median score was 19. Mean PSS scores were slightly lower among women who used DSs 
(M=19.2, SD=5.8) compared to women who did not use DSs (M=21.4, SD=6.3). Differences in PSS 
scores between groups was assessed using the Mann-Whitney U test. There was no statistically 
significant difference between groups (Z=1.20, p=0.231). Table 3.3 summarizes this data. 
Table 3.3: Summary statistics for PSS scores by DS use 
Supplement use Number of subjects 
Perceived Stress Scale score 
Mean (SD) Median Min Max 
No 16 21.4 (6.3) 21 12 36 
Yes 58 19.2 (5.8) 18 10 33 
 
 Supplement characteristics 3.4.2
The total number of DSs cited among the 53 participants who reported using at least one DS was 107. 
The most frequently-cited types of DSs were essential fatty acids (EFAs) which accounted for 
approximately 23% of the 107 DSs reported, followed by multi-vitamins and minerals (MVMs), which 
comprised 16%, followed by vitamin C (13.1%), Magnesium (9.4%), and vitamin B12 (6.5%) (Appendix 
U).  
Frequency and duration of use was recorded for each DS. The majority of the DSs were 
reported as being consumed once daily (65/107=61%). More than 60% of the reported supplements 
were reported as being taken for a duration of over six months, with 25.5% reported as being taken for a 
period of 6-12 months and 38.7% reported as being used for a duration of more than one year 
(Appendix V). 
Of the cited supplements, 59% were perceived to be useful by their user. For 42% of 
supplements, the participant was ‘unsure’ of its efficacy, and the remaining 6% of supplements were 
perceived as not being useful. The most commonly reported motivation for DS use was to ‘increase 
energy (around 35% of cited supplements) and the least commonly reported motivation was ‘lose 
weight’ (<10% of cited supplements). 
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A doctor prompted the use of 29% of the DSs cited while the prompt for use for 55% of the 
DSs was reported to be a source other than those listed. The primary place of purchase for the DSs 
were health stores (35.5%) (Appendix W). 
 Nutrient Intake via DSs 3.4.3
Each of the DSs contained one or more nutrients of interest. The most common nutrient of interest 
consumed via DSs was vitamin C, with about 64% of supplement takers (n=53) obtaining vitamin C 
through supplementation. Close to 60% of users supplemented with magnesium, vitamin B6 and B12 
and half of DS users supplemented with vitamin B1, B2 and B3 (Appendix X). 
Mean daily nutrient intake from DSs was estimated based on the dosage and frequency 
information provided by participants in relation to each DS they reported. For example, a participant 
reporting the use of 500mg of vitamin C per week would have an estimated daily intake of vitamin C of 
71.4mg/ day (500mg/7days). If the frequency of use was not specified, an estimate for daily intake was 
not able to be determined. Daily nutrient intakes were calculated to be consistent with the unit of 
measure for estimated nutrient intakes derived from the FFQ (daily intake) (Appendix Y). 
Nutrient intake via food was ascertained via the FFQ, which was completed by the entire 
sample (N=74 participants). Among the nutrients of interest, Omega 6 had the highest intake 
(mean=13,250mg/day), followed by Omega 3 (mean=1,543mg/day), magnesium (mean=492mg/day), 
vitamin C (mean=9.5mg/day) and folic acid (mean=103.96mg/day) (Appendix Z). 
3.4.3.1 The effects of DS usage 
There was little indication for a linear relationship between PSS scores and participant age (Pearson’s 
r=-0.202, p=0.0844 and Figure 3.1). However previous research has indicated an association between 
age and PSS scores and analyses will be controlled for age to minimize potential confounding.353  
  Chapter 3 
78 
 
Figure 3.1 PSS Scatterplot of PSS scores against age for N=74 participants. 
Supplement users were on average older than non-supplement users, with mean ages of 44.8 
and 35.3 years for the two groups, respectively. The relationship between age and DS use was 
examined using logistic regression. The odds of being a DS user were estimated to increase by 32% for 
every 5 year increase in age from the mean age of the sample (OR=1.32, 95% CI 1.05, 1.67, p=0.019). 
Summary statistics for age in relation to supplement status are reported in table 3.4 and Figure 3.2. 
Table 3.4: Summary statistics for age in relation to supplement status 




Mean (SD) 44.8 years (13.7 years) 35.3 years (11.8 years) 
Median 45 years 36 years 
Min 21 21 
Max 70 61 
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Figure 3.2: Supplement use by age group. 
The relationship between age and the number of DSs used per participant was assessed using 
Poisson regression. Rate of DS use was estimated to increase by an average 2% for every 5 year 
increase in age from the mean age of the sample, although this increase was not statistically significant. 
(IRR=1.02, 95% CI 0.95, 1.09, p=0.570). Summary statistics for age and number of DSs used are 
presented in Figure 3.3. 
 
Figure 3.3: Number of supplements used by age group. 
The relationship between the number of DSs used and PSS scores was examined using linear 
regression, controlling for age. Participants who did not use DSs (n=16) and those who used DS, which 
did not contain nutrients of interest (n=5), were excluded. Participants were grouped according to the 
number of DSs they reported using (1 DS, 2 DSs and 3 or more DSs). Summary statistics for PSS 
scores by DS use group are reported in Table 3.5. 
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Table 3.5: Summary statistics for PSS scores for DS use groups 
Number of cited supplements N 
PSS Score 
Mean (SD) Median Min Max 
1 22 19.09 (5.55) 17 10 28 
2 16 16.75 (4.22) 15 12 24 
3 or more 15 20.67 (6.33) 20 11 30 
 
Participants who reported using two DSs were estimated to have, on average, PSS scores that 
were 2.07 units lower than those reporting the use of one DS (95% CI -1.43, 5.57 p=0.240). Participants 
using three or more DSs had PSS scores that were on average 3.96 units higher compared to 
participants using 2 DSs (95% CI 0.14, 7.77 p=0.043). There was no statistically significant difference 
between PSS scores between these groups (global p-value=0.125). 
3.4.3.2 Effects of nutrient intake via DSs on PSS score 
The effect of supplementation for each nutrient of interest on PSS scores was examined using linear 
regression, controlling for age. For each nutrient, participants were classified according to whether they 
had consumed that nutrient via supplementation based on their reported intake details. Model adequacy 
was assessed via visual examination of residuals plots. 
The age-adjusted coefficient for each supplemented nutrient gives the estimated average 
change in PSS score associated with a change in supplementation status, providing all other factors are 
held constant. The Sidak correction was applied to the p-values to account for multiple testing to control 
the Type I error rate. Inspection of the point estimates and 95% CIs indicates that potentially substantive 
reductions in PSS scores associated with the use of specific nutrients cannot be ruled out. These 
nutrients include ALA, where PSS scores were an average of 3.3 units lower among supplementers and 
LA where PSS scores were an average of 4.1 units lower among supplementers. However, there is no 
consensus on what constitutes a clinically meaningful change in PSS scores. Vitamin C and B12 were 
associated with a small increase in PSS scores, however, after adjusting for multiple testing, there were 
no statistically significant relationships between the use of a particular nutrient and PSS scores. Table 
3.6 provides a summary of the results. 
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Table 3.6: Results of linear regression models for PSS scores according to supplementation 















ALA -3.34 2.32 -7.97 1.29 0.154 0.886 
LA -4.08 2.45 -8.97 0.82 0.101 0.775 
EPO -2.23 2.49 -7.20 2.74 0.375 0.996 
EPA/DHAa -4.05 2.02 -8.07 -0.03 0.048 0.522 
Undefined Omega-3 -1.56 2.19 -5.92 2.80 0.478 0.997 
Vitamin C 0.05 1.37 -2.68 2.77 0.973 0.998 
Magnesium -0.85 1.40 -3.64 1.94 0.545 0.997 
Zinc -0.85 1.45 -3.75 2.05 0.559 0.997 
Vitamin B1 -1.27 1.41 -4.07 1.54 0.372 0.996 
Vitamin B2/B3b -1.14 1.42 -3.97 1.69 0.426 0.996 
Vitamin B5 -0.63 1.51 -3.65 2.38 0.678 0.997 
Vitamin B6 -0.90 1.38 -3.65 1.85 0.517 0.997 
Folic Acid -0.40 1.46 -3.30 2.51 0.786 0.998 
MTHFRc -0.81 3.46 -7.70 6.08 0.816 0.998 
Vitamin B12 0.24 1.38 -2.51 3.00 0.860 0.998 
ALA, Alpha linolenic acid; LA, Linoleic acid; EPO, Evening Primrose oil; EPA, Eicosapentaenoic acid; DHA, 
Docosahexaenoic acid; MTHFR, methylenetetrahydrofolate reductase  
* The coefficient for ALA is -3.34, which means that the PSS scores are 3.34 units lower, on average, for those who 
supplement with ALA compared to those who do not supplement with this nutrient. The 95% CI provides the range of 
plausible values for the ‘true’ effect of ALA supplementation on PSS scores that are compatible given the observed data. We 
therefore cannot rule out that the ‘true’ effect of ALA supplementation is as extreme as a 7.97 unit decrease in PSS scores 
and we cannot rule out that the ‘true’ effect of such is a 1.29 unit increase in PSS scores (95% CI -7.97, 1.29) and the ‘true’ 
effect may lie anywhere between these two values. 
a Model estimates for EPA and DHA use are identical, since every person who was an EPA user was also a DHA user. 
b Model estimates for B2 and B3 use are identical, since every person who was a B2 user was also a B3 user. 
c Activated folic acid supplement  
 
3.4.3.3 Correlation between nutrient intake from DSs and PSS scores 
Spearman rank correlation coefficients were calculated between intakes for each nutrient and total PSS 
score. It has been suggested that the minimum sample size for a Spearman correlation is n=10 
observations. Correlations were therefore carried out only for those supplemented nutrients for which 
there were at least 10 users with daily intake data available. The results indicated a strong positive 
correlation between EPA and DHA intake and PSS scores (!=0.79), and a weak negative correlation 
  Chapter 3 
82 
between vitamin C intake and PSS score (!=-0.35) and vitamin B6 intake and PSS scores (!=-0.50). 
The Sidak correction was applied to account for multiple testing. The results are reported in Table 3.7. 
Table 3.7: Spearman’s Rank Correlations for daily nutrient intake via DS and PSS scores for 
selected nutrients of interest (for n≥10) 
Nutrient 
No. 





EPA (milligrams/day) 10 0.7903 0.0065 0.0753 
DHA (milligrams/day) 10 0.7903 0.0065 0.0753 
Omega-3 (milligrams/day) 23 0.1157 0.5991 0.9947 
Omega-6 (milligrams/day) 11 0.0780 0.8197 0.9947 
Vitamin C (milligrams/day) 33 -0.3453 0.0491 0.3956 
Magnesium (milligrams/day) 29 -0.1035 0.5930 0.9947 
Zinc (milligrams/day) 22 -0.2444 0.2730 0.9220 
Vitamin B1 (milligrams/day) 25 -0.0296 0.8885 0.9947 
Vitamin B2 (milligrams/day) 23 -0.3533 0.0982 0.6055 
Vitamin B3 (milligrams/day) 24 -0.0931 0.6654 0.9947 
Vitamin B5 (milligrams/day) 20 -0.1504 0.5268 0.9947 
Vitamin B6 (milligrams/day) 29 -0.4971 0.0060 0.0750 
Vitamin B12 (micrograms/day) 27 -0.1249 0.5347 0.9947 
3.4.3.4 The effect on PSS scores of supplementation with specific nutrient 
combinations 
Table 3.8 summarizes the use of magnesium and vitamin B6 among supplement users. Twenty-seven 
participants obtained both magnesium and vitamin B6 from DSs. Most magnesium users were also 
vitamin B6 users (27/31=87%). Many of the supplements cited by participants had magnesium in their 
composition, with more than half of all supplementers (31/58) obtaining magnesium through DSs. 
Table 3.8: Distribution of magnesium and Vitamin B6 use among N=74 supplement users 
Magnesium 
User 
Vitamin B6 User 
Yes No 
Freq. (%) Freq. (%) 
Yes (n=31) 27 (87.1) 4 (12.9) 
No (n=43) 4 (9.3) 39 (90.7) 
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The effect of concurrent magnesium and vitamin B6 supplementation on PSS scores was 
examined using linear regression. All effect estimates were adjusted for age. PSS scores among 
participants who used magnesium without concurrent vitamin B6 had PSS scores that were on average 
1.92 units lower compared to those who did not supplement with either nutrient although this difference 
was not statistically significant (95% CI -8.68, 4.83, p=0.571). PSS scores among participants using 
vitamin B6 without concurrent magnesium were estimated to be an average of 1.98 units lower 
compared to those who do not supplement with either nutrient. Again, this difference was not statistically 
significant (95% CI -8.20, 4.23, p=0.526). When both magnesium and vitamin B6 were consumed via 
DSs, PSS scores were estimated to be on average 0.92 units lower compared to participants who did 
not supplement with either nutrient. The difference was not statistically significant (95% CI -3.88, 2.03; 
p=0.536).  
 Association between nutrient intake from food and PSS scores 3.4.4
3.4.4.1 Correlation between nutrient intake from food and PSS scores 
The relationship between the intake of nutrients of interest from food (generated via the FFQ) and PSS 
scores was examined using Spearman’s Rank Correlations. The Sidak correction was applied to 
account for multiple testing. The results suggest that there is limited evidence for a monotonic 
relationship between the level of intake of any of the nutrients consumed via food and PSS scores 
(Appendix AA). 
Linear regression was used to investigate the relationship between each specific nutrient of 
interest consumed via food and PSS scores adjusted for age. The results are presented in Table 3.9. 
After adjusting for age, a 10mg increase in vitamin B6 from food was associated with an average 
decrease of approximately 3.5 units in PSS score, although inspection of the 95% CI indicate a high 
level of uncertainty for this effect (95% CI -28.43, 21.47). The point estimates and associated 
confidence intervals for the other nutrients of interest reveal relatively small effects of nutrient intake on 
PSS. 
Table 3.9: Results of linear regression models for Perceived Stress Scale (PSS) scores for 















ALA (per 1000 mg) 0.298 1.187 -2.070 2.666 0.803 1.000 
LA (per 1000 mg) -0.072 0.138 -0.346 0.202 0.602 1.000 
EPA (per 100 mg) 0.352 0.571 -0.787 1.490 0.540 1.000 
















DHA (per 100 mg) 0.172 0.291 -0.409 0.753 0.558 1.000 
Total Omega-3 (per 500 mg) 0.243 0.482 -0.719 1.205 0.616 1.000 
Total Omega-6 (per 500 mg) -0.034 0.069 -0.172 0.103 0.619 1.000 
Vitamin C (per 25 mg) -0.273 0.230 -0.732 0.187 0.241 0.988 
Magnesium (per 10 mg) -0.022 0.039 -0.010 0.056 0.582 1.000 
Zinc (per 10 mg) 2.004 2.161 -2.304 6.313 0.357 0.999 
Vitamin B1 (per 1 mg) 0.051 0.830 -1.602 1.705 0.951 1.000 
Vitamin B2 (per 1 mg) 0.202 0.762 -1.319 1.722 0.792 1.000 
Vitamin B3 (per 10 mg) 0.500 0.844 -1.183 2.182 0.556 1.000 
Vitamin B5 (per 1 mg) 0.355 0.562 -0.765 1.478 0.529 1.000 
Vitamin B6 (per 10 mg) -3.481 12.513 -28.432 21.470 0.782 1.000 
Vitamin B7 (per 1 mg) -0.036 0.040 -0.115 0.044 0.378 0.999 
Vitamin B12 (per 1 microgram) 0.646 0.390 -0.132 1.423 0.102 0.839 
Total folates (per 100 micrograms) 0.069 0.347 -0.623 0.761 0.842 1.000 
 Association between reported nutrient intakes from food and DS status 3.4.5
Binary logistic regression was used to investigate whether intake of nutrients of interest via food was 
associated with the supplementation status for that nutrient. The effect estimates are presented in the 
form of odds ratios (ORs). The OR for a nutrient describes the change in the odds of being a DS user of 
that nutrient associated with a 1-unit increase in intake of that nutrient from food. All estimates were 
adjusted for age. With the exception of vitamin C and vitamin B6, all of the ORs are greater than 1, 
which suggests that on average, as the intake of the nutrient from food increased so too did the odds of 
supplementing with that nutrient. However, after adjustment for multiple comparisons, there was no 
statistically significant difference on the effect of nutrient intake from food on supplementation status for 
any of the nutrients. The results are presented in Table 3.10. 
Table 3.10: Results of logistic regression models for supplementation status for selected 
nutrients according to recorded intake from food* 
Nutrient 














ALA (per 1000 mg) 1.310 0.866 0.359 4.789 0.683 0.943 
LA (per 1000 mg) 1.105 0.090 0.943 1.296 0.217 0.851 
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Nutrient 














EPA (per 100 mg) 2.196 0.855 0.996 4.839 0.051 0.466 
DHA (per 100 mg) 1.368 0.231 0.983 1.904 0.063 0.511 
Total Omega-3 (per 500 mg) 1.130 0.275 0.701 1.821 0.616 0.943 
Vitamin C (per 25 mg) 0.932 0.077 0.793 1.095 0.391 0.918 
Magnesium (per 10 mg) 1.030 0.015 1.001 1.060 0.043 0.435 
Zinc (per 1 mg) 1.253 0.116 1.046 1.502 0.014 0.191 
Vitamin B1 (per 1 mg) 1.319 0.384 0.746 2.335 0.341 0.918 
Vitamin B2 (per 1 mg) 1.553 0.432 0.900 2.680 0.114 0.664 
Vitamin B3 (per 10 mg) 1.699 0.532 0.920 3.139 0.090 0.611 
Vitamin B5 (per 1 mg) 1.094 0.230 0.724 1.653 0.671 0.943 
Vitamin B6 (per 1 mg) 0.728 0.341 0.291 1.824 0.499 0.937 
Vitamin B12 (per 1 microgram) 1.461 0.230 1.073 1.989 0.016 0.202 
Total folates (per 100 micrograms) 1.173 0.150 0.913 1.506 0.212 0.851 
* For example, for every 1 microgram increase in vitamin B12 intake from food, the odds of supplementing with B12 
increased by 46.1% (OR:1.46; 95% CI 1.07, 1.99; adjusted p=0.202). 
 
For each participant, total intake of each nutrient was calculated by summing the reported 
intake from food, and the reported intake for DSs (if the participant consumed this nutrient via DSs). 
Linear regression was used to investigate associations between total nutrient intake from the combined 
nutrient sources and PSS scores, adjusting for age. The results are presented in Table 3.11. The point 
estimates and 95% CIs for the effect of increased intake of any nutrients of interest on PSS are very 
small, with most in the order of less than 1 unit in PSS. 
Table 3.11: Results of linear regression models for Perceived Stress Scale (PSS) scores by 















ALA (Per 1000 mg) 0.294 1.187 -2.073 2.661 0.805 0.999 
LA (Per 1000mg) -0.072 0.138 -0.346 0.202 0.602 0.997 
EPA (Per 100 mg) -0.012 0.187 -0.385 0.360 0.948 0.999 
DHA (Per 100 mg) 0.042 0.174 -0.305 0.390 0.808 0.999 
Total Omega-3 (Per 500 mg) -0.093 0.145 -0.381 0.195 0.523 0.997 
















Total Omega-6 (Per 500 mg) -0.049 0.065 -0.179 0.081 0.456 0.997 
Vitamin C (Per 25mg) -0.085 0.042 -0.168 -0.002 0.045 0.499 
Magnesium (Per 10 mg) -0.021 0.026 -0.073 0.030 0.408 0.997 
Zinc (Per 10 mg) -0.372 0.301 -0.972 0.229 0.222 0.962 
Vitamin B1 (Per 1 mg) -0.002 0.012 -0.026 0.022 0.882 0.999 
Vitamin B2 (Per 1 mg) -0.046 0.026 -0.097 0.005 0.079 0.684 
Vitamin B3 (Per 10 mg) -0.119 0.177 -0.472 0.235 0.505 0.997 
Vitamin B5 (Per 1 mg) -0.029 0.028 -0.085 0.027 0.299 0.986 
Vitamin B6 (Per 10 mg) -0.027 0.127 -0.524 -0.019 0.036 0.444 
Vitamin B12 (Per 1 microgram) -0.004 0.007 -0.018 0.009 0.535 0.997 
Folic acid (Per 100 micrograms) -0.245 0.323 -0.889 0.398 0.450 0.997 
3.5 Discussion 
Chapter 1 cited population level studies that revealed a relationship between some mood states and DS 
use, with the presence of anxiety, depression and stress being associated with an increased intake of 
MVMs.4-6, 230 However, as evidenced in the systematic review (Chapter 2), very few randomized 
controlled or quasi-randomized studies have investigated the effectiveness of specific nutrients in the 
diet or DSs on stress levels among women without also addressing a specific stage of the reproductive 
cycle.10 Due to the lack of evidence to support dietary intervention and/or DS use to manage stress in 
women clinically, this exploratory study aimed to explore this relationship. To the knowledge of the 
researcher, this represents the first cross-sectional survey to examine such. 
Although mean PSS scores were lower among participants who used DSs compared to those 
who did not, the difference was not statistically significant. In addition, among supplementers, average 
PSS scores differed according to level of DS use but again, the overall effect of level of DS use on PSS 
scores was not significant. For the majority of the specific nutrients of interest, besides vitamin C and 
B12, PSS scores were on average lower among supplementers compared to non-supplementers. In 
addition, the 95% CIs demonstrate that potential differences in stress scores between supplementers 
and non-supplementers may be as large as approximately 9 units (LA), 8 units (ALA) and 7 units (EPO). 
Although the clinical importance of changes in PSS scores of these magnitudes has not been 
empirically determined, such differences may represent considerable change in perceived stress, 
despite differences not being statistically significant after adjustment. 
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Correlational results suggest that DHA and EPA use was associated with increased PSS 
scores and vitamin C and B6 with lower PSS scores, although after adjustment these correlations were 
not statistically significant. The effect of the combination of magnesium and vitamin B6 supplementation 
on PSS scores revealed that PSS scores were estimated to be an average of 0.92 units lower 
compared to no supplementation with either nutrient, but this effect was not significant. Furthermore, the 
point estimates for the average differences in PSS scores for magnesium supplementers in the present 
study are consistent with some literature that suggest this nutrient has stress-lowering effects.352, 369 In 
addition, in the present study it was found that magnesium was a common ingredient in the 
supplements cited by participants. Participants were therefore frequently obtaining magnesium in 
varying dosage from multiple supplements, which may partly account for the lower stress levels 
observed among supplementers relative to non-supplementers. However, the relative duration of use of 
a single nutrient was unable to be validly determined.  
Some research has suggested specific single-nutrient DSs, such as vitamin C or EFAs, had 
stress-lowering effects in both genders.184, 194 However, in the present study, use of DHA and EPA was 
associated with higher PSS scores. This may be a reflection of high stress scores being present when 
participants started using the DS, which may also reflect their motivation for use. Being a cross-
sectional study a causative relationship between these variables cannot be established. 
Previous studies suggested that a B complex reduced stress among women over 30 and 90 
days respectively.180, 270 In contrast, the effect of vitamin B supplementation on stress in the present 
study was largely inconclusive. This is likely due to confounding by dose and duration of 
supplementation, which could not be controlled in a cross-sectional setting, and by low study power to 
detect anything other than large differences. Furthermore, this study investigated the effects of each 
individual B vitamin rather than a vitamin complex. However, Haskell et al. reported a reduction in self-
reported stress over 9 weeks using a MVM and Benton et al. reported mood improvements among 
women taking a MVM after one year of continued supplementation.272, 317 The duration of 
supplementation may be an important factor influencing effectiveness. 
The effect of intake of specific nutrients via food on PSS scores was examined using linear 
regression. There was little evidence for an effect of intake of a particular nutrient on PSS score. In 
addition, the total intake of each nutrient from food and DSs combined was examined in relation to PSS 
scores using linear regression. The results indicated an effect of vitamin C intake and vitamin B6 intake 
on stress. However, given the large number of tests performed and limited sample size, caution is 
required when drawing conclusions from these findings. To constrain Type I error rate, a Sidak 
correction was applied and after this adjustment, no effects were found to be statistically significant. 
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The findings from the present study are contrary to those from a number of similar cross 
sectional studies that investigated dietary influences on mental health. Bhattacharyya et al.370 
investigated the association between dietary factors and psychological distress, and reported that 
increased fish intake was associated with lower psychological distress, suggestive of an impact via 
EFAs. In addition, Jacka et al. investigated the association between ‘Western’ and ‘traditional’ diets and 
depression and anxiety in a sample of women in Australia. It was found that less healthy, ‘Western’ 
foods were associated with higher scores of psychological symptoms, including anxiety, compared to 
more traditional diets comprising fresh produce, grains, fish and meat.164 In the following year, Jacka et 
al. investigated the association between habitual diet and mental health in elderly Norwegian men and 
women, and found that a healthy dietary pattern (DP), similar to the ‘traditional’ diet in the 2010 study, 
was associated with reduced anxiety only in women.163 Conversely, in another study, the impact of 
magnesium intake via food on depression and anxiety revealed no association between magnesium 
intake and anxiety scores.187 In addition, Begdache et al. reported on a mixed-gender cross-sectional 
study that men were more likely to experience mental wellbeing until severe nutrient deficiencies arose 
while women were less likely to experience the same until a balanced diet and healthy lifestyle were 
followed.278 The authors proposed that dietary sufficiency may potentiate heightened limbic system 
regulation in women, which is suggestive of nutrients, in the form of different DPs, impacting mental 
wellbeing more in women than men. It should be noted that most of these studies examined food groups 
and DPs rather than individual nutrient intakes. The effect of individual nutrients may not be able to be 
isolated from the context of an individuals broader DP. In addition, the small size of the present sample 
meant that only very large effects would have resulted in significance at the 5% level. Indeed, inspection 
of the estimated effects and CIs for the specific nutrients reveal that further research is warranted before 
concluding that no relationship exists between specific nutrients and PSS scores.371  
The association between reported nutrient intakes from food and supplementation status was 
examined. With the exception of vitamin C and B6, on average, the odds of supplementing with a 
particular nutrient increased as intake of that nutrient via food increased, although these effects were 
not statistically significant after adjusting for multiplicity. This suggests that in this sample, 
supplementers were also consuming more of the examined nutrients in their regular diets compared to 
non-supplementers, which leads to the assumption that the former group are at lower risk of 
micronutrient deficiencies compared to the latter group. (Note that examining the nutritional adequacy of 
participants based on their reported food frequency intakes was beyond the scope of this study.) This 
result is broadly compatible with a 2013 NHANES survey, which found that DS use was greater among 
healthier respondents compared to less-healthy respondents.372 Motivations driving supplementation 
behaviour among the healthy remain unexamined but may include a few factors. Firstly, DS users may 
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be unsure of effectiveness (as DS use is unrelated to measurable health outcomes) yet decide to use 
DSs as a form of ‘insurance’ against possible illness. Secondly, the use of DSs in the presence of an 
adequate diet may be a form of health anxiety and may be associated with the reported increase of DS 
consumption in anxious populations.4-6, 230, 373 Thirdly, whether DS users are aware of which nutrients 
they are deficient in, which foods contain those nutrients, and whether they choose to eat more of, and 
supplement with those nutrients, is presently unexamined. Therefore, in the presence of health, and 
possibly related to a preoccupation with health or illness, and/or knowledge about which nutrients they 
may be deficient in and where they are found, a portion of the population may use DSs regardless of a 
lack of evidence to support use. Indeed, a population level survey that examined the influence of 
government statements regarding efficacy claims from DS manufacturers revealed that only 25% of 
users would cease DS use if they were shown to be ineffective.374 Clearly, motivations driving this 
behaviour and reasoning require continued investigation. 
Further, the association between DPs, specific nutrients and chronic stress remains 
unexamined among women. In addition, the prevalence of chronic stress among the present sample is 
not known. Chronic stress imposes an additional nutritional burden on the CNS that may only be 
ameliorated by significant increases in nutrients via supplementation. As examined in Chapter 1, 
research suggests that people experiencing chronic stress may change their diet, with the majority 
choosing to eat more nutrient-deficient food.158, 375-379 The previously mentioned studies that reported on 
nutrient intervention leading to stress-reduction may have provided nutrients lost via appetitive changes 
and increased metabolic demands.180, 270, 317  
Apart from nutrient deficiencies, the form of nutrients may influence their impact. For example, 
polymorphisms on the MTHFR gene, which influence the breakdown of vitamin B6, B9 (folic acid), B12 
into their active, co-enzyme forms and into methionine, an amino acid that facilities protein synthesis 
and antioxidant utilization, may have a role to play in chronic stress, due to its presence in a number of 
mental health challenges.334-337 These polymorphisms also negatively impact neurotransmitter 
synthesis, including serotonin and GABA, via a number of mechanistic pathways.334 As 10-20% of the 
population worldwide may possess this gene variant, activated forms of these nutrients may provide 
benefit to women experiencing chronic stress.172, 334-337 Indeed, stress levels may not be reduced unless 
these nutrients are available in their activated form. This may further predispose vulnerable women to 
the development of affective disorders, such as depression, via neurobiological and neurochemical 
mechanisms not yet fully understood.380, 381  
Six other factors related to DS consumption were examined, including motivations for use and 
perceived efficacy. The results revealed a variety of motivations, which included reducing stress (27%), 
however the most commonly cited reason for using a DS was to increase energy (35%). In addition, the 
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use of 31% of the DSs were cited as being prompted by a doctor whereas a mixed-gender NHANES 
survey reported that 23% of the use of such products were based on health care provider 
recommendations.372 This discrepancy may reflect increased PCP visits by women or may be naturally 
higher in the surveyed population.207, 208 Perceived efficacy of DS use was examined and results 
revealed that 59% of cited DSs were perceived as being useful, however, for 42% of DSs used, 
participants were unsure of efficacy, and 6% of cited DSs were perceived as not being helpful. These 
results may be related to the increased odds of using DSs as nutrient intake increases, where despite 
uncertainty of effectiveness, women may use DSs as an ‘insurance’ against illness. (Appendix BB 
contains the other four reported factors related to DS use.) 
 Limitations 3.5.1
There are a number of limitations in this study. Similar to all cross-sectional surveys, the 
methods do not enable inference of a causal relationship between the independent and dependent 
variables, therefore, whether the amount of nutrient consumed (the exposure), preceded or followed the 
amount of stress (outcome) experienced by participants remains unknown. Therefore, DS use may not 
only influence stress but stress may drive DS use. In addition, the study size and non-random sampling 
methods preclude generalizing the results to women in general, and the sampling procedure may have 
introduced selection bias. Chronically stressed women may have been unaware of the study, or been 
unable to participate, and would therefore be underrepresented in this sample. Furthermore, many more 
women used DSs in this study versus non-users, so users may have been disproportionally 
represented. In addition, the small sample size limited the precision of results. A larger sample would 
have increased the precision of results and provided greater power to detect true effects. 
In relation to the PSS, many of the validations were done on college students not 
representative of the population of interest in this project. In addition, this tool is not a diagnostic or 
screening tool so no normative data exists with which to compare study results, so researchers make 
comparisons between the total scores within the sample of interest. The PSS is also not a measurement 
tool that reflects chronic stress levels. In relation to the DQES, multiple weeks of recording dietary intake 
is the ideal method of assessing nutrient intake versus a once-off assessment. In addition, over- and 
under-reporting are challenges inherent in all FFQs, possibly including the DQES.382, 383 In relation to 
the SUQ, this tool was not formally tested for intra- or inter-rater reliability prior to use. In addition, due to 
the possible sporadic nature of DS use it is not possible to obtain an accurate intake of nutrients 
supplied via DSs for each participant although this would be the case with any self-administered DS use 
questionnaire. 
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Further, the SUQ gathered data on DS intake over differing time periods compared to the FFQ, 
which gathered dietary nutrient intake over a 12-month period, and the PSS investigated the perception 
of stress over the last month. In addition, it is likely that recall bias of varying degrees was associated 
with each instrument.384  
The dose-response and the duration of specific-nutrient consumption in relation to PSS scores 
could not be assessed as most DSs contain more than one nutrient, as evidenced by the inclusion of 
magnesium in many used DSs, which may have led to confounding. Finally, due to the small sample 
size, multivariate analysis was not possible, so analysis was restricted to evaluating the effect of single 
nutrients only and the intake of other nutrients was not controlled for. 
 Conclusion 3.5.2
Although previous research has suggested that a broad spectrum of nutrients are supportive of 
brain health, this study sought to examine the effect of specific nutrients, given that a variety of specific-
nutrient DSs and stress-management formulations are marketed and consumed globally. Indeed, 
according to Goldstein Research, the global stress management DS market, which includes 
magnesium, B vitamins and zinc, is expected to reach USD16.7 billion by 2025.8 
As previously discussed, a number of studies have examined the role that some of these 
purportedly stress-ameliorating nutrients play in mental health, either in various combinations or alone, 
and in various contexts, and a number of reviews have summarised such studies.172, 385, 386 However, 
there is a lack of evidence to support the clinical use of specific-nutrient DSs in the presence of chronic 
stress among women despite the acknowledged role that chronic stress plays in both physiological 
disease states and diminished mental health.31, 108, 381, 387-390 When experienced chronically, stress 
becomes a catalyst for the development of stress-associated affective disorders, such as anxiety and 
depression, possibly due to lack of nutrients required to maintain emotional stability and resilience 
against such.46-51 As depression is now the leading cause of disability globally, it is timely to address 
one of its possible antecedents to examine whether the impact of nutrients on chronic stress is similar to 
the reported effects of such on depression, and whether genetic polymorphisms impact nutrient 
bioavailability and thus stress levels.163, 276, 277, 334, 391-395  
In the present study, DS users were significantly older than non-DS users, but the relationship 
between PSS scores and age was not significant. Prior to adjustment for multiple testing there was 
evidence for a number of significant relationships between nutrients consumed via DSs and PSS 
scores. The effect estimates and 95% CIs indicated that there were potentially substantive reductions in 
PSS scores related to intake of ALA, LA and EPO via supplements compared to those not 
supplementing with these nutrients. There was a strong positive correlation between PSS scores and 
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intakes of EPA and DHA among those participants who used these supplements, and a weak 
correlation between PSS scores and intakes of vitamin C and B6.  Contrary to previous research, the 
combination of B6 and magnesium was not found to be significantly associated with lower stress levels 
either before or after adjustment for multiplicity. When assessing the relationship between nutrient 
intake from food and PSS scores, a 10mg increase in B6 was associated with an average decrease of 
about 3.5 units in PSS scores. Similarly, it was found that for most nutrients, as the intake from food 
increased so too did the odds of supplementation with that nutrient. However, after adjustment for 
multiple comparisons there was little evidence for significant relationships between any of these 
variables. Finally, analysis of the relationships between total intake of each nutrient (from food and DS 
combined) and PSS scores yielded estimates of effect considered to be very small in magnitude. 
Although there is a substantial body of research that suggests that such nutrients have critical roles to 
play in the CNS, there was inconclusive evidence from the present study for the effect of these nutrients 
on stress, regardless of whether they were obtained from food or dietary supplements. However, as 
discussed, the limitations of this study, particularly the limited statistical power due to the small sample 
size, are likely to have affected the results obtained. 
This study has suggested that DS use to ameliorate stress among women warrants further 
research attention, ideally in the form of a prospective cohort study or RCT. A longitudinal study will 
allow for the investigation of DPs and nutrient intake via diet and DSs and associated behaviour and 
perceived stress and affective disorders over time. This will inform on any causal relationships between 
these variables, for example, whether DSs are consumed in response to high stress levels and whether 
cessation occurs when stress levels decrease, or whether they are used as a form of nutrient 
‘insurance’ in the presence of stress. Furthermore, such studies will be better able to control for cyclical 
reproductive hormones compared to cross-sectional surveys wherein they become confounding 
variables. In addition, as current research suggests, overall DPs may be a better indicator and predictor 
of mental health. Knowledge is also required about the overall balance and intake of micro- and 
macronutrients, along with the ratio of specific nutrients, such as omega 3 and omega 6, in relation to 
chronic stress and depression over time. Furthermore, including the use of biological markers of nutrient 
intake will further inform on the relationships between nutrient intake, physiological stress markers and 
genetic polymorphisms. A well designed RCT will allow for the examination of an effect of specific 
nutrient intervention on perceived stress in a defined population under controlled conditions, such as 
duration, dosage, timing etc. This will inform on the efficacy and safety of specific nutrients with the aim 
of informing clinical practice. 
Results from studies such as these may provide evidence to either support dietary changes 
and/or dietary supplementation to ameliorate chronic stress, or prevent the use of such ineffectual 
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solutions to these ends. In addition, they may inform on the relationship between chronic stress and 
nutrient intake and the development of affective disorders. However, such studies lack the ability to 
inform on variables that are challenging to quantify, such as the psychological experience of stress 
among women, how diet and/or DSs are used to manage stress, and other factors related to the lived 






THE LIVED EXPERIENCE OF STRESS AND THE USE OF DIET 
AND/OR DIETARY SUPPLEMENTS TO MANAGE STRESS: 
A PARTICIPATORY ACTION RESEARCH (PAR) STUDY 
4.1 Introduction 
The purpose of this chapter is to report on the paradigm, methodology, methods and results of the 
participatory action research (PAR) project that investigated the lived experience of stress and the role 
of diet and/or DSs in this experience among eight women, over an eight-week period. This chapter will 
briefly address the philosophical considerations underlying the choice of a PAR approach and will report 
the methodology and methods used, including the quality control measures taken to ensure credibility, 
dependability and data transferability. A description of how the in-depth data analysis, coding and 
categorisation occurred and how the resultant themes were developed follows. The position of this 
project within the JBI EBHC model is examined, along with a discussion about the results, limitations 
and implications. 
The aim of this PAR project was to answer two research questions: what is the lived 
experience of stress among women and what role do diet and/or DSs play in this experience? 
Investigating these questions within a PAR framework was a logical progression from investigating the 
relationship between perceived stress and nutrient intake in the cross sectional project (Chapter 3). 
Employing a qualitative approach to these research questions provided depth and insight into these 
lived experiences that the cross-sectional project (Chapter 3) was unable to elicit. 
4.2 Philosophical Considerations 
Qualitative research is grounded in a particular worldview, or paradigm, which significantly influences 
how the research question is investigated and answered. Therefore, defining and situating the paradigm 
is an important component of providing the context in reporting qualitative research. A paradigm can be 
defined as a ‘loose collection of logically related assumptions, concepts or propositions that orient 
thinking and research’ (p. 22).396 This research project investigated a specific psychological construct 
which is at present not well understood. How a phenomena is investigated and how knowledge is 
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gained, or ‘how we know what we know,’ is aligned with the paradigm within which researchers situate 
their research (p. 8).397, 398 Paradigms are underpinned by a particular ontology, defined as being 
‘concerned with the nature of the social world and what can be known about it’ and a particular 
epistemology, defined as being ‘concerned with the nature of knowledge and how it can be acquired’ (p. 
22-23).399 Therefore, it was incumbent on the researcher to choose a paradigm that was capable of 
supporting an exploratory and flexible examination of this construct. 
The ontological framework underpinning the positivist approach is the assumption that there is 
a single, objective, external reality or truth, which can be observed and measured.398, 400 Research 
undertaken within this theoretical framework (such as the study in the previous chapter) aims to keep 
the researchers from influencing the outcomes or results by stipulating methods of gathering and 
analysing data to maintain objectivity. Quantitative research is aligned with positivism and post-
positivism (where it is held that accurate knowledge about the world can be identified through sensory 
experience because the world exists independently of our knowledge of it) and because knowledge is 
objectively gathered, represented and quantified.401 However, it has been argued that the positivist and 
post-positivist paradigms fail to address the complexity of unobservable variables that underpin the 
human experience, such as emotions, feeling and thinking.402  
The ontological framework underpinning the interpretive paradigm is the assumption that no 
single objective truth exists; instead, social meaning is created through engagement between individuals 
within groups.398, 403 Reality is thus understood ‘in the form of multiple, intangible mental constructions, 
that are socially and experientially based’ and rely on the meanings that individuals and groups ascribe 
to their experiences (p. 110).404 Thus, if reality is subjective, interpreted by people and differs from 
person to person and within groups, it is socially constructed and is therefore capable of changing.398, 
403-405 ‘Meanings and interpretations’ are therefore of primary importance in the interpretative paradigm, 
while ‘observed phenomenon’ are the focus in the positivist paradigm (p. 26).398  
The ontological framework underpinning the critical paradigm is the assumption that ‘reality is 
shaped by social, political, cultural, economic, ethnic and gender values’ (p. 109).404 Critical theory has 
its origins in the philosophy of Karl Marx and its development has been attributed to the Frankfurt school 
of social theory and philosophy in Germany, which was associated with the Institute for Social Research 
at the Goethe University in Frankfurt.406 These researchers suggested that reality was socially 
constructed and influenced by groups of powerful people within society who wield power over less 
powerful people. Critical theory and research within this paradigm is concerned with emancipation from 
these powerful and dominating forces, which often occur within a political context.398, 407 This approach 
to research was therefore the most suitable one in which to position this study as it takes into account 
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that reality is subjective, and thus changeable, and makes provision for examining complex human 
experiences that are shaped by social, political, economic, ethnic, and gender values. 
Critical theory’s leading proponent today, Jurgen Habermas, proposes that there are three 
human interests or orientations related to the human species and our interaction and the work that we 
engage in, including an ‘emancipatory’ interest, which focuses on emancipation from domination and 
leads to ‘being in control of the conditions under which one lives’ (p. 27).398, 407, 408 This theory of 
emancipatory interest is underpinned by Habermas’s belief that when people use ‘communicative 
action’ purposefully, their situations can improve. However, although ‘theory is a powerful resource for 
developing insight and understanding’ it is necessary to bridge the gap between theory and practice so 
as to allow research to impact on, or improve practice (p. 104).409 Therefore, a method was required to 
bridge the gap between Habermas’s theoretical framework and practice, and ‘Action Research (AR)’ 
met this need.408 AR has been described as a ‘family of practices of living enquiry that aims, in a great 
variety of ways, to link practice and ideas in the service of human flourishing’ (p. 1).410  
Kurt Lewin, a Prussian born, pioneering social psychologist, has been called the ‘Father of AR’ 
and coined the term in a 1946 article.411, 412 Critical theory generally, and Habermas more specifically, 
provides a theoretical framework for Lewin’s formative work on AR.410 AR bridges the gap between 
theory and practice by encouraging ‘collective self-reflective’ and self-imposed enquiry undertaken by 
participants who aim to improve their situations via critically examining their activities (p. 5).413 AR 
accomplishes this by combining the identification of a problem with action aimed at improvement and 
reflection on action.398 Lewin’s focus on action within social settings and the use of what he termed a 
‘cycle of enquiry,’ leads to research proceeding in a ‘spiral of steps, each of which is composed of a 
circle of planning, action and fact-finding about the result of the action’ (p. 206).414 This cyclical process 
is one in which ‘problem identification, planning, action and evaluation are interlinked’ (p. 11).415  
Two adult educators, Freire and Fals-Borda, put AR into practice in Latin America in the 
1950’s, where they gave it an ‘emancipatory orientation,’ and encouraged participation between all 
group members investigating a research question (p. 131-2).416 Social liberation and the transformation 
of communities via participation are both cornerstones of PAR methodology today and it is recognised 
as a methodology that can be used to ‘solve problems and transform consciousness and ultimately 
society’ (p. 11).417-420 AR is different to PAR in a number of ways, for example, AR does not necessarily 
engage participants directly in an emancipatory research process, whereas PAR does so, 
collaboratively, albeit at different levels of engagement.421  
McTaggart suggested that instead of viewing emancipation in PAR as needing to be 
‘revolutionary,’ the process of change can also be evaluated according to whether it has resulted in 
improvement that is valued by all the participants (p. 205).422 McTaggart goes on to suggest that 
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participatory action researchers regularly ask themselves whether things are more ‘reasonable, 
coherent, just, humane and satisfying for participants than they were’ (p. 205).422 McTaggart’s line of 
thought was deeply influential in this work as change was not anticipated to occur within a social or 
organisational context, but rather in a personal context, so change was measured according to shifts in 
individual perspective, possibly viewed by participants as being ‘emancipatory’ in nature. 
4.3 Methodology 
Methodology is defined as the ‘strategy, plan of action, process or design lying behind the choice and 
use of particular methods of data collection and links the choice and use of methods to the desired 
outcomes’ (p. 3).397 Macdonald states that ‘the purpose of qualitative methodology is to describe and 
understand rather than to predict and control’ (p. 34).423 The methodology underpinning PAR goes a 
step further and aims to study ‘disenfranchised and vulnerable populations’ and in so doing ‘address 
racial, ethnic, socio-economic and health disparities’ with the aim of emancipation for such groups (p. 
9).412 Thus, the individuality of participants impacts how the research progresses and influences what 
actions are taken because participants are partners, or collaborators with the researcher and have a 
high level of involvement and influence.410  
 
Figure 4.1: The traditional PAR cycle of enquiry. Australian Government: Action Research Induction Kit. Department of 
Families, Housing, Community Services and Indigenous Affairs. Commonwealth of Australia, p. 11 
Many authors have advocated for diversity in methodology and method using AR and PAR 
approaches. Green et al. extends the concept of ‘there’s no one size fits all’ PAR methodology by 
stating that ‘the key to PAR lies not in any given method, but, rather, in the attitudes of the researchers, 
which in turn affect how and for whom the research is constructed and conducted’ (p. 28).424 Other 
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authors have proposed that ‘No study conforms exactly to a standard methodology: each one calls for 
the researcher to bend the methodology to the uniqueness of the setting or case’ (p. 7.)425  
The unique contexts within which PAR is undertaken provide for the ‘self-determination of 
research partners in the PAR process,’ as Bergold et al. suggests, and demonstrates why PAR cannot 
be canonised as a single methodological approach (p. 192).426 Each project therefore provides 
researchers and participants with ‘many opportunities to construct knowledge and integrate theory and 
practice in ways that are unique and practical to a particular group’ suggests McIntyre (p. 67).427 
However, a broad conceptualisation of this methodological approach is possible, and represented in 
Figure 4.2, where participation (life in society), action (experience) and research (mind, knowledge) 
combine to support research in which participants can find solutions to their problems using action and 
knowledge relevant to their experience.428 Within PAR, people insert themselves into the research 
process as participants of their own life story.419 For these reasons, and due to the flexibility inherent in 
this methodology, this research project was positioned within a PAR methodology. 
 
Figure 4.2: Intersection between participation, action and research. Chevalier JM, Buckles DJ. Participatory Action 
Research: Theory and Methods for Engaged Inquiry. United Kingdom: Routledge; 2013, p. 10 
4.4 Situating Qualitative Research Evidence Within The JBI Model 
of EBHC 
As discussed in Chapter one and three, the JBI Model of EBHC (Figure 1.5, Section 1.9) takes into 
account that a wide variety of methodological approaches to health research may be useful because 
different approaches answer different questions. Therefore, although evidence of effectiveness is 
valuable, it is not the only type of evidence that can inform clinical decisions. The centre of the model, 
the ‘pebble of knowledge’ summarises the foundation of evidence and how it informs practice via the 
FAME scale.265 JBI-FAME acknowledges that there is a need for diverse forms of evidence to support 
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complex knowledge needs when investigating complex clinical questions including mental health 
challenges. This framework therefore supports the use of alternative research approaches that require 
flexibility and sensitivity informed by the specifics of the research question, such as was the case with 
this PAR project.265  
The JBI Model of EBHC does not rank results of qualitative research below those of 
quantitative research, but considers all research methods as contributing to evidence generation and 
able to be synthesised and contribute to EBHC. This model therefore acknowledges that healthcare 
‘needs to take a patients perspective into account and understand their experiences in the context of 
their everyday life’ (p. 386-7).429  
4.5 Methods 
 Background to the PAR approach 4.5.1
As stated by Green et al. ‘PAR seeks to ensure community representation and ownership of questions 
to be asked, the methods to be used and, ultimately, the interpretation and application of research 
results’ (p. 2).424 The foundation of this approach to research rests therefore on the researchers 
attitudes, rather than any given method. Cornwall et al. suggests that ‘methods are seen less as a 
means to an end … the emphasis not on outcomes but on processes’ (p. 1667).430 However, there is 
still a need to be able to draw valid and trustworthy meaning from data generated qualitatively, so that 
the knowledge gained can be relied upon.425 To this end, the cycle of inquiry proposed by Lewin is 
commonly used within a PAR methodological approach, because it takes into account that investigating 
lived experiences and the understanding that individuals give them will diverge from the planned 
research path.423 Lewin’s methods account for changes within the cycle of enquiry by enabling 
‘overlapping’ of action and reflection (p. 170).431 Thus, knowledge gained while researching, leads to 
reflection and informs action and this iterative process led Lewin to suggest that a system could not be 
understood until an attempt was made to change it, and takes into account that a system under 
investigation will change, possibly in unexpected ways, demanding a flexible and responsive approach 
that is unable to be anticipated or prepared for (p. 19).432 As such, iterative processes have the potential 
to lead to a deep understanding of the phenomenon under investigation and facilitate change within and 
between participants in a natural process. Therefore, ‘actual research will continue to evolve and be 
shaped by the realties of the context’ (p. 90).433  
Due to the contextual differences outlined below, and as per Green et al’s.424 position that no 
single method will suit each PAR study, and as this study was not entirely ‘co-planned’ and the 
researcher was dealing with a new area of enquiry, including social phenomena not yet investigated, an 
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exploratory PAR approach was taken (p. 25).434, 435 Figure 4.3 illustrates the process of exploration and 
action, which has an unknown endpoint within this PAR project. 
This project was not aligned with the goals or aims of any organisation or specific community 
group. Instead, the context within which the participants engaged with each other was informal and 
guided by their personal desire to explore the research topic after participating in the cross sectional 
study (Chapter 3). In addition, their shared experience of living with stress can be seen as an 
overarching, shared context. Co-planning commenced when the research process was underway (stage 
one, Figure 4.3) and included participants exploring, analysing and reflecting on the research questions 
in ways they chose to do so. Participants observed and reflected on action taken in the second stage by 
sharing their actions and personal progress. It was not possible to cycle back to re-examine and reflect 
on the questions and action taken and observe changes in a pre-determined or planned manner due to 
the informal context and nature of this exploratory project. However, the ‘overlapping’ of action and 
reflection, as per Lewin’s methods, did occur at the start of each week’s session, as participants 
discussed the transcripts from the previous week and shared their journal notes, including how they had 
used the knowledge gained and what action was taken using this knowledge. Transcript reading, or 
‘member checking,’ became a form of ‘cyclical reckoning,’ which also prompted journaling among 
participants, thus providing another natural cycle of personal reflection within this project. 
 
Figure 4.3: Process of Exploratory Action Research. Smith, R. and Rebolledo, P. (2018) A Handbook for Exploratory Action 
Research. British Council. 
 Sampling and recruitment (Access to the sample) 4.5.2
On the 1st of September 2016, as recruitment and data collection for the cross sectional project 
(Chapter 3) was concluding, recruitment for this project was initiated via an email and Facebook 
message invitation (Appendix CC). All 74 participants who had completed all three cross-sectional 
surveys (reported in Chapter 3) were invited to participate in the eight-week study; 22 indicated their 
interest by responding and eight took part in total. One participant dropped out after the second session, 
and another only attended two sessions due to work commitments. A total of six women completed all 
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eight sessions. Five of the participants were aged over 50 and three were aged between 31 and 41, two 
having no immediate family commitments. 
This group was relatively homogenous as the sample originated from the same geographical 
area and had personal Internet access, suggestive of similar socio-economic status and had self-
selected from the previous study (Chapter 3). Some authors advocate for homogeneity within focus 
groups as large gaps between social background and life style can hinder participants desire to speak 
freely.436  
 Ethics 4.5.3
The Office of Research Ethics, Compliance and Integrity at the University of Adelaide provided ethical 
approval for this project on the 6th of May 2016 (Appendix H). 
Upon confirmation of attendance all participants received a plain language information sheet 
(Appendix DD) explaining the aims and the processes of study, the identity and contact details of the 
researchers and a telephone number for psychological support if required during the study. Consent 
forms (Appendix EE) were signed at the first session, participants were also advised that the sessions 
would be recorded and that confidentiality and anonymity would be maintained throughout the project 
and any subsequent reports and articles for publication. Participants chose their own pseudonyms that 
were used in transcripts. 
All electronic data from the study in the form of audio recordings, transcripts, and journal 
entries are held on a private password protected computer with two backup systems in place. 
 Focus groups 4.5.4
Focus groups ‘offer unique insights into the possibilities of critical inquiry as deliberative, dialogic, 
democratic practice’ suggest Kamberelis et al. (p. 547).437 The use of focus groups was therefore a 
natural methodological fit with the PAR process because, as suggested by McTaggart, ‘PAR is in 
principle a group activity’ (p. 170).431 In addition, the concept of ‘the whole is greater than the parts,’ as 
suggested by Morgan, is clearly evident in focus group interaction, revealing subtleties and depth while 
addressing the research question, which other data generating approaches, such as interviews or 
participant observation, are unable to elicit.436 The natural affinity that people have to others who have 
similar experiences to them further supported the use of focus groups within a PAR process of 
enquiry.438  
Using email or Facebook, the researcher provided interested women with five possible time 
options for group sessions: four options during the day or at night and a weekend option. The meeting 
place was chosen as being equidistant for each of the interested women. A safe, neutral, quiet and 
spacious room, with a large table and comfortable chairs was hired from the local Gold Coast 
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community centre, with easy access to bathrooms and a kitchen where refreshments were made prior to 
each session. Using the same venue for all eight sessions established a feeling of familiarity and 
comfort for the participants, which was important toward the aims of this project and increased 
incentives for attending.439 Prior to the commencement of the first session the use of Chatham House 
rules was explained to the participants to encourage safe psychological sharing as was the cyclical 
nature of PAR. The two research questions guided the discussions, with the first question being 
addressed during the first four sessions and the next four sessions addressing the second question. 
Deviations from these questions were accommodated although the researcher guided the discussion 
back to the question when necessary. 
Eight focus groups took place between 10 October 2016 and 28 November 2016 consisting of 
between one hour and one and a half hours at each session. A final follow up, or PAR reunion, took 
place on 23 September 2017, requested by the participants, and was used as a data-checking 
opportunity. (Appendix FF contains the study timeline.) 
 Planning the analysis 4.5.5
An interactive model of data analysis was used which combined four components during the analytic 
process: data collection, data condensation or analysis, data display or results and conclusions 
(discussion) as advocated in Miles et al. and illustrated in Figure 4.4.440 An additional component, 
quality control, was included, using Lincoln and Guba’s criteria for assessing the ‘trustworthiness’ of 
qualitative data (p. 218).441 (See Section 4.5.5.3, ‘Quality Control.) 
 
 
Figure 4.4: Components of Data Analysis: Interactive Model. Miles, MB. and Huberman, AM. (1994) Qualitative data 
analysis: An expanded sourcebook (2nd Ed.). Thousand Oaks, CA: Sage Publications. 
4.5.5.1 Data collection 
Data collection took place using focus groups, journal entries, a follow-up (reunion) session to check 
data, and via emails after the reunion session. Data recording, transcription and storage was initiated 
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from the first focus group session. Focus group discussions were recorded using an electronic 
application and transcribed verbatim by the researcher. Participants were provided with a copy of the 
transcripts within two days after each session via email, a process known as ‘member checks’ (p. 
247).442 Data from participant reflective journals was collected after the last session and data from the 
researchers own reflective journal was collected after each session. Emails from participants after the 
last reunion session became an unexpected source of data. See Table 4.1 for a detailed explanation of 
collection methods. 
Table 4.1: Outline of data collection methods 
Stage Description Date 
Focus group 
sessions  
Eight focus groups lasting between 60 and 90 minutes were conducted, recorded and 
transcribed verbatim. 
10 Oct – 




Voice Memos (Apple iPhone Application) recorded all group sessions and were 
converted into MP3 audio files after each session; transcripts were generated in 
Microsoft Word, totalling 218 A4 typed pages (average 27 pages/ session).443, 444  
The researcher typed up researcher reflective journal notes and participant journal 
notes that resulted in 11 A4 typed pages.  
Final data codes and categories were recorded in Excel spread sheets and imported 
into NVivo where final data analysis was confirmed.445, 446  





Participants shared additional detail about their early life with the researcher via email, 
which the researcher copied into a word document.  
Aug – 
Nov 2017  
4.5.5.2 Data analysis (condensation) 
Data analysis (condensation) was accomplished in phases, firstly by analysing the data semantically, 
which involved looking at the surface, or explicit meanings of the data.447 Subsequent analysis extended 
to an interpretation of patterns within the data, using thematic analysis.447 In phase 1, the researcher 
analysed focus group transcripts, journal entries line by line to find data pertinent to answering the two 
research questions, including any reference to reflection, action and change, all of which were 
highlighted in the text. Codes were ascribed to highlighted illustrations that related to similar concepts 
using a variety of coding strategies, including etic, emic and a priori coding. Highlighted illustrations and 
codes were imported into Excel. In phase 2, 3 and 4, the researcher compared the data between each 
new session with the previous sessions, noting differences and similarities across time. A number of 
codes addressed both research questions and were therefore grouped together to denote this. Codes 
were analysed and grouped together to form categories if they related to similar concepts as the data 
set evaluation progressed. Third-party code and category verification occurred when the researcher 
discussed the codes with her supervisors. In phase 5 the full range of codes and categories were 
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positioned on large pieces of cardboard (Appendix GG), to support the visual comparison of codes and 
categories between the sessions. As the emails were received after the reunion session, data generated 
from them was not available to add to this verification process, however this data was included in the 
next phase, phase 6, when the data was moved from Excel into NVivo. Examining the data in NVivo 
confirmed the patterns noted between all data sources, sessions and participants in the spread sheets 
and visually on the cardboard. This final stage of data analysis led to the development of 16 categories 
and six themes, three of which addressed both research questions. Table 4.2 provides details of the 
analytic process and Table 4.4 provides details of the categories and themes. 
A specific number of cycles, or coding phases are not stipulated for qualitative research using 
thematic analysis.447 Six coding phases occurred in this project as the researcher aimed to ensure all 
the nuances within the data were addressed and aimed to compare data between different data 
sources. The six coding cycles led to a deep understanding of the data, as it allowed for a process of 
‘abstracting, focusing, selecting and simplifying the data,’ also referred to as ‘data condensation’, which 
is preferable to data summarization which reduces, versus distilling, the meaning within the data (p. 
12).425 As suggested by Padgett, ‘a constant comparative analysis stays close to the data’ and is, in 
practice, cyclical, which may be ‘repeated many times over,’ and ‘subsequent cycles of coding help to 
narrow the analyses to ever important findings’ (p. 177).448 Data saturation or ‘informational redundancy’ 
was reached when no new information was being shared or uncovered within sessions (p. 875).449  
The participants were not involved in data analysis because of their time limitations and in 
practice, ‘many tasks associated with the PAR process may be burdensome, impractical, or even 
infeasible for some participants’ (p. 84).450 However, ‘member checks’ across eight weeks provided 
participants with the emerging analysis and at the reunion session, the three attendees reviewed the 
codes, categories and patterns that had been developed during data analysis for authenticity and 
representativeness. Table 4.2 provides details about the six phases of data analysis as per Miles et al. 
and Padgett’s approach.425, 448 Appendix HH contains an image representing the files containing raw 
and analysed data on the researchers computer. 
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Table 4.2: Phase, description and dates related to data analysis 
Phase Description Date 
1 – Initial coding Transcriptions were typed in Microsoft Word and analysed by the researcher 
semantically, line by line with illustrations highlighted when they referred to a feeling, 
belief, experience, discovery, personal revelation, action or replies to such related to 
the research questions. Highlighted illustrations were linked to a researcher-generated 
short phrase or a single word, termed descriptive coding. Codes were generated 
based on a variety of concepts including the research questions and researcher 
experiences (etic codes); ‘emic’ or ‘in vivo’ codes based on participant’s words and 
concepts; ‘a priori’ codes based on existing literature; codes based on the conceptual 
framework established prior to analysis (process coding), which uses gerunds (‘ing’ 
words) to signify observable and conceptual action within the illustrations; emotion 
coding which labels emotions experienced or being recalled by participants; values 
coding which uses the prefix ‘V’ to code a value, ‘A’ to code an attitude or ‘B’ to code a 
belief.348 Initial codes were ‘generic’ as they did not convey personal insights, but 
rather general comments about experiences, feelings and ideas. Comparing the data 
and codes between sessions in Word documents revealed that codes became more 
personal as the sessions progressed. Some codes were applicable to more than one 
session and were used as such, and constant comparison between data and codes 
revealed patterns within the data. Journal notes and emails were analysed similarly 
after the last session. Transcriptions were shared with all participants after each 
session (member checks). Pertinent illustrations were imported into Excel spread 
sheets after initial coding, with a separate spread sheet created for each session. 
10 Oct 2016 
– 23 Sept 
2017 
Phase 2, 3 and 







Codes were distilled into more succinct codes after each new transcription was 
analysed, as a result of a deeper understanding of the data and between-session data 
comparison. Some codes addressed both research questions and were grouped 
together. Third-party code verification occurred via sharing of Excel spread sheets 
with the researchers’ supervisors. Categorisation arose by grouping codes that related 
to similar concepts together. Analysing categories led to the researcher becoming 
aware of patterns appearing across categories, resulting in the development of 
themes. Themes thus identified function as a way to group together data that 
comprises a topic made up of repeating ideas, and ‘a clear and identifiable distinction 
between themes’ occurred (Braun et al. (p. 91).348, 447 Researcher reflective notes and 
participant journal notes verified this data with the emerging categories and themes 
across sessions. Ongoing reflection about shared insights, interaction between 
participants and similarities and differences in their experiences informed these cycles 
of data analysis.  
10 Oct 2016 
– 1 Aug 
2017 
Phase 5 – 
Visual data 
analysis 
All codes were positioned on large pieces of cardboard with a column for each 
session and a ninth column for the journal entries to ensure the emergent categories 
were true to the data and codes that had been created. Codes were grouped within 
columns, using coloured sticky notes, which facilitated the observation of code, 
category and theme development over the eight weeks via visual examination. 
Participants checked and verified the data in this form. (Appendix GG.) 
30 Aug – 23 
Sept 2017 
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Phase Description Date 
Phase 6 – NVivo 
confirmatory 
data analysis 
Data was imported into NVivo from Excel where final analysis and confirmatory 
coding, categorisation and theme development occurred, with the aim of examining 
word frequencies and creating a digital visual network of emergent themes. Using 
NVivo facilitated data comparison between participants, between and within each 
session and across all eight sessions, journal entries, and emails, which resulted in 
both highlighting similarities between, and differences among, participants. Data 
comparison revealed changes in the depth of sharing over time and supported the 
visual comparison of codes, categories and themes. By examining 250 of the most 
frequently used words (minimum length of six letters and including stemmed words) a 
table was created (Appendix II) which verified the qualitative data.440 The relationships 
between codes and categories was confirmed and sixteen categories were verified. 
Ten categories (10/16) related to the role of relationships in both the lived experience 
of stress and in managing physical health and stress, two (2/16) related to confusion 
and scepticism about diet and dietary supplements, two (2/16) related to thinking 
patterns, and one (1/16) related to causes and effects of stress and one (1/16) to 
strategies aimed at managing stress. A total of six themes were developed from the 
repeated reading of these categories, four of which had more data driving their 
emergence than the others, as evidenced in the summary of codes and categories in 
Section 4.6 (Results of the PAR study), Table 4.4. 
23 Sept – 15 
Dec 2017 
4.5.5.3 Quality control 
Quality control involved, ‘member checking’ of transcripts and codes and categories. Mertens et al. 
suggests the standards for quality in qualitative research necessitates careful documentation regarding 
how the research and data were conducted and analysed, along with how the interpretative and thinking 
process of the researcher unfolded.402 This study was based on careful transcribing, reflective note 
taking, analysing journal data and emails and data comparison in the development of codes, categories 
and themes that reflected the data.425, 451 These practices aim to increase the ‘trustworthiness’ of the 
data so ‘one can establish confidence in the truth of the findings’ suggest Lincoln and Guba (p. 218).441 
Several criteria have been identified for judging whether such can be established in qualitative research, 
including ‘dependability’ and ‘credibility.’442  
Lincoln and Guba have advocated for the use of a number of techniques to establish 
‘credibility,’ a number of which were present in this study.441 Firstly, ‘prolonged engagement,’ which 
requires the researcher to immerse themselves in the participants experience, which was accomplished 
in this study over eight weeks of data collection, transcription and reflective journaling. Secondly, 
‘persistent observation,’ which required in-depth, detailed investigation, gathering detail about the 
context and the participants, which in this study was evidenced by the richness and depth of description 
in the data collected, specific to the phenomena of interest, which lent itself to the analytic depth 
indicative of this technique being adhered to, according to Miles et al.440 Thirdly, ‘member checking,’ 
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which in this study included the checking of data, interpretations and conclusions by those from whom 
the data was gathered (p. 247).442 Within this study, the data and interpretations were checked each 
week via transcripts, and participant’s commented on them at the next session, which also provided a 
‘member check’ among group members. A final ‘member-check’ occurred ten months after the eighth 
recorded session, at the reunion (23 September 2017), to which all the participants were invited to 
review the final data analysis in poster form. The three participants present at the reunion agreed that 
their ideas, experiences and stress-management strategies had resulted in codes, categories and 
themes that resonated with them, their experience and the data they had provided. This result supports 
these authors opinion that, ‘credibility’ is enhanced when the ‘data sources (most often humans) find the 
inquirer’s analysis, formulation and interpretations to be credible (believable)’ (p. 246).442 Thus, there 
was a ‘fit’ between the authors interpretation of the data and the original data source.452  
These three techniques included the study participants, whereas the next one included a form 
of ‘peer debriefing’, wherein the researchers’ supervisors checked the developing codes and categories 
in the third and fourth phases of data analyses, which was helpful in ensuring no ‘biases, motivations, 
interests, and perspectives …’ were existent on the researchers part (p. 218).441 (See Table 4.2.) In 
addition, the researcher maintained a reflective journal for critical self-reflection about herself and the 
research relationship, which Lincoln and Guba propose increases the quality of the research findings.441  
These authors also advocate using a variety of ‘data sources, different perspectives … to 
cross-check data and interpretation’ (p. 247).442 In this study, transcriptions, journal entries and emails 
were used. The transcriptions were shared with all group members via email, and journal entries from 
the participants and the researcher were shared by reading aloud to the group each week, which 
provided data crosschecking and interpretation.442 Emails were not shared with participants due to the 
personal nature of such but were included in data analysis. 
Finally, the research steps were transparently described from the start of the project through to 
data analysis and the reporting of the results. This depth of reporting, reflective journaling and the use of 
the techniques as proposed by Lincoln and Guba described above, combined to increase the quality of 
the research findings.441, 453  
Figure 4.5 provides a visual summary of data sources and verification procedures that 
occurred during and after the project, which supported quality control. 
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Figure 4.5: A Model of Data Sources and Verification 
Solid black arrows link the data generation, collection and comparison processes and the 
generation of codes, categories and themes from such. The light grey solid arrows link the eight 
consecutive sessions with each other including the final reunion session. A broken line between Q1 and 
Q2 represents the ‘overlap’ of discourse between sessions four and five that occurred when moving 
between research questions. Broken arrows between data transcriptions and each of the sessions 
represent ‘member checking’ of such and similar arrows between transcriptions and journal notes 
represent data checking between these sources. 
4.6 Results of the PAR study 
The two key questions this study sought to address were: what is the lived experience of stress among 
women and; how do diet and/or DSs play a role in this experience? Data generated from eight focus 
groups, participant and researcher journal notes and email correspondence were analysed to 
investigate these research questions using thematic analysis via an exploratory PAR enquiry. 
The participants were aged between 31 and 70, three were full-time employees, two were 
semi-retired, one was fully retired, one was a full time student and one was a part time student and full 
time carer for her husband. One woman was single, one was widowed, two were married, one was 
living with a partner and five women had been divorced. Only one woman had children still living at 
home, three women were child-less and the rest had adult children. Table 4.3 presents a visual 
summary of the participants personal and relationship demographics. 
S1 S2 S3 S4 S5 S6 S7 S8 Reunion
Codes, Categories, Themes
DATA: Transcriptions DATA: 
Emails
DATA: Participant journal notes
DATA: Researcher journal notes
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Table 4.3: Group composition and summary of personal and relationship demographics 
(pseudonyms used) 
Names Age Occupation Marital Status Children 
Amy 31 Full-time student Single None 
Cindy 38 Full-time employee Married 2 at home 
Jan 41 Full-time employee Divorced None 
Poppy 51 Full-time employee Divorced None 
Sandy 51 Full-time carer and part-time 
student 
Divorced and re-married 3 grown 
Mandy 62 Semi-retired Married 2 grown 
Tanya 64 Semi-retired Divorced and living with 
partner 
2 grown 
Danni 70 Retired and volunteer Widow; first marriage 
ended in divorce 
3 grown: 1 from 1st marriage 
2 from 2nd marriage 
 
During data analysis 438 codes and then 16 categories were generated using data from the 
eight focus groups, journal entries and emails. Comparing the data between sessions and sources led 
to the detection of patterns across the data set, which resulted in the development of six themes and 
illustrations were chosen that clearly articulated the theme. Three themes related to both research 
questions: ‘role of relationships in the lived experience of stress,’ ‘role of relationships in managing 
physical health and stress’ and ‘strategies aimed at managing stress.’ Two themes, ‘thinking patterns’ 
and ‘causes and effects of stress’ related to the question addressing the lived experience of stress, and 
the theme ‘confusion and scepticism about using diet and/or DSs to manage stress’ related to the 
second research question about the role that such may play in managing stress. Table 4.4 provides a 
summary of these themes and categories. 
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A network summary of the six themes and their relationship to the two research questions, 
including where themes addressed both questions is presented in Figure 4.6 below. The data driving 
each theme has been proportionally represented by the size of the theme’s ovals. 
 
Figure 4.6: A network summary of themes in relation to the research questions 
The themes were informed by illustrations of the action and change that occurred across the 
eight weeks. In a number of cases it became evident that the change process had escalated from the 
first focus group to the last email as participants increasingly reported and recorded more examples of 
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changed thinking and behaviour. The themes and illustrations are discussed in more detail below. The 
illustrations are presented in narrative format, and summarised in tables organised according to 
participant name, source of data (sequentially across the eight sessions, including journal entries and 
emails after the reunion) and theme name. The themes are: 
• Causes and effects of stress 
• Thinking patterns and stress 
• Confusion and scepticism about using diet and/or dietary supplements to manage stress 
• The role of relationships in the lived experience of stress 
• The role of relationships in managing physical health and stress 
• Strategies aimed at managing stress 
 Theme 1: Causes and effects of stress 4.6.1
This theme contributed to answering the research question about the lived experience of stress. The 
researcher was surprised by the confusion in participants’ minds about the differences between anxiety 
and stress, as this group of women were volunteers from the cross-sectional survey (Chapter 3). 
Participants wanted clarity about what we were investigating, so the pursuit of this topic became a group 
activity via discussion and became a common springboard from which we participated in and engaged 
with the research questions across the sessions. 
This shared, exploratory activity was useful to the participants as it clarified their personal 
experience of stress and/or anxiety, which helped them examine its causes and effects. A number of 
participants stated that their psychological experience of stress often accompanied a physical sensation. 
One of the participants acknowledged that she might play a role in creating her own stress, an idea that 
has the potential to improve her quality of life, and which was acknowledged, albeit from a different 
perspective, by other participants and is reported in the next theme. Illustrations from the discussion 
about the definitions of stress and anxiety and the causes and effects of stress are presented below. 
Table 4.5: Causes and effects of stress (illustrations) 
Names Source Causes and effects of stress (illustrations) 
Sandy S2 ‘They're hand in hand (referring to stress and anxiety) aren't they?’ … ‘Stressed, unhappy, 
pressure on my chest is constant.’ 
Poppy S2 ‘In relation to reading last weeks transcript and thinking about 'butterflies' in stomach 'I think 
(what I feel) it's more anxiety than stress.’  
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Names Source Causes and effects of stress (illustrations) 
Poppy S3 Reading from an Internet post: ‘ … stress is a state of mental or emotional strain, or tension 
resulting from adverse or demanding circumstances. Anxiety is a feeling of worry, nervousness, 
or unease about something with an uncertain outcome … it manifests itself physically as panic 
attacks, hot and cold flashes, racing heart, tightening of the chest, quick breathing, restlessness 
or feeling tense, wound up and edgy. Psychologically, excessive fear, worry, catastrophizing or 
obsessive thinking, and it’s avoidance of situations that make you feel anxious, which can impact 
on study, work, or social life.’ 
Tanya S3 (Discussing the difference in Sessions 1 and 2) ‘I know now, anxiety is something I have a lot of, 
heaps… but stress, it’s different. It’s 50,000 things to do at once. That’s my version of it.’ 
‘Anxiety’s different, it’s just as you read; you’re stricken. That’s how I had the ah-ha moment that 
was the difference between stress and anxiety.’ 
Cindy S4 ‘But yeah, I've noticed that I've created all of it … So I've just been thinking, how much do I 
create unnecessarily? How much stress in my life do I create unnecessarily?’ 
Cindy S6 ‘Your body starts to seize up when you can’t control how many things are coming at you.’ 
Mandy  Journal 
Entry 
‘I used to experience an almost constant ‘fight or flight’ feeling when I was working.’ 
 Theme 2: Thinking patterns and stress 4.6.2
This theme contributed to answering the research question about the lived experience of stress. A 
number of illustrations recorded in participant’s journals as their ‘conversations with self’ suggest an 
increased propensity to reflect on their thinking related to stress, which was driven by their involvement 
in this project. Some participants acknowledged that thinking patterns are a learned response and can 
be habitual, and a tentative idea emerged that they may also be learned behaviour. Apart from one 
participant, it was recognized that thoughts and thinking patterns play a role in their experience of stress 
and these participants alluded to having some control, or desiring some control over such. Two 
categories supported this theme: ‘self-awareness about stress’ and ‘role of thinking patterns in stress.’ 
The following illustrations demonstrate participants’ thoughts about their thinking patterns and how they 
changed over the eight weeks. 
Table 4.6: Thinking patterns and stress (Illustrations) 
Names Source Thinking patterns and stress (illustrations) 
Danni S2 ‘Today … I was having a fantastic day until I allowed something to stress me. I really shouldn't 
have gotten tensed up and angry about it, because there was nothing I could do.’ 
Mandy S2 ‘So, I had to then acknowledge that a lot of that stress is the person. It's managing the thoughts 
that go on in my head.’ 
‘I've been working on trying to be mindful when driving, so that I’m not gripping the wheel tight 
and I’m not clenching my jaw about people’s behaviour.’ 
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Names Source Thinking patterns and stress (illustrations) 
 S4 ‘I had a triumph. I have turned around a behaviour, I think, that has had me in its grip for many 
many, years, and that's road rage … So now when I get in the car I go through a process. I make 
sure everything is done when I back out. I'm mindful. Then I say “I'm going to have a safe, calm 
journey. I've left plenty of time.” I'll do this little speech. And it's working.’ 
‘My driving attitude has been completely transformed as I accept that I don't have to 'police' every 
driver who behaves badly. This has resulted in my driving becoming a much more pleasant 
experience. It is part of recognising "the things that I cannot change.’ 
Jan S4 (Referring to what another participant was sharing about pausing before reacting.) ‘… to just 
pause like you did, because that's such a brilliant example... just to pause sometimes before 
responding.’ 
Tanya S2 Referring to thinking: ‘I think it's a learned response. You've learnt it all your life, and you go back 
to it again whenever your body does or whatever, until you become mindful … Step back a bit 
and see what you're doing …’ 
‘I have actually made a change, I downloaded Andy Puddicombe, I don’t know if anybody’s heard 
of it. Headspace, it is. (Referring to an app for meditation) It’s all about just letting the thoughts 
flow through.’ 
 S3 ‘ … I thought, this is bullshit. That’s exactly what I thought. You’ve got to start thinking in here, 
change your thoughts.’  
 S8 (Referring to a quote that this participant sent to the group relating to not having the power to 
change circumstances, but having the power to choose how you respond) ‘Things we can’t 
change. A bit like serenity... That really resonated with me. Because we don’t have control.’ 
Sandy S2 ‘And yes, it’s very stressful, but I can't change who I am.’ [Exception] 
 Theme 3: Confusion and scepticism about using diet/ dietary 4.6.3
supplements to manage stress 
This theme contributed to answering the research question about the lived experience of using diet 
and/or DSs to manage stress. A general sense of scepticism about using DSs was shared by all but one 
participant but did not prohibit purchasing them by some of the sceptics. All the participants shared 
dissatisfaction with the evidence available for the effectiveness of DS consumption and diet in relation to 
health generally. None of the participant’s were positive about using prescription pharmaceuticals to 
manage anxiety or stress, regardless of whether they had used them previously or were still using them. 
Only one participant shared a positive experience using an activated form of folate and vitamin B12. 
Participants who used DSs brought them to the last three sessions and shared their usage habits. Two 
categories supported this theme: ‘alternatives to pharmaceuticals’ and ‘supplementation and diet.’ The 
following illustrations demonstrate participants’ thoughts about their confusion and scepticism with 
regards to the use of diet and/or DSs to manage stress. 
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Table 4.7: Confusion and scepticism about using diet and/or dietary supplements to manage 
stress (Illustrations) 
Names Source 
Confusion and scepticism about using diet/ dietary supplements to manage stress 
(illustrations) 
Cindy S2 ‘… how to fix it (stress) without going to the doctor and getting the doctor to fix it’ 
 S4 ‘I'm so conflicted with all these different ideas of how to eat.’ 
 S5 ’(Referring to the supplements on display) ‘I am really bad with supplements. I’ll take them for a 
month, and then I just forget about them. I just found that, and I think I’m going to take that 
because that’s good for stress, so I thought that might just be good for now. And that. And I’m 
going to start taking that. And I should be taking...They’re just ‘sometimes ones,’ so that’s how I 
go. But that will change. In a month that will look different.’ 
 S6 ‘I was very confused over what I was investing in.’ 
‘Is it really making a difference? There was just no real markers to see, to give me the evidence. 
So I think that’s why I do get over it, and just don’t do it anymore.’ 
Mandy S4 ‘… he put me on antidepressants you see, because none of this was discussed. I’ve been on 
antidepressants for 20 years, so trying it is not the issue. Ever being not on antidepressants is the 
issue. I’m not on a high dosage. But I wish in some ways that I had got the cognitive therapy 
along with the antidepressant.’ 
 S5 ‘I’ve always been caught between skepticism of anything that hasn’t been researched in the 
traditional scientific way, and given the seal of approval.’  
Tanya S4 ‘When I was younger I was always on antidepressants. But then I wouldn’t do it again, because I 
thought this is not the right way to go …’ 
(Referring to a MTHFR gene polymorphism) ‘Through a blood test it was discovered that I had 
two gene mutations, one from my mother, and one from my father. Part of those mutations also 
gives you anxiety, or makes your anxiety worse. So I thought, ‘oh for god’s sake, this all sort of 
makes sense to me.’ My body hadn’t been absorbing these B vitamins that I’d been taking for 
years.’ 
 S7 Referring to the use of dietary supplements to manage anxiety and stress: ‘This is working for 
me. This is the best I’ve ever been in years. I’m not obsessing as much’ [Exception] 
Poppy S7 (Referring to using dietary supplements) ‘You know the stuff that scientists say, all you’re doing is 
making expensive urine.’ 
Amy S7 ‘Why would any of us, and I don’t know because I’m not qualified to say this … if we maintained a 
healthy diet, and a healthy physical regimen would we need supplements forever and a day?’ 
‘So I wouldn’t know how long to take something, unless I’m told so yeah. But with education I 
guess. Education needs to be done about all the supplements.’ 
 Theme 4: The role of relationships in the lived experience of stress 4.6.4
This theme contributed to both research questions. Relationships were experienced as being stressful in 
many of the participant’s lives, including at work, within marriages and relationships with adult children, 
and during specific life stages when children were younger. In addition, some participants revealed via 
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email after the reunion, that childhood family relationships had been extremely stressful. The data 
revealed that change occurred sequentially. Five categories supported this theme: ‘empathizing with 
participants,’ ‘accepting and offering help,’ ‘family of origin – psychological influences,’ ‘offering 
participants suggestions to manage stress,’ and ‘comparisons between participants – stress.’ The 
following illustrations demonstrate participants’ thoughts about the role of relationships in their 
experience of stress. 
Table 4.8: The role of relationships in the lived experience of stress (illustrations) 
Names Source The role of relationships in the lived experience of stress (illustrations) 
Poppy Journal 
Entry 
‘Why am I so worried about what people will think?’ 
 S4 ‘I have a problem with speaking up for myself. I'll do anything for a quiet life.’ 
 S4 (Referring to a situation acted on at work after writing about it in her journal) ‘That was just me 
standing up for myself, which is a first.’ 
Poppy Email ‘I’d never have met ‘Assertive Poppy if not for these PAR sessions. She’s given me, or shown 
me I have, what it took to endure the last 12 months. What would it have been like if hadn’t 
learned I can say no, or yes less often, or speak up for myself and people would still like me? … 
One notices when I revert to ‘Little Miss Sunshine’ and asks "where's Assertive Poppy?”’ 
Poppy Email ‘My mother got pregnant at 20 while she was still at home … She became pregnant again when 
I was 4 … We were sent away until my sister was born … She was bad with money and all that 
entails. Won’t go into detail but it wasn’t fun. Missed Nanie so much I’d cry myself to sleep.’ 
Tanya S2 ‘I have been stressed all my life. Alcoholic father, mother left us when we were young. He was 
very abusive. Uncle in our family was very abusive. So, I never had a normal life.’ 
 S7 (Referring to a habitual response to a colleague and action taken to overcome such) ‘ ... I got off 
the phone and I went, 'now this is my chance, how I react to this, because this is where my 
buttons do push.' So every time I sort of thought about it again I thought ‘don’t speak to me like 
this. I know why you are, and I understand your reasons.’ I haven’t really thought about it since. 
Yes. That’s a hell of an accomplishment.’ 
Cindy S5 (Referring to her family) ‘… and so I’m starting to get into that victim mentality of ‘why do I have 
to do it at all, and can’t someone help me?’ 
 S8 (Referring to her family) ‘I felt like, okay, maybe they don’t understand, or they don’t notice what 
is ticking me off, so maybe I just need to be more obvious.’  
 Email ‘… been quite busy really, promotion at work has stretched me mentally but I seem to be in calm 
waters … have been running more meditation groups lately and had the chance to practice 
formulating a relaxation session … getting good feedback … ‘ 
Mandy Journal 
Entry 
Alcoholic father, brothers and daughter…’ 
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Names Source The role of relationships in the lived experience of stress (illustrations) 
 S5 ‘I was working four jobs at four different locations … I was painting the house …  doing 
gardening. I was coaching … athletics, and taking them (children) to swimming, and piano 
lessons ... So it was a typical 40 something then, crazy time.’ 
 S8 (Referring to her daughters alcoholism) ‘… my job is not to take on internally the burden of her 
stress, for my health…. she is the only one who can fix ... make the offer, and then step back. 
That’s all I feel I can do.’ 
 Email In relation to her mother, who later divorced her father: ‘Her pregnancies were not planned ... At 
that time they had two rooms in an old tenement building.  
Danni S1 ‘Years ago, I was going through a very despairing time, felt highly stressed because I mean I 
had a successful career, some would say, happily married with three children and juggling tasks 
and …’ 
 S2 ‘I think my experience is that women are almost expected to be able to cope under any 
circumstance and that they're always there for other people …’ 
 Theme 5: The role of relationships in managing physical health and 4.6.5
stress 
This theme contributed to answering both research questions, about the lived experience of stress and 
using diet and/or DSs to manage such. Results revealed that some of the participants use diet and/or 
dietary supplements to manage stress and that close relationships or the lack of them, did impact food 
choices. Family and friends may have influenced participant’s choices of dietary supplements, through 
‘word-of-mouth’, and the Internet and Social Media also played a role in nutritional and dietary 
supplement education. During the eight weeks, some of the participants initiated changes that they felt 
were supportive of their well being, which included hiring a personal trainer and using vitamin D 
supplements. Four categories supported this theme: ‘family of origin – health influences,’ ‘comparisons 
between participants – diets,’ ‘social media and Internet health advisors,’ ‘role of relationships in health’ 
and ‘doctors advice.’ The following illustrations demonstrate participants’ thoughts about the role that 
relationships play in managing physical health and stress. 
Table 4.9: The role of relationships in managing physical health and stress (Illustrations) 
Names Source The role of relationships in managing physical health and stress (illustrations) 
Cindy S3 ‘Then, he had the hide to say, “well, you spent $200 at the supermarket the other day … you've 
been buying too many blueberries. You've been buying heaps of health food, and it's costing a lot 
… “ ‘… But it’s to help me manage the stress.‘  
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Names Source The role of relationships in managing physical health and stress (illustrations) 
 S6 ‘I have invested in a personal trainer. And she’s on me, and it is really good. It’s a good reminder, 
it’s in my face … I just thought support is actually really big. Just like our emotions need support 
of others, I can see how our physical body would require support, and how much better we feel 
when we get that input from others. So we’re not meant to do it alone. Support gives you 
confidence.’ 
'I don’t know. I’ve just heard they’re good for stress.' 
Poppy S6 ‘ … I would always go for the healthy. But I just can’t be bothered making it. I think it’s because I 
live on my own. So what I have toast, there’s no one here to see me … I made a food diary, and 
it’s shocking.’ 
Danni S7 ‘I’ve done it, and I’ve heard you all say it … Good old Dr. Google has told us something. Because 
some of these you look at, and you go, you start reading it and then it’s sort of advertising 
something. You sort of think, what value has this got. What qualifications do the people have who 
are saying this?’  
Mandy Journal ‘Bought Magnesium tablets on the suggestion of my mother who claimed that taking them had 
reduced her leg cramps and was helping her sleep.’ 
 Email ‘I am still very much a work in progress needing to take more responsibility for dietary choices; 
but I have been taking large doses of Vitamin D and have been on a program for improving my 
hormone balance. The natural progesterone, in combination with magnesium seem to have 
improved my sleep pattern. I think the Vitamin D has given me more energy. I no longer need to 
lie down in the afternoon for a rest.’ 
 Theme 6: Strategies aimed at managing stress 4.6.6
This theme contributed to answering both research questions, about the lived experience of stress and 
using diet and/or DSs to manage such. Results revealed that participants used different strategies to 
manage stress, some of which related to diet and exercise. One participant had already established 
practices in her life related to stress, aspects of which she shared with the group. Another participant 
believed a specific DS helped her manage stress and another believed that being healthy and taking 
responsibility would have a similar effect. Some participants believed that supportive relationships were 
helpful in managing stress. There were no changes noted in relation to these strategies. One category 
supported this theme: ‘strategies aimed at managing stress – including reflecting on diet and exercise 
choices.’ The following illustrations demonstrate participants’ thoughts about strategies they use to 
manage stress. 
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Table 4.10: Strategies aimed at managing stress (Illustrations) 
Names Source Strategies aimed at managing stress (illustrations) 
Danni 
 
S1 ‘I went to a seminar where I was given all sorts of tips on how to manage my stress levels.  And I 
can say, 15 years later, I'm still practicing most of those and as a result, I very rarely feel super 
stressed anymore.’ 
 S8 (Referring to the eight sessions). 'I’ve gone full circle. I understand when I become stressed it has 
a detrimental effect on every aspect of my life. It is within my power to use strategies learned over 
the years to cope as best I can. Occasionally I believe supplements can be beneficial, especially 
if they are natural, taken for the correct duration, and are necessary. Diet and exercise play an 
enormous role in our mental and physical well-being. That’s how I summed it up.’  
 Journal 
Entry 
‘On my return home, I rang one of my friends and as soon as she answered … I said: “Can I 
vent?” I told her about my day, then had a lovely catch up chat … Immediately felt less stressed! 
Have definitely realized how important support can be in helping to relieve stress.’ 
‘Last night’s discussion really provoked a lot of deep thought for me. Not only is the relationship 
between anxiety and stress interesting, but how different personality types react to stress. Also 
realized for myself that verbalizing my anxieties/stress to others immediately helps me to feel 
better.’ 
Tanya S6 (Referring to the supplements she brought with her to the session) ‘These are the MTHFR tablets 
that I take … When she (Doctor) found out I had these gene abnormalities she got me onto 
these, so I know that the Bs are working, I don’t get so stressed.’ 
Poppy S2 ‘I've got a friend … we get together for hugs. He’ll pull me in at the coffee shop, and the hug has 
to last at least five seconds or it’s not a hug … At least three or four times a week. And he’s been 
away for six weeks, so I’m going through withdrawal from hugs.’  
Amy S5 ‘The best thing is taking responsibility. Because once you take the responsibility then you know 
you have the power to take control over what’s happening. As much control as what you can do. 
But if you don’t take any of the responsibility then you’re left at the whim of what’s happening to 
you.’  
 Planning for action 4.6.7
Participants were more open in their introspective journaling and more likely to anticipate action in the 
service of managing their stress in this medium versus what they communicated with each other within 
the group setting. Furthermore, it was noticeable to all present that reflective journaling occurred less 
regularly as the sessions continued, with a number of the participants commenting on this phenomena 
and interpreting it as progress in terms of their understanding of themselves, their response to stress 
and their ability to manage it more effectively. For example, as Danni stated in the last session: 
‘Interesting to note that initially I made copious notes but the more I understood how 
and when I was stressed, plus how I could manage it better, I began to make less 
notes!’ 
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The table below contains illustrations reflecting ‘plans for action’ that appeared in the 
participant’s journals and which were vocalized differently in the group sessions. 
Table 4.11: Plans for action (Illustrations) 





‘Have noticed over these weeks that I work myself up and I just stop and say ’no’ or ‘disagree’ it’s 
not the end of the world.’ 
 Journal 
Entry 
‘Decide I will say something at union meeting: feel sick, cold, shaking.’ 
 Journal 
Entry 
‘In other stressful situations, I find myself recognizing and examining the cause of the symptoms 
when I feel anxious. My self-talk has become more positive, though a lifetime of being negative 
and ‘down on myself’ will not disappear overnight.’  
Mandy Journal 
Entry 
‘I have been reading a lot about diet and nutrition and am committed to improving my habits … 
and discussed lifestyle changes with my husband. If I can persevere with this mental and physical 
health focus, I am hopeful I will be able to suffer less anxiety and feel less fatigued.’ 
 Journal 
Entry 
‘Today I made ‘laid back’ driving a focus, being mindful of not allowing other road users to trigger 
angry responses in me. Really enjoyed the exercise and felt quite pleased with myself.’  
 Journal 
Entry 




‘In an attempt to reduce caffeine consumption and aid relaxation: ‘I bought Chai tea to replace 
evening cuppa and then discovered that it also has caffeine.’ 
 Sharing progress and action 4.6.8
Although participants continued to comment on and discuss their experiences in relation to both 
research questions towards the end of session eight, all the participants articulated the feeling that the 
group had circled back and completed our investigation. As Tanya stated at the final session: 
 
‘I don’t know where we can go from here. We can listen, and be supportive of one 
another when problems arise, but I don’t feel that we can achieve much more 
regarding our original topic.’ 
 
One participant suggested that the group get together again, for a reunion, to which all the 
participants were amenable, and which did lead to a reunion ten months after the final session, which 
became the final ‘member check’ of the study: 
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‘But what I would like to see, and I don’t know if this can be arranged, is in six months 
if we did meet, whether we met for a lunch and just said what have we done, what 
have we changed, has it worked.’ (Mandy) 
 
This suggestion provided a data verification opportunity and initiated a discussion about stress 
in childhood, which unexpectedly led to another source of data, and to a final cycling back to the first 
research question, the lived experience of stress. However, ‘cycles don't just mean returning to the past; 
cycles mean moving forward in the present, recalling past experiences …. for references as comparable 
situations in the future’ according to Saldana (p. 43).454This participant was planning on moving forward 
within her cycle of new knowledge, referencing the past to ascertain whether what she and other 
participants had put into action, was still working. 
4.7 Discussion 
This exploratory PAR project examined an under investigated phenomenon that is both deeply personal, 
yet shared by many women globally; the experience of stress and the role that diet and/or DSs may play 
in attempting to manage stress. The PAR methods provided an opportunity for flexibility by allowing the 
participants to respond as they saw fit, to develop insight and possibly improve their lives.398, 422, 435  
Six themes were developed from the analysis of focus group data, the journal notes and the 
emails received after the reunion session. The six themes related to action and change in relation to the 
two research questions. (See Figure 4.6, Section 4.6, ‘Results of the PAR study’). 
 Causes and effects of stress 4.7.1
A general lack of clarity regarding the difference between stress and anxiety was pervasive among the 
participants, which led to a group activity to examine the differences leading to descriptions of the 
physical sensations that accompanied the experience. Some of the causes related to time pressure and 
a lack of control, as illustrated by Tanya and Cindy’s comments: ‘ … stress, it’s different. It’s 50,000 
things to do at once … you’re stricken‘ and ‘Your body starts to seize up when you can’t control how 
many things are coming at you.’ Mandy confirmed the physical sensation by stating: ‘I used to 
experience an almost constant ‘fight or flight’ feeling when I was working …’  
 Thinking patterns 4.7.2
Thinking patterns were recognized among participants as influencing their lived experience of stress 
and behaviour and were acknowledged as possibly becoming habitual via introspective comments 
shared in sessions and journal entries. Attempts to change such were noted among many of the 
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participants. For example, Tanya stated that: ‘I thought, this is bullshit. That’s exactly what I thought. 
You’ve got to start thinking in here, change your thoughts.’ Tanya also stated that: ‘You've learnt it all 
your life, and you go back to it again … until you become mindful … Step back a bit and see what you're 
doing …’ Mandy changed an habitual, thinking pattern: ‘I had a triumph. I have turned around a 
behaviour, I think, that has had me in its grip for many, many, years, and that's road rage … So now 
when I get in the car I go through a process. I make sure everything is done when I back out. I'm 
mindful. Then I say “I'm going to have a safe, calm journey. I've left plenty of time.” I'll do this little 
speech. And it's working.’ In relation to introspection Danni stated: ‘Today … I was having a fantastic 
day until I allowed something to stress me. I really shouldn't have gotten tensed up and angry about it, 
because there was nothing I could do.’ There is little research to support whether thinking patterns are 
recognized as contributing to the experience of stress among women or whether chronic stress 
contributes to them becoming habitual. However, one mixed gender study which allocated student 
volunteers (n=44 (11 men and 33 women)) to either an experimental group (n=21) that repeated positive 
thoughts in the presence of feelings of anxiety, depression or stress, or a control group (n=23) which did 
not, revealed that positive thinkers experienced a reduction in such mental states including a reduction 
in stress.455 In addition, a study that investigated women (n=98) with fibromyalgia (FM), found that high 
levels of rumination, previously defined as ‘the engagement of negative and unwanted past-centred 
thoughts,’ were correlated with stress as measured using the PSS (p. 245).45, 456 Rumination may thus 
lead to poor problem solving capacity and inflexible thinking.456 Although not directly related to stressed 
women these results suggest that, as in this study, chronic stress was related to ruminative thinking 
which may become entrenched over time, and is reflected in Tanya’s comment about her thinking 
patterns and stress: ‘I think it's a learned response.’ 
 Confusion and scepticism about using diet and/or DSs to manage 4.7.3
stress 
Confusion and scepticism regarding the use of diet/and or DSs to manage stress was pervasive among 
participants with Cindy stating ‘Is it really making a difference? There was just no real markers to see, to 
give me the evidence.’ The same participant admitted she was ‘really bad with supplements. I’ll take 
them for a month, and then I just forget about them.’ However, a desire to use alternatives to 
pharmaceuticals to manage stress and anxiety may drive purchasing, as stated by the same participant: 
‘ … how to fix it (stress) without going to the doctor and getting the doctor to fix it.’ Conversely, Tanya 
stated, in relation to a gene-specific nutrient: ‘This is working for me. This is the best I’ve ever been in 
years. I’m not obsessing as much.’ However, for the rest of the participants, purchasing behaviour and 
the use of DSs may be based more on ‘Hope and Hype,’ than confidence as to their efficacy (p. 188).457 
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In addition, all the participants agreed with Amy who stated: ‘Education needs to be done about all the 
supplements.’ There is no research examining whether confusion and scepticism is related to the use of 
diet/ DSs to manage health or stress, despite growth of the stress-management DS market being 
expected to reach USD16.7 billion by 2025.8  
 The role of relationships in the lived experience of stress 4.7.4
A variety of relationships played a role in the experience of stress among the participants. In relation to 
the multiple roles that women play in society, Danni stated: ‘I think my experience is that women are 
almost expected to be able to cope under any circumstance and that they're always there for other 
people, so they're there for their husband or their children, their parents … you take it on as if you have 
to.’ Although there is scant research that has focused on female anxiety and stress generally, or 
whether being expected to cope just by virtue of being a women leads to anxiety or stress, a Swedish 
study (n=60) that investigated work-life challenges, time scarcity and the physiological response to 
such, revealed that female cortisol levels stayed high after work in relation to men’s levels.79 In addition, 
Luecken et al. reported that mothers have higher levels of stress than women without children as 
revealed by a survey where levels of strain at work and at home were measured in women (n=109) over 
a 24-hour period using a validated Strain Scale measurement tool.87 Furthermore, a study investigating 
parents’ perceptions of parenting in the UK via interviews found that work-home conflict did generate 
stress in female participants (n=17 (1 male and 16 women)).458  
Personal insight into what stress means personally, change and increased control within and in 
relation to relationships, occurred in a myriad of ways. For example, Poppy stated in an email after the 
reunion session that: ‘I’d never have met ‘Assertive Poppy if not for these PAR sessions. She’s given 
me, or shown me I have, what it took to endure the last 12 months. What would it have been like if 
hadn’t learned I can say no, or yes less often, or speak up for myself and people would still like me? … 
In relation to being more direct with her family in terms of what she needed, Cindy stated that: ‘I felt like, 
okay, maybe they don’t understand, or they don’t notice what is ticking me off, so maybe I just need to 
be more obvious.’ In relation to her daughter’s alcoholism, Mandy stated that: my job is not to take on 
internally the burden of her stress, for my health…. she is the only one who can fix ... make the offer, 
and then step back. That’s all I feel I can do.’ There is a paucity of research examining a personal 
change process that occurs as a result of insight into stress and challenging relationships. However, the 
link between close relationships and quality of life has been established in light of the basic human 
desire to belong, be accepted and maintain close relationships.459-461  
Although present relationships were primarily reported on during the focus group sessions, 
emails after the reunion session reported on relationships during childhood. This change in the depth of 
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sharing became an unexpected and additional source of data and revealed that the three participants in 
the project who reported experiencing the most stress and anxiety in adulthood also shared the 
experience of childhood trauma, also known as early life stress (ELS). Mounting evidence supports a 
causal relationship between the stress they experienced as children and their adult stress-responses. 
For example, results from the Helsinki Birth Cohort Study 1934-44 (n=13,345) in which approximately 
14% of the children were temporarily separated from both parents during child evacuations in WWII, 
revealed that these individuals later experienced increased stress reactivity among other psychiatric 
effects.125, 127 Partial explanations are the disruption of optimal HPA development and functioning and 
the possible disruption of optimal PFC development with the concomitant inability to manage self and 
environment optimally in the face of adulthood stressors.42, 128, 130, 462-467 In addition, ELS in the form of 
caregiver deprivation impacts amygdala development negatively in humans, which reduces the ability to 
assess and respond to affective stimuli, which may explain higher rates of anxiety noted in such 
populations.129 Indeed, a positive habitual response to stress exposure may be acquired when ELS is 
not present.468 However, there is no research examining how women respond to discovering that ELS 
may impact their ability to manage stress nor whether using specific nutrients can ameliorate the 
experience of such when ELS was present.  
 Role of relationships in managing physical health and stress 4.7.5
Whether relationships directly supported their health or not was discussed among the participants and 
one of the women decided to invest in a personal trainer because she felt that: ‘ … support is actually 
really big. Just like our emotions need support of others, I can see how our physical body would require 
support, and how much better we feel when we get that input from others. So we’re not meant to do it 
alone. Support gives you confidence.’ Positive personal relationships do impact health and happiness 
levels as evidenced by a review that investigated such.469 Furthermore, the presence or absence of 
family members may also impact food choices as suggested by Poppy: ‘But I just can’t be bothered 
making it. I think it’s because I live on my own.’ 
With regards to ‘word of mouth’ DS use prompting, Cindy stated that: 'I don’t know. I’ve just 
heard they’re good for stress. As a result of the discussion about DSs in the focus groups, Mandy 
investigated whether she was deficient in any nutrients with the help of her medical doctor and stated: ‘I 
am still very much a work in progress needing to take more responsibility for dietary choices; but I have 
been taking large doses of Vitamin D and have been on a program for improving my hormone balance. 
The natural progesterone, in combination with magnesium seem to have improved my sleep pattern. I 
think the Vitamin D has given me more energy. I no longer need to lie down in the afternoon for a rest. 
There is limited research evidence examining how and why relationships impact the use of diet and/or 
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DSs as stress-management strategies despite large multi-level marketing companies using relationships 
to encourage the purchase of DSs generally.470 One Italian survey of students (n=770) reported that 
some of the respondents took advice about food supplements while nearly half of them reported that 
their advice came from medical doctors.471 Similarly, results from an Indian survey (n=120) reported that 
12% of the respondents relied on family and friends for advice about MVM supplementation, while close 
to 70% relied on the advice of a medical practitioner.472 The role of relationships in the purchasing and 
use of DSs was articulated by Mandy: ‘Bought Magnesium tablets on the suggestion of my mother.’ 
 Strategies aimed at managing stress 4.7.6
Participants commented on strategies already used to manage stress levels, for example, as stated by 
Poppy: ‘I've got a friend … we get together for hugs. He’ll pull me in at the coffee shop, and the hug has 
to last at least five seconds or it’s not a hug …  Danni agreed by stating: ‘ … realized for myself that 
verbalizing my anxieties/stress to others immediately helps me to feel better …’ A review of 81 studies 
that investigated the relationship between social support and physiological processes found that 
relationships may act as a buffer against stress and that familial sources of support may impact 
health.473 The researchers suggest that secure and supportive family relationships are critical 
determinants of the capacity for regulation of emotional and physiological processes.473 Similarly, Burns 
et al. reported on a study (n=364) that examined psychological functioning and the quality of 
interpersonal relationships, which found that interpersonal relationships moderated the effect of life 
events on subjective wellbeing more than number of life events.460 However, there is limited research 
available that has investigated self-imposed stress-management strategies among women, although a 
small study was undertaken to investigate such via interviews with 18 women who juggled a number of 
roles.474 The results revealed that the participants employed up to six strategies, including managing 
time and energy, releasing responsibility and maintaining health and wellbeing to find balance between 
their roles. In support of these findings, some participants believed that managing stress should include 
a focus on health and taking responsibility, as Danni stated: ‘Diet and exercise play an enormous role in 
our mental and physical well-being’ while Amy stated that: ‘The best thing is taking responsibility. 
Because once you take the responsibility then you know you have the power to take control over what’s 
happening.’ 
The difference between the depth of detail of participant sharing between data sources may 
suggest a desire by the participants to avoid verbalising intentions. Participants may have felt 
comfortable writing about an anticipated action before expressing their intention in the group setting. In 
their minds, thinking and journal writing may have represented planning for action. They may thus have 
avoided establishing expectations or accountability in the group, so as to avoid disappointing 
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themselves or others. The decreased journal writing over the eight-weeks suggests that as participants 
became more active in controlling and self-managing their stress, it became less important for them to 
document their behaviour, their stressful experiences and how they managed such. As stated by Danni: 
‘Interesting to note that initially I made copious notes but the more I understood how and when I was 
stressed, plus how I could manage it better, I began to make less notes!’ There is no research to 
support either the difference between planning for action privately and sharing such plans, or decreased 
journaling as personal control increased. 
Many of these introspective and reflective theme-based illustrations reflect changes in 
behaviour and thinking patterns that occurred during and after the eight weeks, with illustrations from 
journals reflecting sentiments shared in the sessions related to change and thinking patterns. For 
example, Poppy stated in her journal: ‘‘Have noticed over these weeks that I work myself up and I just 
stop and say ’no’ or ‘disagree’ it’s not the end of the world.’ While Mandy, referring to feeling anxious 
and stressed, stated in her journal: ‘Working on strategies to recognize and defuse the feelings…’  
These changes signify emancipatory change and action from specific thinking patterns and habitual 
responses that participant’s became aware of and acted on to change. 
Greater personal change was noted in a number of the participants as the project progressed, 
with significant changes in participants lives reported via email after the reunion, as evidenced by the 
illustrations in the tables reflecting such. For example, Poppy stated: ‘‘I’d never have met ‘Assertive 
Poppy if not for these PAR sessions …’ As expected, emancipatory change and action was unique to 
each participant and did not follow a pre-planned or anticipated format because progress evolved 
iteratively across the project, with ‘action’ and ‘reflection’ overlapping as per Lewin’s proviso.431, 475 In 
addition, emancipation, as per McTaggart’s definition, was not ‘revolutionary’ but instead resulted in 
value driven changes (including in perspective) that the participants felt improved their lives compared 
to what they experienced prior to this project (p. 205).422  
 Limitations 4.7.7
There are a number of methodological limitations to this study. There are a large number of variations in 
method and methodology for PAR studies, including that participants should ideally be co-planners and 
analyse the data, both of which did not occur in this study.426 In addition, this project was not conducted 
in a specific political or organisational context aimed at emancipation from external domination or 
control, another goal that many critical social theory PAR methods share. Instead, this was an 
exploratory study to investigate a psychological phenomenon, initiated by the researcher, who also 
decided on the research approach in the context of a PhD candidature. This required the researcher to 
develop and lead the inquiry in a suitable timeframe. 
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The written word, via transcription, is not a completely reliable data source because it cannot 
accurately reflect all ‘the mental, social, affective and cultural components of both the individual and 
group performance’ (p. 65).476 Subtle nuances may be missed despite careful transcribing. However, 
obtaining feedback from the participants via transcription reading between sessions somewhat mitigated 
this limitation, as did using journal entries to validate transcription data and final data checking at the 
reunion. In addition, the informal structure and relaxed atmosphere within which the focus groups took 
place, led to laughter and humorous comments between participants, and these moments were 
recorded in transcriptions, and considered in contextualizing the analysis. 
The difficulty recruiting time-poor women, the over-representation of older women, and only 
eight of 22 interested women taking part in the project could be perceived as limitations. However, it 
may also be a confirmatory factor within the developing theory that relationships, including family 
responsibilities during certain life stages, play an integral part in women’s lived experience of stress. In 
addition, this limitation would exist for any research project attempting a deeper understanding of this 
topic. 
That participants were equally confused and sceptical regarding this topic is further evidence 
of a knowledge gap in this area of women’s health. In addition, although the positive impact of healthy 
social relationships on psychological wellbeing is well documented, the impact of challenging personal 
relationships, and/or ELS, on the experience of female stress is an area that warrants further 
investigation. It is recommended that evidence regarding the lived experience of stress and the impact 
on chronic stress of diet and/or DSs should be made available via online resources in light of their 
prolific use globally and women’s use of the Internet for health-related information.8, 232 In light of the 
growing body of evidence linking ELS to heightened stress-reactivity, the conceptualisation and 
development of intervention strategies targeting pregnant women and mothers, with the aim of 
mitigating ELS for children, so as to improve anxiety and stress reactivity in adulthood, is warranted. 
 Conclusion 4.7.8
Many PAR projects, including this one, aim to create positive change on a small scale, with a view to 
further research that can support change on a larger scale. Engagement with a small community or 
group is as important as large-scale projects because any attempts made by people to increase their 
ability to make sense of their world and act effectively within it improve their quality of life and the lives 
of those around them. This in turn creates positive change in the world.410 The benefit to participant’s 
within this project were an increased understanding of what living with stress feels like for other women, 
being exposed to positive strategies used by others to manage their feelings of stress, insight into ways 
of being, including thinking patterns and habitual behaviour that may increase stress levels, and 
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information about whether diet and/or DSs were useful in managing stress. The findings suggest that 
the participant’s benefited from being in this project as evidenced by positive action and behaviour 








Despite a growing body of evidence suggesting that diet may be a modifiable risk factor in relation to 
mental health and that a specific DP can prevent depression, the impact of nutrition on chronic stress 
remains unexamined.163, 164, 170, 277 As this thesis has shown, women report higher rates of stress than 
men globally and consume more DSs, and due to the growing expenditure on stress-targeted DSs, the 
objective of this thesis was to investigate the relationship between perceived stress and specific 
nutrients consumed in the daily diet and/or via DSs in among women.4-6, 8, 17-28, 230  
To investigate this issue, three studies were conducted, a systematic review (Chapter 2), a 
cross-sectional survey (Chapter 3) and a PAR project (Chapter 4). How these projects formed a 
cohesive whole with which to answer the research question is addressed in this chapter, along with 
limitations specific to these projects and those related to broader ones in EBM and mental health. 
Implications for practice and future research into the use of nutrients for female stress management are 
also discussed. 
The JBI Model of EBHC (Figure 1.5, Section 1.9) introduced in chapter 1 provided the 
framework for evidence synthesis and generation to investigate the high levels of stress reported by 
women globally and the prolific use of DSs to manage stress.265 This model visually presents generation 
of knowledge as being iterative in nature and illustrates that although global health improvement is ‘both 
the goal and the endpoint of any or all of the model components …’ this process may not be linear (p. 
209).269 Therefore, the relationship between the ‘inner wedges’ may at times be bi-directional, as 
occurred within this study, where evidence synthesis preceded evidence generation. Thus, the 
systematic review (Chapter 2), which identified a knowledge gap, led to the generation of evidence that 
informed the following two research projects. These projects were underpinned by the models broad 
conceptualisation of evidence, which aligns the type of evidence generated to the particular knowledge 
need.265 The ‘evidence generation’ wedge therefore provided a framework for both research projects: 
the cross sectional survey (Chapter 3) which generated quantitative evidence about the phenomena of 
interest and the PAR project (Chapter 4) which generated qualitative evidence using a participatory 
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group process and focus groups. Thus, combined, evidence was generated in relation to the research 
topic that provided empirical knowledge in the form of frequencies and quantities and also a deep, 
personal perspective about the experience under investigation. In addition, the centre of the model, the 
‘FAME’ scale, broadly conceptualises the different types of evidence that can be generated and which 
clinicians are concerned with when using evidence in point of care practice.265 Combined, all three of 
the thesis projects provided evidence that informed on the practical application of best practices 
(feasibility), on the specific context (appropriateness), on the individual experience (meaningfulness) 
and on which interventions were beneficial (effectiveness). The JBI model recognises that both robust 
quantitative and qualitative evidence may be required to inform complex healthcare challenges and 
practices, which was required for this research topic.265 This model thus provides a conceptual 
framework within which such evidence can be generated, synthesised, transferred and implemented, 
providing healthcare researchers with a comprehensive EBHC model aimed at improved global 
health.265 
5.2 Systematic review 
The use of stress-targeted DSs fuels a growing global multibillion-dollar industry, with expenditure 
expected to reach USD16.7 billion by 2025, despite very little evidence to support the effectiveness of 
such to reduce stress levels.8 Studies have suggested the use of vitamin and mineral supplements 
increases in people with a history of anxiety and/or depression. As women experience higher rates of 
these disorders than men, and consume more DSs than men, it is likely women also use more stress-
targeted DSs.4-6, 229, 230 The systematic review results in chapter two revealed a dearth of evidence to 
support the use of such DSs in the general female population, although the use of some specific DSs 
provided anxiolytic and stress-reduction benefits to some women during specific reproductive life 
stages. However, disregarding a specific hormonal stage, only vitamin B6 reduced anxiety in a group of 
older women and vitamin C reduced anxiety and mitigated increased blood pressure in response to 
stress among another group.184, 293  
Although how hormones play a role in emotional modulation and impact the ability to manage 
stress was discussed in chapter 1, they do not account entirely for the high rates of stress reported by 
women globally. However, as evidenced by the Systematic review, current research that has examined 
stress in relation to hormonal disequilibrium and nutrient intake excludes women who are experiencing 
chronic stress regardless of reproductive life stage. The gap in the evidence base identified through the 
systematic review informed both the design of the cross-sectional project (to generate descriptive data) 
and the PAR project for evidence of the impact of stress on the lives of study participants.  
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5.3 Cross Sectional Project 
The cross sectional study was undertaken to examine the topic of chronic stress and nutrient intake 
among women regardless of hormonal stage. This study revealed that the relationship between PSS 
scores and age was not significant, however, DS users were significantly older than non-DS users. In 
addition, prior to adjustment for multiple testing, there was evidence for a number of significant 
relationships between nutrients consumed via DSs and PSS scores. There were substantive reductions 
in PSS scores related to intake of ALA, LA and EPO via supplements compared to non-supplementers. 
There was also a strong positive correlation between PSS scores and intakes of EPA and DHA among 
supplementers of these nutrients. This may be an indication that as stress levels rose so did the intake 
of DHA and EPA. In addition, there was a weak correlation between PSS scores and intakes of vitamin 
C and B6, and contrary to previous research, the combination of B6 and magnesium was not found to 
be significantly associated with lower stress levels either before or after adjustment for multiplicity. 
When assessing the relationship between nutrient intake from food and PSS scores, an increase in B6 
was associated with a decrease in PSS scores. In relation to most nutrients consumed via food, as the 
intake of such nutrients increased so too did the odds of supplementation with that nutrient. However, 
after adjustment for multiple comparisons there was little evidence for significant relationships between 
any of these variables. Finally, analysis of the relationships between total intake of each nutrient (from 
food and DS combined) and PSS scores yielded estimates of effect considered to be very small in 
magnitude. Therefore, although there is a substantial body of research that suggests that such nutrients 
have critical roles to play in the CNS, evidence from the present study was inconclusive for the self-
reported effect of these nutrients on stress, regardless of whether they were obtained from food or DSs. 
Apart from the relationships between nutrients and PSS scores, behaviour associated with DS 
use revealed that the two main reasons for using DSs was to increase energy (35%) and reduce stress 
(22%). In addition, the use of 31% of the DSs were cited as being prompted by health care provider 
recommendations, although for 42% of DSs used, participants were unsure of whether the DSs were 
useful. Whether there is a relationship between these variables is uncertain, although it may be that 
participants used DSs as directed and as ‘health insurance’ but a lack of measurable health outcomes 
led to uncertainty in self-reporting usefulness. Furthermore, as the nutrients of interest increased in the 
participant’s diets, so too did the odds of them using DSs. The concept of ‘health insurance’ 
(Discussion, Section 3.5) may partly explain the use of DSs despite the lack of self-reported benefits. 
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5.4 PAR Project 
The PAR project was undertaken to gain a deeper understanding of the experience of living with stress 
and the role that diet and/or DSs play in this experience. Relationships emerged as playing the most 
significant role in both the experience of stress and the decisions made about DS use. Stress was 
understood by participants as being related to the multiple roles women play at specific life stages, such 
as being mothers and working outside the home. In addition, relationships were also understood as 
having the capacity to provide support during times of stress, and the use of DSs was prompted by 
suggestions from trusted others who had experienced positive results. Furthermore, the three 
participants who reported experiencing the most stress and anxiety in adulthood also shared the 
experience of ELS. Other research suggests the quality of personal relationships contribute to a sense 
of wellbeing, that ELS impacts the ability to modulate stress neurobiologically in adulthood and that 
relationships impact food choices, yet there has been no research about how relationships impact DS 
choice and use in female stress, nor whether DS use impacts the effect of ELS on the adult stress 
response.128-130, 465-467, 477 In addition, similar to previous research that has revealed that women use the 
Internet prolifically to gather health related information, which included the use of SM, the PAR 
participants acknowledged their use of such for the same purpose. 
Although the use of the Internet for health related information is prolific among women and the 
use of DSs to manage stress is also prolific globally, and a number of participants did use DSs to 
manage stress, this study showed participants all shared a general sense of confusion and scepticism 
about the use of diet and/or DSs to this end. Furthermore, they all shared a desire for education about 
DSs to be made available. 
Although relationships were related to the experience of stress, and DS use, and their 
confidence in DS efficacy was poor, some participants also revealed a rudimentary understanding about 
the neuropsychological processes underpinning long-established, habitual thinking patterns, which they 
described as learned responses. During this project, participants self-awareness increased and led to 
positive changes in their thinking patterns and behavioural responses, and changes in DS use, all of 
which they described as helpful experiences resulting from participating in this project. 
5.5 Recent research 
There is limited evidence linking the amelioration of chronic stress experienced by women to specific 
nutrients, consumed either via the diet and/or DSs. This is despite evidence linking the same nutrients 
to stress hormone and neurotransmitter synthesis, and the possibility that stress hormone synthesis 
may take precedence over the synthesis of neurotransmitters that modulate emotion and mood.2, 172, 282, 
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340, 478 Similarly, although evidence links chronic stress to the development of affective disorders, and 
research suggests that the first stress-induced episode of depression increases the likelihood of 
subsequent episodes, there is no evidence to suggest that ameliorating chronic stress via the 
consumption of specific nutrients in any form may prevent the development of affective disorders among 
women.46-55, 479, 480 For example, a systematic review that investigated the effectiveness of MVM 
supplementation in reducing stress levels only included one exclusively female study that examined 
psychological distress.172, 317 In addition, although studies have reported a reduction in stress among 
women using a B-complex DS, impact on chronic stress is under-reported.180, 270 
Nevertheless, more recent research suggests a gender-influence; nutrients may impact female 
versus male neurobiology differently, which in turn may impact subsequent experiences of chronic 
stress. Men are more likely to experience mental wellbeing until severe nutrient deficiencies arise while 
following a western-type diet, while women are less likely to experience the same until a balanced diet 
and healthy lifestyle are attained, such as that obtained using the Mediterranean diet and lifestyle.278 
The authors suggest dietary sufficiency potentiates heightened limbic system regulation in women, 
which is suggestive of nutrients impacting mental wellbeing differently in women than men.278 In 
addition, a recent systematic review and meta-analysis revealed female subjects noted significantly 
greater benefits from dietary interventions for symptoms of depression and anxiety.279  
Therefore, by the time depression and/or anxiety manifest, due to the neurobiological impact of 
chronic stress, nutrient deficiencies may have become severe and been present for a considerable 
period of time. However, the evidence is that benefits in relation to female mood take up to a year of 
MVM supplementation.272 In addition, individual variation in relation to HPA activation and a possible 
inability to return to homeostasis, nutrient-specific genetic polymorphisms and the presence of ELS, 
may further influence nutrient requirements in that specific nutrients may be more useful to stress-
reduction than others. Therefore, as per the conceptual framework developed in chapter 1, women may 
be both uniquely predisposed to experiencing chronic stress and uniquely experience benefits from 
nutrient interventions in relation to chronic stress. However, the paucity of evidence examining these 
variables prevents the clinical recommendation of specific nutrients to reduce stress levels. 
The lack of research examining the neurobiological effect of specific nutrients on female stress 
is compounded by the lack of evidence for the use of specific forms of nutrients by women who have 
MTHFR gene polymorphisms. Research suggests that individuals with these genetic variations may be 
more susceptible to mood disorders, although no research has examined whether this may impact the 
ability to manage stress; similar mechanisms may underpin such.336 As mental wellbeing relies on a 
wide variety of biochemical activities, minor dietary deficiencies and genetic variations in enzyme 
efficiency may combine to impact emotional modulation and cognitive functioning and impact stress 
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management abilities.172, 334, 481 (See Sections 2.12 (Limitations of the studies), 3.5 (Discussion) and 
4.6.3 and 4.6.6 (Results), for information about the use of activated DSs.)  
ELS significantly increases the likelihood of nutritional deficiencies due to the circumstances 
within which it exists, (including deficiencies of specific nutrients in utero and childhood that influence 
CNS structural development and function and the development of neurotransmitter systems), all of 
which predispose adults to less adaptive coping strategies in the face of stressors.482, 483 Animal studies 
have suggested early nutritional interventions provided clinical benefits to offspring in relation to brain 
structure and function by offsetting the neurobiological effects of ELS during early brain development.484 
Whether this is the case in relation to human neurological development in the presence of ELS remains 
unexamined. 
Similarly, despite the prolific use of the Internet by women to gather health related information, 
there is limited evidence about what percentage of such behaviour is aimed at managing chronic stress 
and whether it results in the use of stress-targeted DSs. There is also limited evidence about whether, 
and how often, advice from friends and family inform stress-management DS use, although some 
studies suggest friends and family do impact DS use, although use is more influenced by advice from 
medical doctors.471, 472 However, none of these studies report on whether DS use was perceived as 
being beneficial. Lack of evidence does not correlate with belief, as a 2015 online survey (n=2,016), 
initiated by the Council for Responsible Nutrition, reported that 85% of participants were confident in 
their use of MVMs.485 Therefore, the use of the Internet for gathering information about managing stress 
using DSs, whether advice from friends and family inform DS use for the same end and whether there is 
confidence in the use of DSs for stress-management purposes all remain poorly examined areas of 
research. 
5.6 Limitations 
The lack of standardisation in the amounts, combinations, and confounding substances in DSs used in 
the EFA studies in the systematic review was a limitation, as was the lack of baseline data on chronic 
stress in relation to daily life regardless of reproductive life stage. In addition, the heterogeneity and 
varying rates of reliability of the outcome measures made study comparisons challenging, as did the 
variations in study length. Overall, the evidence identified through the systematic review was conflicting 
and no consensus was able to be established on the effectiveness of using any nutrient for stress 
and/or anxiety reduction, regardless of life stage. 
The directionality of the relationship between perceived stress and nutrient intake and/or DS 
use cannot be ascertained from cross sectional studies. In addition, the sample was small and not 
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randomly selected although it is likely that recruiting stressed women is a research challenge inherent to 
this field of research. In relation to the measurement instruments, the SUQ was not fully tested for 
construct validity or reliability. Assessing chronic stress presents diagnostic challenges due to individual 
perception and response to stress. Within the cross sectional survey perceived stress scores could only 
be compared across the sample using the PSS instrument, which although being a well-validated self-
assessment measurement tool, is not a diagnostic or screening tool. Therefore, using the PSS in 
conjunction with biological stress markers would go some way to addressing this challenge. 
In relation to the PAR project, stressed women may have been unable to participate in the 
focus groups, which would have contributed to selection bias. The nature of action research does not 
lend itself to generalizability, therefore the results are best considered as applicable to participants, and 
transferability of these findings to other women in similar circumstances may not lead to the same 
results.  
5.7 Within EBM/H 
Due to the complexity inherent in social interventions, there may be a need for clinicians to consider 
evidence based on both experimental and non-experimental methods.266 Therefore, the JBI model not 
only provided a framework for the research approaches within this thesis, it also allowed for the 
examination of a research topic that included components from the disciplines of psychology, nutrition 
and neurology. 
5.8 Contributions and implications for practice and future 
research 
The projects that comprise this thesis contribute to the scholarly research and literature in the field of 
human nutritional neuroscience and chronic female stress in a number of ways. Firstly, despite the 
prolific consumption of stress-targeted DSs in the form of isolated nutrients, no research has examined 
the relationship to chronic stress among women. Secondly, the lived experience of stress among 
women and the use of nutrients to cope has been identified as a research gap, as is the effect of DSs 
on women who experienced ELS and as adults have experienced stress-related affective disorders. 
Despite robust evidence linking chronic stress to the development of affective disorders, and 
research linking depression to specific DPs, there is no evidence to suggest that the consumption of 
specific nutrients, in any form, can prevent the development of these disorders among chronically 
stressed women.46-55, 277, 480 Whilst previous research has causatively linked nutrition and depression, 
these results cannot be generalised to stressed women, regardless of the fact that many of the women 
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in these studies may have developed depression as a result of chronic stress.277 Furthermore, 
polymorphisms on the MTHFR gene have not been examined in relation to female stress. Although 
some research has suggested that specific nutrients may be effective at reducing some forms of stress 
in both genders, until now, no research has examined the relationship between specific nutrients, 
consumed in any form, and chronic stress among women. 
Being the first study to examine this relationship, the knowledge gained speaks to a number of 
health professionals in relation to improving clinical practice. For example, until evidence is available, 
PCPs, psychiatrists and psychologists who treat chronically stressed female patients (with or without 
ELS) using DSs to manage stress, possibly under their, or the guidance of other clinicians, may propose 
other evidence-based stress-management strategies. 
There are three areas where future research is warranted, the results of which may inform 
clinical practice. Firstly, as depression is now the leading cause of disability worldwide and the role of 
chronic stress in this disorder is widely recognised, preventative strategies are sorely needed. Research 
examining nutrient interventions prospectively via RCTs in the presence of chronic stress is therefore 
warranted. In addition, such studies are able to control for cyclical reproductive hormones unlike cross 
sectional studies. Secondly, although the role that genetic polymorphisms play in the experience of 
mental health is acknowledged, a similar role in relation to stress vulnerability remains unexamined, and 
such research is therefore warranted. Thirdly, it is well established that mental wellbeing in later life is 
largely determined by the first few years of life, and nutrition plays a critical role in brain development, 
research examining ELS interventions that target nutrition in parenting is warranted. Although animal 
research has suggested that micronutrient supplementation may be useful to offset the neurobiological 
effects of ELS during early brain development, similar research is lacking among human subjects.484 
Due to the potential for long-reaching effects, research examining preventative strategies in all these 
areas is warranted. Well-designed prospective cohort studies and RCTs can provide evidence regarding 
the interaction of variables identified in the projects undertaken in this thesis and in affiliated research. 
Turning to preventative strategies, Australian clinical guidelines for the treatment of affective 
disorders recommend changes in behaviour related to diet, exercise, smoking and sleep before other 
forms of treatment are considered.486 Although chronic stress is acknowledged as a predisposing factor 
for the development of such disorders, and nutrition likely plays a role, there is as yet no evidence to 
support the development of similar guidelines. The results of future research examining the relationship 
between stress and nutrient intake should be included in such guidelines. 
In the general population, due to a lack of guidelines, pregnant women and mothers may 
benefit from knowledge about the relationship between ELS and later mental wellbeing being translated 
and implemented via PCP’s, schools or the Internet, considering its prolific use by women. In light of its 
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potential to advise women about health generally, evidence about nutrition and chronic stress should 
also be made available online to counter the lack of evidence-based information available, hence 
preventing the pursuance of ineffective stress-management strategies. Considering the prolific global 
use of stress-targeted DSs this behaviour may be challenging to address, therefore more effective 
evidence translation and implementation strategies via this medium are required. 
5.9 Conclusion 
Although the use of specific nutrients in DSs have been examined in relation to stress or anxiety during 
specific reproductive life stages and some studies have addressed the use of a combination of nutrients 
in relation to stress among women regardless of life stage, no studies to date have examined the 
relationship between specific nutrients consumed in the diet and/or via DSs and chronic stress generally 
among women. This study investigated the relationship between chronic stress and the use of diet 
and/or DSs among a group of women with the aim of generating evidence about this relationship. 
Although the two primary research projects were exploratory in nature and the results of the survey 
were based on a small sample, initial observations suggest that there may be a relationship between 
specific nutrients and stress levels and that personal relationships, thinking patterns and confusion and 
scepticism about using DSs may contribute to the lived experience of stress. 
The relationship between the consumption of specific nutrients among women and stress 
levels, and the lived experience of stress, including how other factors are related to this experience, are 
thoroughly under-examined. The combined results of these projects provide the most up to date, 
quantitative and qualitative evidence about a previously unexamined facet of the lived experience of 
stress and stress management among women. 
Applying this knowledge and other accumulating evidence linking neurobiological functioning 
and nutrition in well-designed studies will further elucidate the relationship between nutrition and chronic 
stress among women. Considering the high levels of stress reported by women globally, the growing 
use of stress-targeted DSs, the recognized neurobiological role that chronic stress plays in the 
development of affective disorders, the costs associated with such disorders and the long-reaching 
implications for individuals, families and society, this research topic has been neglected for too long. 
The growing body of research regarding how nutrition impacts brain function, which is informing the field 






Appendix A: Search strategy 
PubMed (pubmed.gov) 
Search on 15 October 2015 
Search Query 
#1 Female[tw] OR Female[mh] OR Female*[tiab] OR Women[tw] OR Women[mh] OR Woman[tw] OR 
Woman[mh] 
#2 Anxiety/psychology[mh] OR Anxiety[tw] OR anxiet*[tiab] OR Anxiety/etiology[mh] OR Anxiety 
disorders/etiology[mh] OR Anxiety/prevention and control[mh] OR Burnout, professional[mh] OR Burnout[tw] 
OR Mental Fatigue/psychology[mh] OR mental fatigue[tiab] OR mood disorders[tw] OR mood[tiab] OR 
Stress*[tw] OR Stress, psychological[mh] OR Stress, physiological/drug effects[mh] 
#3 Flax[mh] OR flax seed*[tiab] OR linseed[tw] OR linseed*[tiab] OR Omega-3 Fatty Acids[mh] OR Omega-3 
Fatty acids[tw] OR n-3 PUFA[tw] OR n-3 Fatty Acid*[tw] OR n-3 Polyunsaturated Fatty Acid*[tw] OR essential 
fatty acid[mh] OR essential fatty acid[tw] essential fatty acid*[tiab] OR Unsaturated fatty acids[mh] OR 
Unsaturated fatty acids[tw] OR Unsaturated fatty acid*[tiab] OR alpha linolenic acid[tiab] OR alpha linoleic 
acid[tiab] OR Eicosapentaenoic Acid[tw] OR Docosahexaenoic Acid[tw] OR fish oil[mh] OR fish oil[tw] OR fish 
oil*[tiab] OR Omega-6 Fatty acids[tw] OR n-6 PUFA[tw] OR n-6 Fatty Acid*[tw] OR n-6 Polyunsaturated Fatty 
Acid*[tw] OR Micronutrient[tw] OR Micronutrients[mh] OR micronutrient*[tiab] OR Dietary supplements[mh] OR 
dietary supplements[tw] OR dietary supplement*[tiab] OR Food supplement*[tw] OR Vitamins[mh] OR 
vitamins[tw] OR vitamin*[tiab] OR multivitamin*[tw] OR Thiamine[mh] OR Thiamine[tw] OR Vitamin B1[tw] OR 
Vitamin B 1[tw] OR Riboflavin[mh] OR  Riboflavin[tw] OR vitamin b2[tw] OR vitamin b 2[tw] OR niacin[tw] OR 
nicotinic acid[tw] OR Niacinamide[tw] OR Nicotinamide[tw] OR vitamin b3[tw] OR vitamin b 3[tw] OR 
Pantothenic Acid[mh] OR Pantothenic Acid[tw] OR vitamin b5[tw] OR vitamin b 5[tw] OR Pyridoxine[mh] OR 
Pyridoxine[tw] OR vitamin b6[tw] OR vitamin b 6[tw] OR Folic acid[mh] OR folic acid[tw] OR Folate[tw] OR 
Folacin[tw] OR vitamin B9[tw] OR vitamin B 9[tw] OR vitamin b12[mh] OR Cyanocobalamin[tw] OR vitamin b 
12[tw] OR Ascorbic Acid[mh] OR ascorbic acid[tw] OR L-ascorbic acid[tw] OR vitamin C[tw] OR 
magnesium[mh] OR Magnesium[tw] OR Zinc[tw] 
#4 #1 AND #2 AND #3 
Limit to English 
 
Embase (embase.com) 
Search on 28 October 2015 
Search Query 
#1 Female*/syn OR female*:ab,ti OR women:ab,ti OR woman:ab,ti 
#2 anxiety/de OR anxiety:ab,ti OR 'anxiety disorders'/de OR 'anxiety disorders':ab,ti OR burnout/de OR 
burnout:ab,ti OR Stress/de OR stress:ab,ti OR ‘emotional stress’/de OR ‘emotional stress’:ab,ti OR ‘mental 
fatigue’:ab,ti OR ‘mood change’/de OR ‘mood change’:ab,ti OR mood/de OR ‘mood’:ab,ti 
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Search Query 
#3 'flax'/de OR flax:ab,ti OR 'flax seed':ab,ti OR 'flax seeds':ab,ti OR 'linseed oil'/de OR 'linseed oil':ab,ti OR 
'omega 3 fatty acid'/de OR 'omega 3 fatty acid':ab,ti OR 'omega 3 fatty acids':ab,ti OR 'linolenic acid'/de OR 
'linolenic acid':ab,ti OR 'omega 6 fatty acid'/de OR 'omega 6 fatty acid':ab,ti OR 'omega 6 fatty acids':ab,ti OR 
'linoleic acid'/de OR 'linoleic acid':ab,ti OR 'fatty acids':ab,ti OR 'essential fatty acid'/syn OR 'essential fatty 
acids':ab,ti OR 'polyunsaturated fatty acid'/syn OR 'polyunsaturated fatty acids':ab,ti OR 'docosahexaenoic 
acid'/syn OR dha:ab,ti OR 'icosapentaenoic acid'/syn OR 'eicosapentaenoic acid':ab,ti OR epa:ab,ti OR 'fish 
oil'/de OR 'fish oil':ab,ti OR 'fish oils':ab,ti OR 'micronutrient'/de OR micronutrient:ab,ti OR micronutrient*:ab,ti 
OR 'diet supplementation'/syn OR 'vitamin'/de OR vitamin:ab,ti OR vitamins:ab,ti OR 'vitamin b complex'/de 
OR 'vitamin b complex':ab,ti OR 'multivitamin'/de OR multivitamin*:ab,ti OR 'thiamine'/de OR thiamine:ab,ti OR 
'riboflavin'/de OR riboflavin:ab,ti OR 'nicotinic acid'/de OR 'nicotinic acid':ab,ti OR nicotinamide:ab,ti OR 
'pantothenic acid'/de OR 'pantothenic acid':ab,ti OR 'cyanocobalamin'/de OR cyanocobalamin:ab,ti OR 'l 
ascorbic acid'/de OR 'l-ascorbic acid':ab,ti OR 'l ascorbic acid':ab,ti OR 'magnesium'/de OR magnesium:ab,ti 
OR 'zinc'/de OR zinc:ab,ti 
#4 #1 AND #2 AND #3 
Limit to English AND Embase 
 
SCOPUS (scopus.com) 
Search on 31 October 2015 
Search Query 
#1 female OR women OR woman 
#2 anxiety OR “anxiety disorder*” OR "mental fatigue" OR mood OR ‘psychological stress’ OR stress OR burnout  
#3 “Flax seed*” OR linseed* OR “omega-3 fatty acid*” OR “n-3 PUFA” OR “n-3 Fatty Acid*” OR “n-3 
polyunsaturated fatty acid*” OR “essential fatty acid*” OR “polyunsaturated fatty acid*” OR “unsaturated fatty 
acid*” OR “omega 6 fatty acid*” OR “omega-6 fatty acid*” OR “n-6 PUFA” OR “n-6 Fatty Acid*” OR “n-6 
polyunsaturated fatty acid*” OR "alpha linolenic acid" OR  "alpha linoleic acid" OR DHA OR EPA OR 
“docosahexaenoic acid*” OR “eicosapentaenoic acid*” OR “fish oil*” OR micronutrient* OR “dietary 
supplement*” OR “food supplement*” OR vitamin* OR multivitamin* OR “vitamin B complex” OR “vitamin B 
group” OR Thiamine OR “vitamin b1” OR Riboflavin OR “vitamin b2” OR Niacin OR Niacinamide OR “vitamin 
B3” OR “Pantothenic acid” OR “vitamin B5” OR Pyridoxine OR “vitamin B6” OR “Folic acid” OR folate OR 
“vitamin B9” OR “vitamin B 12” OR “vitamin B12” OR Cyanocobalamin OR “ascorbic acid” OR “L-Ascorbic 
acid” OR “Vitamin C” OR magnesium OR Zinc 
#4 rat OR  rats OR poultry OR cattle OR hen* OR mice 
#5 #1 AND #2 AND #3 NOT #4 
Limit to English AND article 
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CINAHL (health.ebsco.com/products/cinahl-with-full-text) 
Search on 30 October 2015 
Search Query 
#1 MH female OR MH women OR MH woman OR AB female* or TI female* OR AB wom?n OR TI wom?n 
#2 MH stress OR MH stress, psychological OR AB “psychological stress” OR TI “psychological stress” OR MH 
stress, occupational OR AB “occupational stress” OR TI “occupational stress” OR MH burnout, professional 
OR AB Burnout OR TI Burnout OR MH Anxiety OR AB Anxiety OR TI Anxiety OR AB “anxiety disorder*” OR 
TI “anxiety disorder*” OR AB “life stress*” OR TI “life stress*” OR AB “chronic stress” OR TI “chronic stress” 
OR AB “emotional stress” OR TI “emotional stress” OR AB “mental fatigue” OR TI “mental fatigue” OR AB 
mood OR TI mood 
#3 MH flaxseed OR AB flax OR TI Flax OR AB flaxseed* OR TI flaxseed* OR AB “flax seed*” OR TI “flax seed*” 
OR MH fatty acids, omega-3+ OR AB “omega-3 fatty acids” OR TI “omega-3 fatty acids” OR AB “omega 3 fatty 
acids” OR TI “omega 3 fatty acids” OR AB “n-3 PUFA” OR TI “n-3 PUFA” OR AB “n-3 Fatty Acid*” OR TI “n-3 
Fatty Acid*” OR AB “n-3 polyunsaturated fatty acid*” OR TI “n-3 polyunsaturated fatty acid*” OR MH fatty 
acids, essential+ OR AB “essential fatty acid*” OR TI “essential fatty acid*” OR AB “docosahexaenoic acid*” 
OR TI “docosahexaenoic acid*” OR AB “eicosapentaenoic acid*” OR TI “eicosapentaenoic acid*” OR AB 
“alpha linolenic acid” OR TI “alpha linolenic acid” OR MH fatty acids, omega-6+ OR AB “omega 6 fatty acid*” 
OR TI “omega 6 fatty acid*” OR AB “omega-6 fatty acids” OR TI “omega-6 fatty acids” OR AB “n-6 PUFA” OR 
TI “n-6 PUFA” OR AB “n-6 Fatty Acid*” OR TI “n-6 Fatty Acid*” OR AB “n-6 polyunsaturated fatty acid*” OR TI 
“n-6 polyunsaturated fatty acid*” OR AB “n-6 polyunsaturated fatty acid*” OR TI “n-6 polyunsaturated fatty 
acid*” OR MH fish oils OR AB “fish oil*” OR TI “fish oil*” OR MH dietary supplements OR AB “dietary 
supplement*” OR TI “dietary supplement*” OR AB “food supplement*”OR TI “food supplement*”OR AB “dietary 
supplementation” OR TI “dietary supplementation” OR AB micronutrient* OR TI micronutrient* OR MH 
vitamins OR AB vitamin* or TI vitamin* OR MH vitamin B complex OR AB “vitamin B complex” OR TI “vitamin 
B complex” OR MH thiamine OR AB thiamine OR TI thiamine OR MH riboflavin OR AB riboflavin OR TI 
riboflavin OR MH niacin OR AB niacin OR TI niacin OR AB Niacinamide OR TI Niacinamide  OR MH 
pantothenic acid OR AB “pantothenic acid” OR TI “pantothenic acid” OR MH folic acid OR AB “folic acid” OR 
TI “folic acid” OR AB “folate” OR TI folate OR MH vitamin B12 OR AB “vitamin B12” OR TI “vitamin B12 OR 
AB “vitamin b 12” OR TI “vitamin b 12” OR AB Cyanocobalamin OR TI Cyanocobalamin OR MH ascorbic acid 
OR AB “ascorbic acid” OR TI “ascorbic acid” OR AB “vitamin C” OR TI “vitamin C” OR AB “L-Ascorbic acid” 
OR TI “L-Ascorbic acid” OR MH magnesium OR AB magnesium OR TI magnesium OR MH zinc OR AB zinc 
OR TI zinc 
#4 #1 AND #2 AND #3 
Limit to English AND exclude MEDLINE 
 
  
  Appendix A: 
140 
PsycINFO and PsycARTICLES (apa.org/pubs/databases/psycinfo/) 
Search on 28 October 2015 
Search Query 
#1 Human females.sh OR women.tw OR woman.tw 
#2 anxiety.tw OR anxiety disorder*.tw OR life stress.tw OR emotional states.sh OR mood.tw OR chronic stress.tw 
OR occupational stress.tw OR psychological stress.tw 
#3 Fatty acids.sh OR Flax seed*.tw OR linseed*.tw OR omega 3 fatty acid*.tw OR n-3 PUFA.tw OR n-3 Fatty 
Acid*.tw OR n-3 polyunsaturated fatty acid*.tw OR omega 6 fatty acid*.tw OR n-6 Fatty acid*.tw OR n-6 
polyunsaturated fatty acids.tw OR essential fatty acid*.tw OR polyunsaturated fatty acid*.tw OR unsaturated 
fatty acid*.tw OR omega 6 fatty acid*.tw OR docosahexaenoic acid.tw OR DHA.tw OR eicosapentaenoic 
acid.tw OR EPA.tw OR micronutrient*.tw OR dietary supplement*.sh OR dietary supplement*.tw OR 
vitamin*.tw OR food supplement*.tw OR multivitamin*.tw OR vitamin B complex.tw OR vitamin B.tw OR 
Thiamine.tw OR Riboflavin.tw OR Niacin.sh OR Niacin.tw OR Niacinamide.tw OR nicotinamide.sh OR 
Pantothenic acid OR Pyridoxine.tw OR Folic acid.sh OR folic acid.tw OR folate.tw OR vitamin B 12 OR vitamin 
B12.tw OR Cyanocobalamin.tw OR ascorbic acid.sh or ascorbic acid.tw OR Vitamin* C.sh or vitamin C*.tw OR 
magnesium.sh OR magnesium.tw OR Zinc.sh or zinc.tw 
#4 #1 AND #2 AND #3 
Limit to English  
 
MedNar (mednar.com), National Institute of Mental Health 
(https://www.nimh.nih.gov) and International Association for Women’s Mental 
Health (www.iawmh.org) 
Search on 20 October 2015 
Search Query 
#1 women 
#2 psychological stress 
#3 Nutrient*  
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Appendix D: Excluded studies 
 
Callender K, McGregor M, Kirk P, Thomas CS. A double-blind trial of evening primrose oil in the 
premenstrual syndrome: Nervous symptom subgroup. Human Psychopharmacology: Clinical and 
Experimental. 1988 Mar;3(1):57-61. 
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Study Methods Participants Intervention A Intervention B Intervention C Intervention D 
Results and 
Notes 
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Study Methods Participants Intervention A Intervention B Intervention C Intervention D 
Results and 
Notes 
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Study Methods Participants Intervention A Intervention B Intervention C Intervention D 
Results and 
Notes 
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Study Methods Participants Intervention A Intervention B Intervention C Intervention D 
Results and 
Notes 
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Appendix F: Stress and anxiety outcome measures 




Used in paper: 
Keenan K et al.294  
Examines the severity of life stressors experienced 
by a primary caregiver either at work or at home in a 
set of 28 yes or no questions. 
Designed to be applicable to socio-
economically disadvantaged people, 
with a score of 6 or less being 





Used in paper: 
Keenan K et al.294  
Designed to measure the degree to which present 
life situations are appraised as being stressful during 
the past month; 14-point instrument scale (also 
available as a 10-point scale). 
Higher scores suggest greater levels of 
perceived stress; 
Range of 14pt scale: 0 – 56; 10pt 
scale: 0-40. 
Good14, 487  
Symptoms of Stress 
Inventory (SOS) 
Used in paper: 
Davis LS.289  
Measures behavioural, physical and psychological 
responses to stress; 118 items aim to measure the 
frequency of a variety of physical and emotional 
symptoms reported by individuals experiencing 
stress; rating occurs on a 5-point Likert scale, 
ranging from 0 (never) to 4 (very frequently) on a 5 
point scale (94 of these items were used in this 
study). 
Measures frequency with which 
respondents have experienced a 
specific symptom of stress over the 
past week; higher scores are indicative 




Depression Scale - 
Anxiety (HADS-A) 
Used in paper: van 
de Rest O et al.287  
Used to assess anxiety specifically, and consists of 7 
items; a 4 point Likert scale which ranges from 0 (not 
at all) to 3 (very often indeed) is used to assess 
anxiety levels. 
Responses based on symptom 
frequency over the last week; possible 
total scores range from 0 – 21, with 
increasing scores indicating increased 
levels of anxiety. 
Constructed nearly 3 decades ago it 
been criticised for a number of 
reasons, one of them which may be of 
relevance to this study, which was 
conducted in the Netherlands, and 
where the results of the translation 
from British colloquial expressions into 
a variety of translations may not have 
offered a reliable scale of assessment. 
Controversial
488-490  
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Outcome measure Dimensions, Items and comments Remarks Reliability 
Profile of mood 
states (POMS) 
Used in papers: 
Benton D et al.293  
The scale assesses 6 primary domains of mood: 
tension: anxiety, depression-dejection, anger-
hostility, vigour-activity, fatigue-inertia and confusion-
bewilderment; mood states are reflected in 65 
adjectives describing a variety of both positive and 
negative mood states, and are based on a 5-point 
scale, ranging from 1 (not at all) to 5 (extremely). 
Participants are requested to report on 
the frequency with which they 
experienced these 65 mood states 
over the last week; scores range from 
20 – 80, with higher scores related to 
greater frequency of depressed mood; 
This measurement instrument has 
been used extensively to assess 
transient and fluctuating affective mood 
states, with consistent reliability over a 
1- week period, although test-retest 
reliability decreased for the day-day 
interval in a test review. As the 
participants were assessed at trial 
initiation, and then 3 months later, this 







criteria for PMS 
Used in paper: 
Sohrabi N et al.297  
Affective symptoms based on the ACOG : 
depression, nervousness, jitteriness, anxiety, low 
concentration, loss of social activity, and 4 somatic 
symptoms; A VAS used to evaluate symptom 
severity. 
Patient reports at least one of the 
affective and somatic symptoms in 
three consecutive menstrual cycles to 






Used in paper: 
Cohen LS et al.295  
Used to assess 7 symptoms of anxiety; one of 4 
scales within each of the 7 items are selected, 
namely 0 (not at all), 1 (several days), 2 (more than 
half the days) or 3 (nearly every day). 
Assesses the severity of symptoms 
that a respondent has experienced 
over the last two weeks; scores of 5, 
10 and 15 taken as cut off points for 
mild, moderate or severe anxiety; 
Higher scores related to higher levels 
of anxiety. 
Good306, 492  
The psychological 
general well being 
index (PGWBI) 
Used in paper: 
Lucas M et al.296  
Used to measure individuals subjective well being 
and psychological distress (PD) symptoms, which 
consists of 22 items that are used as indicators of 6 
affective states; responses range from 5 (excellent) 
to 0 (poor), with total scores ranging from 0 (extreme 
distress) to 110 (optimal well-being). 
Total scores that fall between 0 and 60 
are representative of severe PD, 
between 61 and 72 represent 
moderate PD, while ≥73 represent 
positive well being. 
This measure is a dimensional 
measure of non-specific PD rather than 
a specific disorder diagnostic measure, 
which suited the non-specificity of 
possible menopausal symptoms; 
range: 0 – 110. 
Good307  
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Used in papers: 
Walker AF et al.292  
27 items used to establish menstrual health and Pre-
Menstrual (PMS) symptoms ranked according to 1 
(very mild, 2 (mild), 3 (moderate), 4 (severe) or 5 
(very severe). 





Used in paper: 
Walker AF et al.290  
Dimensions relate to both psychological and somatic 
symptoms, consisting of 47 items, each rated on a 
six point scale, with 1 (no experience of the 
symptom) to 6 (acute or partially disabling 
experience of the symptom); 
Menstrual Diary used a 22-item daily symptom 4-
point scale: 0, none; 1, mild-present but does not 
interfere with activities; 2, moderate-present and 
interferes with activities but not disabling; 3, severe-
disabling, unable to function. 
Items can be used as the basis for a 







Used in paper: 
Kashanian M et 
al.291  
11 items composed of both behavioural and somatic 
symptoms, including anxiety. 
Based on the Diagnostic Statistical 
Measure (DSM) criteria for Pre-
Menstrual (PM) dysphoric disorder. 
Unknown310  
Depression, anxiety 
and stress scales 
(DASS) 
Used in papers: 
Rogers PJ et al.286  
Depression, anxiety and stress; Each scale is 
composed of 14 primary symptoms or subscales; 
items are divided subscales of 2-5 items with similar 
content and responses from 0 – 4, with 0 = ‘did not 
apply to me at all,’ 1 = ‘applied to me to some 
degree,’ or ‘applied some of the time,’ 2 = ‘applied to 
me to a considerable degree,’ or ‘a good part of the 
time’ and 3 = ‘applied to me very much,’ or ‘most of 
the time.’ 
Items are rated on their severity during 
the past week; 
Low scores indicates normal – 
moderate levels of stress or anxiety 




Bond and Lader 
Visual Analogue 
Scale (VAS) 
Used in paper: 
Jackson PA et al.286  
Originally used to assess drug sedative effects: 
mental sedation or intellectual impairment, physical 
sedation or bodily impairment, tranquilization or 
calming effects and other types of feelings or 
attitudes.493  
Researcher combined these 
dimensions to form three mood factors: 






Used in paper: 
Brody S et al.184  
40 item measurement instrument wherein the first 20 
items measure state anxiety, which is a reflection of 
the way a respondent feels at present, while the 
second 20 items measure trait anxiety, which refers 
to the way the respondent feels generally; each of 
the 40 items has a range of four possible responses. 
It is a useful measure to distinguish 
anxiety from depression; Higher scores 
suggest higher levels of anxiety. 
Good312  
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Appendix G: Supplementary statistical data extracted for included 
studies 
Study Outcome measures (Mean±SD) Results 
Keenan K et 
al.294 
PSS Scores 
Baseline treatment (N=20) 27.77±2.2 versus 24 weeks treatment (N=35) 28.06±3.5 
Baseline treatment versus endpoint treatment (N=34) 27.47±3.4 
24 weeks treatment (N=35) 28.06±3.5 versus placebo (N=18) 27.72±2.0 
Endpoint treatment versus placebo (N=17) 29.29±3.1 
DLCS Scores 
Baseline treatment (N=20) 5.16±3.4 versus 24 weeks treatment (N=43) 4.57±3.9 
24 weeks treatment versus placebo (N=18) 3.11±2.4 










Davis LS 289  SOS Scores 
Endpoint (Mg + vitamin B6) treatment (N=11) 66.8±29.7 versus placebo (N=12) 
73.6±39.5 





van de Rest O et 
al.287  
HADS-A Scores 
Baseline 400 mg (N=45) 2.67±2.27 versus 3 months (N=45) 3.22±2.60 
Baseline 400mg versus endpoint (N=45) 3.49±3.5 
3 months 400mg versus endpoint 
Baseline 1800 mg (N=42) 2.67±2.74 versus 3 months (N=42) 2.43±2.09 
Baseline 1800 mg versus endpoint (N=43) 2.67±3.19 
3 months 1800 mg versus endpoint 
Endpoint 400mg versus 1800 mg endpoint 
Endpoint 400 mg versus placebo endpoint (N=46) 2.35±2.10 












Benton D et al.293  In narrative  
Sohrabi N et 
al.297  
In narrative  
Cohen LS et 
al.295  
In narrative  
Lucas M et al.296  Endpoint treatment (MDE) (N=12) 52.3±10.4 versus placebo (N=14) 65.2±20.7 
 
t(24)=1.95;p=0.062* 
Walker AF et 
al.290  
Anxiety Scores 
Baseline treatment (N=35) 10.74±7.81 versus endpoint (N=30) 8.30±8.11 




De Souza MC et 
al.292  
In narrative  
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Study Outcome measures (Mean±SD) Results 
Kashanian M et 
al.291  
In narrative  
Bryan J et al.293  POMS (Tension/Anxiety subscale) 
Young age group 
Endpoint treatment (Folate) (N=14) 17.54±3.67 versus placebo (N=14) 16.71±6.24 
Endpoint treatment (Vitamin B12) 17.22±3.99 versus placebo 
Endpoint treatment (Vitamin B6) 16.90±2.69 versus placebo 
Middle aged group 
Endpoint treatment (Folate) (N=20) 17.17±5.49 versus placebo (N=20) 16.61±7.49 
Endpoint treatment (Vitamin B12) 17.55±6.84 versus placebo 
Endpoint treatment (Vitamin B6) 16.48±6.56 versus placebo 
Older aged group 
Endpoint treatment (Folate) (N=19) 14.76±4.96 versus placebo (N=19) 14.70±3.42 












t(36) = 0.61;p=0.542* 
Rogers PJ, et 
al.286  
DASS stress scores 
Treatment endpoint (N=85) 12.3±7.8 versus placebo endpoint (N=83)12.6±7.4 
DASS anxiety scores 





Jackson PA et 
al.286  
Treatment DHA 
DASS stress scores 
Baseline treatment (N=29) 8.79±5.63 versus endpoint treatment 8.93±6.6 
Endpoint treatment versus endpoint placebo (N=37) 7.51±6.73 
DASS anxiety scores 
Baseline treatment (N=29) 3.55±3.99 versus endpoint treatment 3.10±3.26 
Endpoint treatment versus endpoint placebo (N=37) 3.32±4.39 
Treatment EPA 
DASS stress scores 
Baseline treatment (N=28) 8.68±7.44 versus endpoint treatment 8.5±7.08 
Endpoint treatment versus endpoint placebo (N=37) 7.51±6.73 
DASS anxiety scores 
Baseline treatment (N=28) 3.11±4.36 versus endpoint treatment 3.93±4.83 
Endpoint treatment versus endpoint placebo (N=37) 3.32±4.39 
1 way ANOVA DASS stress (DHA, EPA and Placebo) 

















Brody S et al.184  Subjective stress scores 
Endpoint treatment (N=38) 2.25±1.35 versus placebo (N=33) 2.54±1.71 
Blood Pressure Measurements 
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Appendix M: Example of email sent to all cross-sectional survey 











Thank you for your time. 
The aim of this research is to understand how women report experiencing stress and their 
dietary and supplementary intake of essential fatty acids (EFAs,) B vitamins, vitamin C, 
magnesium and zinc to manage stress. 
This research project is about women and specific nutrients they may or not be eating. It’s also about 
whether there is an association between stress and nutrient supplements. There is very little research 
that has looked at this issue. 
Please remember that your own, personal responses are what I am looking for, not what someone 
else thinks you may or should be feeling. For example, when you are filling in the questionnaire about 
your stress level, do not ask for anyone else’s ideas or opinions. I want and need YOUR replies only. 
It will take you between 30 and 40 minutes to fill all the questionnaires in. 
As we have discussed, your participation in this survey is voluntary, your identity is not linked to your 
answers, and your answers will become anonymous when you submit them. If you have any 
questions while filling in the questionnaires, please call me on:                     
Your time is very precious and I thank you in advance for completing these questionnaires and 
sending them back to me. It will be very helpful to have your completed questionnaires returned to me 





























































































































Appendix P: The PSS-10 
 
1. In the last month, how often have you been upset because of something that happened 
unexpectedly? 
2. In the last month, how often have you felt that you were unable to control the important things in 
your life? 
3. In the last month, how often have you felt nervous and “stressed”? 
4. In the last month, how often have you felt confident about your ability to handle your personal 
problems?* 
5. In the last month, how often have you felt that things were going your way?* 
6. In the last month, how often have you found that you could not cope with all the things that you had 
to do? 
7. In the last month, how often have you been able to control irritations in your life?* 
8. In the last month, how often have you felt that you were on top of things?* 
9. In the last month, how often have you been angered because of things that were outside your 
control? 












Appendix R: Questionnaire design characteristics 
 
Criteria Rationale  
Length Use short questionnaires to sustain engagement and support completion.495, 496  
Aesthetic 





Avoid complexity and confusion so as to foster understanding and accurate completion.495, 496 
Questions need to be understood in the same way by people who may differ in many ways, as the 
researcher is unavailable to paraphrase or explain the intention behind questions.363 Avoid confusing 
phrasing, double negatives and double-barrelled questions, which ask two questions in the same 
sentence.363  
Questioning 
style Use direct questions to avoid confusion and only ask one question at a time.
495, 496  
Word choice 
Use broadly understood, unambiguous, familiar words and avoid technical terms to foster 
understanding and completion.495 Avoid vague qualifiers, such as ‘Often, sometimes, rarely or never’ 
as individual interpretation can vary significantly.495  
Relevance of 
questions 
Select good and relevant questions that flow from research question/s and do not include any 
irrelevant questions or comments.363 A combination of factual and value questions can be used which 
can be relevant to either closed- or open-response options.495  
Sequence of 
questions 
Place broad questions first, which serve as ‘filter or screening’ questions which clarify respondent 
eligibility; direct respondents to whom the research is not directed to a different section of the 
questionnaire to prevent input and possible misinterpretation.363, 495  
Bias 
Avoid words or sentences that are loaded, or biased, such as words or sentences that suggest some 
answers are better or worse than others, which produce misleading answers. For example, in relation 
to personal questions about health behaviours, respondents may feel that some answers are more 
desirable than others.363 Avoid asking questions related to emotions of feelings unless the research 
aims to investigate such as some people prefer to 'agree' with a statement, so as to avoid being seen 
as disagreeable, introducing 'agreement bias.'363  
Context effects Avoid unintentional influences or context effects on responses by presenting alternative answers with 




Collect quantitative data via close-ended response options which can be coded and analysed, but 
response options should include every possible response, including one for those respondents who 




Add open-ended response options when it is not possible to provide for every alternative, or when 
qualitative data is required.363, 495  
Coherence and 
flow 
Ensure the questions are sorted into broad thematic categories to maximise overall questionnaire 
coherence and flow, which maximises engagement and supports completion.363  
Managing recall 
challenges 
Use relatively short reference points for regular events, whereas longer reference periods may be 































Skin Y Span 
























Poliquin zinc Zinc 30mg 1 capsule 
Amcal Lysine Vitamin C 
500mg; Zinc 
5mg 
1 tablet Blackmores 
Multi 
Sustained: 







Vit C 150mg 





















ALA and LA: 
4: 1 in favor 
of omega 3 
1 tsp1 Blackmores 
Women’s 
Multi 
B1 25mg; B2 
12mg; 
Nicotinamide 
50mg; Vit b5 
30mg; B6 
25mg; B12 

















Poliquin Multi Vitamin C 












30 mg (5 
/tab); Folate 























Zinc (as zinc 
glycinate) 


















































Herbs of gold 






















1 Calculation: Flaxseed oil @ 1 tsp = 4.5gms; EFA composition ALA:LA in ratio of 1:4; 4.5/5 = 0.9g of ALA and 3.6g of LA 





































Omega 3 TG 
150mg; B3 

























1 tablet Blackmores 
Vit B (exec 
stress) 


























2 softgels Poliquin 
magnesium 
Mg 240mg 2 
capsules 
Biospark Vit C 
(NTS health) 
Vit C 800mg ½ teas Blackmores 
Mega B 
complex 









Biotin (Vit H) 









TG as: EPA 
270mg; 
DHA 180mg 
1 cap Blackmore 
EPO 
























TG as: EPA 
180mg; 
DHA 120mg 




























TG as: EPA 
180mg; 
DHA 120mg 


















































2 Calculation: 220mg X 8% (GLA) = 17.6 mg GLA 





























































TG as: EPA 
360mg; 
DHA 240mg 
1 cap Cenovis 
Magnesium 
Mg 325mg; 















































































1 tablet Swisse Multi 
(women’s ) 


























































3 Calculation: Magnesium aspartate is 288 molecular mass and magnesium is 24; 24/288=8%;250 mag-aspartate X 8% = 20mg magnesium 






































Vit C - 
250mg ; 
Zinc – 5mg 






1 – 3 
tablets 
per day 






skin nails – 
liquid 



































































skin nails – 
tablets 
Zinc 30mg; 














Complete A – 
Zinc 




























































































































1 tablet Centrum Multi 
Gummies 
1 gummy: 





zinc; Vit D; E 
2 gummies: 
Vit C 18mg; 









Ester C+ Bio 
Vitamin C 
1000mg 
1 tablet Ultiboost 
odourless 
high strength 






























































1 spray Swisse 
Immune 
Zinc 25mg; 









C 50mg; Vit 
B6 50mg 














Nutriway Multi Thiamin 
Nitrate 
(Vitamin 


































































 Udo’s Oil ALA 6.5g; 
LA 2.95 












































(B6) 50 mg; 
Thiamine 
hydrochloride 
(B1) 50 mg; 
Riboflavin 





















































































1 spray:  
magnesium 
57.14mg 














1 tablet Vitamore 
Magnesium 
600mg 




































4 Calculation: Combining Nicotinamide 220 mg and Nicotinic acid 5 mg totals 225mg B3 
5 Calculation: Hemp seeds @ 3 Tablespoons = 25g (3 tablespoons) with 7.5g = LA and 3g = ALA and 0.6g GLA; 1 tablespoon = 2.5g LA and 1g 
ALA and 0.2 g GLA; to get 1 teaspoon divide 1/3 = 0.3g ALA and 0.83g LA and 0.06g GLA 
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Appendix T: Summary of the distribution of DS combinations 
cited by participants who reported using between 1 
and 5 DSs 
 
One DS (n=22) 
DS Type Frequency Percentage 
B12 3 (13.6) 
B6+Magnesium+ Zinc 1 (4.5) 
B vitamins 2 (9.1) 
B vitamins+Magnesium 1 (4.5) 
EFAs 6 (27.3) 
Magnesium 1 (4.5) 
Multi-vitamin 4 (18.2) 
Vitamin C 4 (18.2) 
 
Two DSs (n=16) 
DS Type 1 DS Type 2 Frequency Percentage 
Multi-vitamin Vitamin C 2 (12.5) 
EFAs Vitamin C 2 (12.5) 
EFAs B vitamins 1 (6.3) 
EFAs Vitamin B1 1 (6.3) 
EFAs Vitamin B12 1 (6.3) 
EFAs B vitamins+Magnesium 1 (6.3) 
EFAs Magnesium 1 (6.3) 
EFAs Vitamin B12 1 (6.3) 
Multi-vitamin Magnesium 1 (6.3) 
Multi-vitamin B vitamins+Magnesium 1 (6.3) 
Vitamin C B12 1 (6.3) 
Vitamin C B6+Magnesium 1 (6.3) 
EFAs Multivitamin 1 (6.3) 
Vitamin B+Magnesium Vitamin B+Magnesium 1 (6.3) 
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Three DSs (n=10) 
DS Type 1 DS Type 2 DS Type 3 Frequency Percentage 
EFAs Magnesium Magnesium 1 (10.0) 
EFAs Magnesium+Zinc Vitamin C+Zinc 1 (10.0) 
EFAS Multi-vitamin Vitamin C+Zinc 1 (10.0) 
EFAs EFAs Vitamin B6+Magnesium 1 (10.0) 
Vitamin C B-vitamins+Vitamin C Magnesium+Vitamin C 1 (10.0) 
Vitamin C Multi-vitamin Vitamin B6+Magnesium 1 (10.0) 
Multi-vitamin EFAs Vitamin C 1 (10.0) 
Multi-vitamin Vitamin B12 Magnesium 1 (10.0) 
B vitamins Magnesium Magnesium 1 (10.0) 
B vitamins Magnesium B vitamins+Magnesium 1 (10.0) 
 
Four DSs (n=2) 
DS Type 1 DS Type 2 DS Type 3 DS Type 4 Frequency Percentage 
B6+Mag+VitC EPO VitC+Zinc VitC+Zinc 1 (50.0) 
Vit B1 Multi Vit B12 EPO 1 (50.0) 
 
Five DSs (n=3) 
DS Type 1 DS Type 2 DS Type 3 DS Type 4 DS Type 5 Frequency Percentage 
EFAs Multi VitC Vit B6+Mag EPO 1 (33.3) 
EFAs Multi Mag Zinc Folate 1 (33.3) 





Appendix U: Distribution of DS types for N = 107 cited DSs 
 
Supplement Type Frequency Percentage (as a percentage of all supplements cited) 
EFAs 25 (23.4) 
Multi-vitamin 17 (15.9) 
Vitamin C 14 (13.1) 
Magnesium 10 (9.4) 
Vitamin B12 7 (6.5) 
B Vitamins 6 (5.6) 
B Vitamins+Magnesium 6 (5.6) 
Vitamin B6+Magnesium 5 (4.7) 
Vitamin C+Zinc 5 (4.7) 
EPO 3 (2.8) 
Vitamin B1 2 (1.9) 
Vitamin B6+Magnesium+Vitamin C 1 (0.9) 
Vitamin B6+Magnesium+Zinc 1 (0.9) 
B Vitamins+Vitamin C 1 (0.9) 
Folate 1 (0.9) 
Magnesium+Vitamin C 1 (0.9) 
Magnesium+Zinc 1 (0.9) 
Zinc  1 (0.9) 





Appendix V: General DS usage patterns (all reported DS, N = 107) 
 
Characteristic Frequency Percentage 
Frequency of Use (n, %)   
Daily 65 (60.8) 
4-5 times per week 11 (10.3) 
2-3 times per week 8 (7.5) 
Once per week 8 (7.5) 
Once per month 7 (6.5) 
Other 8 (7.5) 
 
Daily Dosage (n, %) 
 
 
1 time daily 70 (65.4) 
2 times daily 11 (10.3) 
3 times daily 4 (3.7) 
Other 22 (20.6) 
 
Duration of Use (n, %) 
 
 
Less than 1 month 3 (2.8) 
1-3 months 14 (13.2) 
3-6 months 18 (17.0) 
6-12 months 27 (25.5) 
More than 1 year 41 (38.7) 





Appendix W: Summary of associated DS use variables 
 
Characteristic Frequency Percentage 
Is the supplement helping achieve goals? (n, %)   
Yes 59 (55.1) 
No 6 (5.6) 
Unsure 42 (39.3) 
 
Reason for taking supplement 
  
Increase energy (n, %) 37 (34.6) 
Lose weight (n, %) 9 (8.4) 
Prevent disease (n, %) 31 (29.0) 
Reduce stress (n, %) 29 (27.1) 
Improve memory/concentration (n, %) 20 (18.7) 
Other (n, %) 61 (57.0) 
 
What prompted use of the supplement? 
  
Doctor (n, %) 31 (29.0) 
Naturopath (n, %) 15 (14.0) 
Magazine (n, %) 13 (12.2) 
Newspaper (n, %) 1 (0.9) 
Ad (n, %) 0 (0.0) 
Other (n, %) 59 (55.1) 
 
Where is the supplement purchased? 
  
Health store (n, %) 38 (35.5) 
Supermarket (n, %) 25 (23.4) 
Naturopath (n, %) 5 (4.7) 
Online (n, %) 8 (7.5) 
Doctor (n, %) 5 (4.7) 





Appendix X: Nutrients of interest obtained through DS 
 
Nutrient Frequency % of total number of supplement-takers (n=53) 
Vitamin C 34 64.2 
Magnesium 31 58.5 
Vitamin B6 31 58.5 
Vitamin B12 31 58.5 
Vitamin B1 27 50.9 
Vitamin B2 26 49.1 
Vitamin B3 26 49.1 
Zinc 24 45.3 
Folic Acid 24 45.3 
Vitamin B5 21 39.6 
EPA 10 18.9 
DHA 10 18.9 
Omega-3 undefined 8 15.1 
ALA 7 13.2 
LA 6 11.3 
EPO 6 11.3 





Appendix Y: Summary statistics for daily nutrient intake from 
supplementation for selected nutrients 
 
Nutrient No. of consumers 
Amount consumed per day 
Mean (SD) Median Min Max 
ALA (grams) 7 4.83 (5.74) 2.2 0.25 13 
LA (grams) 6 3.18 (2.32) 2.75 0.83 5.90 
EPO (milligrams) 6 65.91 (76.00) 46.43 0.06 200 
EPA (milligrams) 10 635.57 (583.92) 420 71.43 1740 
DHA (milligrams) 10 447.29 (445.15) 260 68.57 1410 
Omega-3 undefined (milligrams) 8 428.57 (345.55) 300 107.14 1000 
Omega-3 (milligrams) 23 2090.68 (3649.07) 760 107.14 13300 
Omega-6 (milligrams) 11 1778.35 (2306.43) 890 2.57 5900 
Vitamin C (milligrams) 33 395.77 (506.76) 250 5.45 2500 
Magnesium (milligrams) 29 187.28 (192.65) 114.3 1.56 845 
Zinc (milligrams) 22 20.26 (35.61) 5 0.17 140 
Vitamin B1 (milligrams) 25 54.56 (89.66) 25 0.90 350 
Vitamin B2 (milligrams) 23 28.67 (41.17) 12 1.16 150 
Vitamin B3 (milligrams) 24 45.06 (50.20) 35.86 1.29 210 
Vitamin B5 (milligrams) 20 36.10 (35.43) 25.50 2.27 150 
Vitamin B6 (milligrams) 29 49.05 (75.36) 25 1.00 382.2 
Vitamin B12 (micrograms) 27 82.08 (152.91) 17.86 1.61 640 
Folic Acid (micrograms) 23 260.21 (257.68) 200 16.50 1200 





Appendix Z: Descriptive statistics for daily nutrient intake for 
selected nutrients derived from the FFQ (N=74) 
 
Nutrient Mean (SD) Median Min Max 
Total omega-6, mg/day 13250.27 (5176.38) 11975.88 4035.27 28768.18 
Total omega-3, mg/day 1542.99 (719.63) 1370.42 505.45 4185.67 
Magnesium, mg/day 492.15 (180.60) 496.61 179.67 944.79 
Vitamin C, mg/day 128.26 (75.13) 111.23 30.47 365.47 
Folic acid, mg/day 103.96 (104.50) 70.16 0 472.18 
Niacin (Vitamin B3+tryptophan-derived), mg/day 40.71 (13.22) 38.89 16.16 75.61 
Biotin (B7), mg/day 36.75 (17.28) 33.13 10.96 102.09 
Niacin (B3) pre-formed, mg/day 23.3 (8.25) 22.66 8.11 48.05 
Zinc, mg/day 9.54 (3.21) 9.72 3.97 20.49 
Pantothenic acid (B5), mg/day 3.35 (1.27) 3.09 1.16 7.93 
Cobalamin (B12), mg/day 2.97 (1.78) 2.76 0.02 9.01 
Riboflavin (B2) mg/day 2.13 (0.93) 2.02 0.64 5.30 
Thiamin (B1) mg/day 1.50 (0.83) 1.27 0.39 4.46 
Pyridoxine (B6), mg/day 1.14 (0.55) 0.99 0.43 3.95 
Folate, microgram/day 319.37 (141.16) 282.13 94.49 660.32 
Total folates, microgram/day 423.43 (200.24) 415.46 112.86 1007.0 
Dietary folate (combined with estimate of higher 
bioavailability of folic acid), microgram/day 





Appendix AA: Correlation between daily nutrient intake from food 
and PSS scores (Spearman’s Rank Correlations 
(N=74)) 
 




Magnesium, mg/day -0.0749 1.000 
Zinc, mg/day 0.1390 0.997 
Vitamin C, mg/day -0.1891 0.925 
Thiamin (B1) mg/day -0.0206 1.000 
Riboflavin (B2) mg/day -0.0542 1.000 
Niacin (B3) pre-formed, mg/day 0.0222 1.000 
Niacin (Vitamin B3+tryptophan-derived), mg/day 0.0508 1.000 
Pantothenic acid (B5), mg/day -0.0889 1.000 
Pyridoxine (B6), mg/day -0.1335 0.998 
Biotin (B7), mg/day -0.2020 0.889 
Cobalamin (B12), mg/day 0.1989 0.894 
Folic acid, mg/day 0.0519 1.000 
Folate, microgram/day -0.0234 1.000 
Total folates, microgram/day 0.0126 1.000 
Dietary folate (combined with estimate of higher bioavailability of folic acid), microgram/day 0.0085 1.000 
LC w3 PUFA 0.0765 1.000 
Total omega-3, mg/day 0.0291 1.000 





Appendix BB: Factors related to DS use 
 
Factor Related to Use Results 
Types of DS used  
Supplements labelled as EFAs and MVMs were the two most commonly-cited DSs. 
However, when considering individual nutrients, vitamin C was the most frequently 
consumed nutrient, with 64% of supplementers consuming this nutrient. Inspection of 
the products cited among the sample revealed that most DSs contained multiple 
micronutrients which suggests that some supplementers may not always be aware of 
the range of micronutrients present in their DSs and highlights the importance of 
inspecting the ingredients list to determine the appropriateness of a DS rather than 
using the product name alone to guide use. 
DS use and age 
Age may be associated with DS use, as increasing age may be associated with 
increased health literacy, increased stress and increased health challenges, among 
other factors.  Among the sample, the odds of being a DS user were estimated to 
increase by 32% for every 5 year increase in age from the mean age of the sample and 
the rate of DS use was estimated to increase by 2% for every 5 year increase in age 
from the same. These results suggest that age may be related to DS use among 
women in as yet unexamined ways. 
Duration of DS use 
The majority of DSs were reported to be consumed once daily (61%) and more than 
60% of the reported DSs had been consumed for a duration of over six months, and 
38.7% over one year. The duration of DS consumption may impact its effectiveness, as 
previously noted, where women reported mood improvements only one year after 
supplementation was initiated.272 However, research is scant on the duration of DS use 
and stress among women, and controlling for duration of use in this study was not 
possible. 
DS purchasing behaviour 
The primary place of DS purchase was health stores (36%), and around a quarter of 
supplements were purchased in a supermarket. There is no evidence with which to 






Appendix CC: Example of recruitment email sent to all cross-





























































































































Appendix EE: Example of consent form 
 
The University of Adelaide 
Human Research Ethics Committee (HREC) 
CONSENT FORM 
1. I have read the attached Information Sheet and agree to take part in the following research project: 
 
Title: 
The experience of the dietary and supplementary intake of essential 
fatty acids (EFAs,) B vitamins, vitamin C, magnesium and zinc to 




2. I have had the project, so far as it affects me, fully explained to my satisfaction by the research 
worker. My consent is given freely. 
3. I have been given the opportunity to have a member of my family or a friend present while the 
project was explained to me. 
4. Although I understand that the purpose of this research project is to improve the quality of medical 
care, it has also been explained that my involvement may not be of any benefit to me. 
5. I have been informed that, while information gained during the study may be published, I will not be 
identified and my personal results will not be divulged. 
6. I understand that I am free to withdraw from the project at any time and that this will not affect 
medical advice in the management of my health, now or in the future. 
7. I agree to the sessions being audio recorded. Yes        No  
8. I am aware that I should keep a copy of this Consent Form, when completed, and the attached 
Information Sheet. 
Participant to complete: 
Name:  Signature:  
Date:   
Researcher/Witness to complete: 
I have described the nature of the research to  
 (print name of participant) 
and in my opinion she/he understood the explanation. 
Signature:  Position:  












Appendix GG: Phase Five Data Analysis code, categorisation and 














Appendix II: Meaningful Word Frequencies 
 




Stressful including stress, stressed and stresses 475 1.9 
Relationships including people, family, others, children, daughter, husband, friends, 
marriage, partner, parents, sharing, childhood, mother and driving 
358 1.4 
Thoughts, including thinking, introspecting and reflection 271 1.1 
Supplements including alternatives, vitamins, magnesium, nutrients and conflicting 
information and scepticism  
217 0.9 
Anxiety including anxious and worried 112 0.4 
Health, including eating, exercise, healthy and cooking 109 0.4 
Actions including meditation, relaxation and therapy 89 0.4 
Pharmaceuticals including medication, prescribing and anti-depressants 76 0.3 
Empathy including empathizing and suggestions 69 0.3 
Beliefs and believing 67 0.3 
Depression, exhaustion and fatigue 49 0.2 
Expectations and expected 34 0.1 
Habitual and habits 25 0.1 
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